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Abstract 
Quantitative proteomics aims at not just identifying, but accurately quantifying the 
cellular proteome, and while technological advances towards accurate and reliable 
quantification of proteins is advancing, this alone does not provide an accurate 
picture of a proteins role within a cell. There is a far greater level of functionality in 
the cellular environment than there are protein coding genes in the genome, owing 
partly to the organisation of individual proteins into larger assemblies. A single 
protein can form interactions with, potentially, a large number of other proteins, 
leading to a variety of different protein complexes, and subunits can move, break 
apart or combine depending on cellular conditions. This complex organisation is 
despite the normal proteomics strategies employing a destructive process, breaking 
protein structure down to the peptide level. Further difficulties in mapping the 
cellular proteome arise from the differential expression level of proteins, which in 
S.cerevisiae can span up to 5 orders of magnitude. This poses problems for the 
quantification of less abundant proteins in the cell, which can be masked by the 
more concentrated proteins. An attempt is made within this thesis to use 
quantitative proteomic techniques to build a picture of the S.cerevisiae cellular 
proteome. 
For the analysis of S.cerevisiae protein complexes ion exchange chromatography 
has been used to separate the cellular proteome into discrete fractions, each 
containing a different array of protein complexes. The aim here was to analyse the 
individual subunits of these complexes by LC-MS, with the use of label free 
quantification strategies. This enables the high throughput identification and 
quantification of 1800 proteins along with their potential interaction partners. 
However, for some of the complexes presented here the accuracy of the label free 
quantification is called into question, as complex subunits known to be equimolar 
are identified at different concentrations. In order to assess the accuracy of the 
label free data QconCATs were also designed to analyse the subunits of some 
complexes by label mediated quantification. 
In addition, an attempt is made to access proteins from the entire dynamic range of 
the cellular proteome using equaliser bead technology. This method uses a library 
of hexapeptide ligands bound to porous beads to bind, theoretically, every protein 
present in the sample to equal amounts. The beads are used here to bring up the 
less abundant proteins in the sample, while simultaneously reducing the amount of 
the abundant proteins. While this goal is achieved, it is also evident that certain 
proteins are able to bind the beads to a much larger extent than others, so rather 
than reducing the dynamic range of proteins identified, there is more of a shift in 
the dynamics, with previously mid-range proteins becoming highly abundant in the 
data presented here. 
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1. Introduction     
1.1 Proteomics  
The term proteomics was coined almost 20 years ago to describe the study of the 
global profile of protein expression (Wilkins et al., 1996). Proteins are biological 
molecules that are responsible for most of a cells functionality, and the proteome 
of an organism is defined as all of the proteins expressed by the genome. The cell is 
a complex environment consisting of a wide dynamic range of proteins which are 
expressed and degraded differentially depending on time and cellular conditions. 
The field of proteomics encompasses the complete study of proteins, which can 
include the function, sequence, identification, localization and quantification of all 
of a given proteome.  
The complex nature of the proteome derives from a number of layers of 
organisation in the cellular environment. The genome encodes all of the potential 
proteins in a given organism, but there are far more functional proteins in a cell 
than there are protein coding genes in the genome (Fields, 2001). This is due to a 
number of cellular processes which mean that a single gene does not simply encode 
a single protein, a process that is controlled at three levels, the transcription of 
genes into mRNA, the translation of these mRNA transcripts into proteins, and in 
post translational modification. At the transcriptional level, frameshifting can cause 
a change in the set of triplet codons that are transcribed (Belew et al., 2011; Advani 
et al., 2013). At the translational level alternative splicing can lead to the creation of 
more than one protein from an mRNA transcript of one gene (Juneau et al., 2009; 
Rossler & Marschalek, 2013). In addition, hundreds of types of post translational 
modifications (PTMs), such as ubiquitination, glycosylation, acetylation or 
phosphorylation, have been documented, and these can alter the structure and 
consequently control the function of a diverse range of proteins (reviewed in Emre 
& Berger, 2006; Molina et al., 2010; Oliveira & Sauer, 2012). The combination of 
these effects means that in some biological samples there is a large array of 
proteins to study. It has been estimated that in some systems the number of 
proteins can be up to an order of magnitude greater than the available genes 
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(Fields, 2001). The concept of protein species was introduced to refer to a final, 
functional protein following all levels of modification, describing an individual 
protein from a family of proteins encoded by one gene (Jungblut et al., 1996; 
Jungblut et al., 2008). 
The diverse nature of the proteome creates a number of challenges in the analysis 
of such a diverse array of proteins, but in the post-genomic era the direct study of 
protein function is becoming increasingly important, and has wide ranging 
applications in enhancing the understanding of cellular processes behind disease, in 
diagnostics, screening and monitoring, or in the discovery of new drug targets. 
Proteomic techniques have proved instrumental in the study of protein function 
and cellular organisation, and led to the discovery of novel biomarkers of diseases 
such as cancer (Goncalves et al., 2008), heart disease (Fu & Van Eyk, 2006), or even 
some psychiatric disorders (Taurines et al., 2010).  
1.2 Saccharomyces cerevisiae as a model organism  
Saccharomyces cerevisiae is a species of budding yeast that has been extensively 
studied as a model organism for a number of years (Botstein et al., 1997; Botstein & 
Fink, 2011; Castrillo & Oliver, 2011). The usefulness of yeast in systems biology 
stems from a number of factors, it is a relatively simple unicellular organism, is 
quick and easy to grow, and as a eukaryotic organism the mechanism of cell 
growth, gene expression, translation, metabolism and signal transduction are all 
under a similar level of control to higher eukaryotes, which means yeast has many 
homologous genes to mammalian cells, which has proved instrumental in the study 
of a number of human diseases (reviewed in (Botstein et al., 1997; Smith & Snyder, 
2006).  
The completion of the S. cerevisiae genome project in 1996 made it the first 
eukaryotic organism to have its whole genome sequenced (Goffeau et al., 1996). 
Knowledge of the gene sequence creates a picture of the potential protein 
complement of the organism, however due to the level of complexity in the 
proteome, the gene sequence alone does not provide adequate information on the 
function of each gene product. The next level of analysis, therefore, in the field of 
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transcriptomics aims to analyse the gene transcription occurring within a cell, by 
identifying the mRNA transcripts present. However, the amount of mRNA present 
in a cell does not necessarily directly correlate with the amount of protein being 
made (Gygi et al., 1999b), due to a combination of effects, including the rapid 
turnover of cellular mRNA (Halbeisen & Gerber, 2009), and the potential for a single 
transcript to encode multiple proteins. 
The existence of a complete catalogue of genes for an organism has led numerous 
researchers to the investigation of the function of the products of these genes. 
Therefore, studying the vast array of cellular proteins becomes necessary. Studying 
the protein product as opposed to the gene provides direct information on the 
cellular function of the protein, and the integration of genomic, transcriptomic and 
proteomic strategies can provide a complete picture of a proteins life cycle within a 
cell. A number of large scale studies have identified S. cerevisiae gene products, and 
it is now possible to gain wide coverage of the yeast proteome in some experiments 
(Ghaemmaghami et al., 2003; Huh et al., 2003; Nagaraj et al., 2012; Hebert et al., 
2014). The wide range of genomics, transcriptomics and proteomics studies 
performed to date have been amalgamated into databases such as the 
Saccharomyces Genome Database (SGD, www.yeastgenome.org) detailing the 
functional role of every gene which has been analysed.  Currently, the SGD lists 
5070 protein encoding genes as experimentally confirmed and 750 as 
uncharacterised, and it is possible to identify the majority of these, with some 
experiments reaching over 4000 proteins (de Godoy et al., 2008; Webb et al., 2013; 
Hebert et al., 2014) .  
1.3 Challenges in the field of proteomics 
The design of a proteomics study faces numerous analytical difficulties due to the 
complexity of the proteome. One of the major analytical problems faced in the 
application of proteomics experiments is in the sheer volume of information 
available in any cellular environment, derived in part from the diversity and 
dynamics of gene expression. The rate and extent of transcription is altered by a 
cell depending on cell type, environmental factors, or age. Differential expression at 
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various stages of the cell cycle or a change of environmental conditions is induced 
by cell signalling events that can lead to rapid changes in protein content. Add this 
effect to the idea that any one gene can actually encode a number of different 
functional proteins, and PTMs can result in a set of very similar proteins, and there 
is potentially a vast number of proteins to analyse in a proteomics discovery 
experiment. 
In addition to the potentially large numbers of diverse proteins, the cellular 
environment contains a further level of complexity in that it can also contain a wide 
dynamic range of proteins. The range of protein functions means that, in every 
biological system, there are some proteins which are necessary in much higher copy 
numbers than others. Even in a relatively simple organism such as S. cerevisiae this 
difference can span up to five orders of magnitude, and some samples such as 
plasma show an extreme asymmetry, with up to 10 orders of magnitude difference 
(Hortin & Sviridov, 2010). When studying the entire protein complement of a 
sample, it can therefore prove difficult to analyse less abundant proteins when the 
biological sample is dominated by a small number of highly abundant proteins 
(Anderson & Anderson, 2002; Ghaemmaghami et al., 2003). In such circumstances, 
traditional proteomics techniques such as electrophoresis or mass spectrometry are 
insufficient as it is difficult to load enough sample to visualise low abundance 
proteins without overloading the high abundance species. 
As quantitative proteomics techniques advance, there are increasingly large data 
sets detailing the precise amount of individual proteins in a sample (Hebert et al., 
2014). These data sets provide a large amount of valuable information on the 
identity, sequence and localization of individual proteins. However, in the cellular 
environment it is rare to find a protein existing as a discrete entity, and many 
proteins carry out their function as part of a complex. In order to understand the 
role of a protein within the cellular environment, it is therefore necessary to also 
study the interactions that the protein exhibits. It has been estimated that more 
than a third of proteins exist at some stage as part of a complex, and in S. cerevisiae 
over 400 different complexes have been identified so far (Gavin et al., 2006), (Liu et 
al., 2008). Multisubunit complexes are responsible for much of a cells functionality 
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(Alberts, 1998), such as RNA polymerase for the transcription of the genome, the 
exosome for RNA degradation or the proteasome for the removal of unnecessary 
protein. They range in size from one or two interacting proteins, such as 
phosphofructokinase with two subunits (figure 1.1 a, (Banaszak et al., 2011), to 
large assemblies consisting of a numerous proteins, such as the ribosome, with 
more than 70 (figure 1.1 b, (Armache et al., 2010), and they can also be dynamic, 
changing composition to suit cellular conditions. By building up an organisational 
map of the protein machinery of a cell, it will be possible to understand the 
interactions occurring, and perhaps build a complete picture of the role of each 
protein within a cell. For this reason the study of protein interactions has become 
increasingly widespread (Gavin et al., 2002; Ho et al., 2002; Krogan et al., 2006) as 
the field of proteomics has developed, as technological advances allow the study of 
increasing amounts of protein in one analysis.  
The function of a protein can be elucidated by knowledge of its interactions, and if 
a cellular proteome is to be fully understood, the role of each protein within the cell 
should be studied in terms of interactions and membership of protein complexes. 
These interactions can form a complex network, and studying them has led to the 
discovery that some proteins perform multiple functions in the cell, such as ARG82, 
which acts as an inositol polyphosphate kinase as well as controlling expression of 
arginine responsive genes (El Alami et al., 2003), or enolase, an abundant glycolytic 
enzyme that was also discovered to stimulate vacuole fusion (Decker & Wickner, 
2006).  Individual proteins therefore have the potential for hundreds of 
interactions, such as the so called hub proteins (Gao et al., 2010). These proteins 
play a key role in cellular organisation and may have up to 100 different 
interactions in a cell.  For some proteins, the potential for multiple interactions 
translates into being found as part of a number of complexes, and one such 
example is lipoamide dehydrogenase, which is part of the pyruvate dehydrogenase 
(Kresze & Ronft, 1981), glycine decarboxylase (Sinclair & Dawes, 1995) and alpha-
ketoglutarate dehydrogenase complexes (Repetto & Tzagoloff, 1991). 
Protein interactions can also be classified as stable or transient. Stable interactions 
cause protein subunits to remain as part of a complex. Other proteins interact in a  
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Figure 1.1 Structure of the eukaryotic phosphofructokinase and 80S ribosome 
complexes 
Protein complexes are visualised using Pymol software. Sequences are obtained 
from PDB, a) phosphofructokinase structure obtained from Banaszak et al. 
2011, b) 80S ribosome crystal structure obtain from Armache et al. 2010.  
 
Eukaryotic 80S ribosome
Eukaryotic phosphofructokinase
a) 
b) 
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more transient fashion, such as those involved in cell signalling pathways, or 
chaperones that assist in protein folding. The study of these transient protein 
interactions has an added complication, in that they can have high on/off rates, 
therefore associating and dissociating rapidly depending on conditions, in particular 
signalling proteins, which alter binding rapidly to suit environmental cues. This gives 
rise to a diverse and dynamic network of interacting proteins, and protein 
complexes that can move, combine or break apart, to suit the role, age or 
environment of the cell in question. 
1.4 Mass spectrometry in proteomics 
A diverse range of techniques are used within the field of proteomics in the study of 
proteins. 2D electrophoresis was developed in 1975 to separate complex 
proteomes (O'Farrell, 1975) and is still used, in conjunction with protein mass 
fingerprinting (PMF) to identify proteins (Gelis et al., 2012). Western blots can be 
used to detect proteins, first separating by SDS-PAGE and later transferring the 
proteins to a membrane where they are bound to an antibody (Renart et al., 1979; 
Towbin et al., 1979). The technique is used to identify and quantitatively measure 
proteins, and has even been used in the determination of yeast protein half-lives 
(Belle et al., 2006). More recently, mass spectrometry has become a more 
commonly used method for protein identification, and the technology involved is 
developing rapidly, with new, improved mass spectrometers being developed 
(Mann, 2008, Han et al., 2008), and the implementation of new techniques such as 
label free quantification by MSE, or PRMs in recent years (Law & Lim, 2013).  
A mass spectrometer separates and identifies ions according to their mass to 
charge ratio (m/z). The instrument consists of three parts, an ionizer to generate 
gas phase ions, a mass analyzer to separate the ions in time or space, and a 
detector to measure the amount of each ion present. The design of two types of 
‘soft’ ionization techniques, matrix-assisted laser desorption/ionisation (MALDI) 
(Karas & Hillenkamp, 1988) and electrospray ionization (ESI) (Fenn et al., 1989), 
which are capable of ionizing peptides without fragmenting them allowed mass 
spectrometry to be used in the study of proteins. The invention of these techniques 
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has allowed the development of mass spectrometry for the identification, 
localisation, sequencing and quantification of proteins. 
In proteomics, MALDI can be used for the analysis of relatively simple protein 
mixtures. In this technique the sample is crystallized with a matrix solution, and 
then a laser is directed towards the sample/matrix mixture, and the sample is 
ionized. In this technique, the sample molecules are ionized by the addition of a 
proton, creating positively charged species, which are often then separated by a 
time-of-flight (TOF) mass analyser. TOF analysers were first used in 1954 (Wolff & 
Stephens, 2004) but were only available for use in proteomics after the advent of 
soft ionisation techniques. A TOF consists of a flight tube, which charged ions are 
drawn into using an electric field. Ions are then analysed based on the time taken to 
reach the detector at the end of the flight tube. Mass to charge ratio (m/z) is 
calculated based on the time taken for the ions to reach the detector, at the far end 
of the flight tube (Watson, 2008). MALDI-TOF is applied generally in peptide mass 
fingerprinting (PMF) methods, where the peptide m/z identified are searched 
against a database of peptides to identify the protein (Henzel et al., 1993; James et 
al., 1993; Pappin et al., 1993). This type of analysis can only be used, therefore, on 
simple mixtures, for example the identification of a protein band excised from SDS-
PAGE, or a purified protein sample. The technique also has applications in imaging, 
in discovering the spatial arrangement of proteins and peptides (Caprioli et al., 
1997). 
For the identification of proteins in more complex samples, it is more common to 
use ESI as the ionization technique, in which the liquid analyte is passed through a 
fine tip while an electrical current is applied, leading to the generation of gas phase, 
charged molecules (Loo et al., 1989). One advantage of this type of ionization is that 
it can be preceded by a liquid chromatography (LC) step. Liquid chromatography 
mass spectrometry (LC-MS) can be coupled to provide separation of the peptides in 
a complex mixture, allowing for the identification of more ions. ESI is also 
commonly coupled to TOF, as well as ion trap, Fourier-Transform Ion Cyclotron 
Resonance (FT-ICR) and Quadrupole mass analysers. In an ion trap, the charged 
molecules are first trapped for a time in an electric field before release to the 
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detectors. In this type of mass analyser, different electric fields are applied to the 
trap to cause the retention, and therefore separation, of ions of a different m/z. FT-
ICR is based on a similar principle, of trapping ions, but in this case under high 
vacuum and using a magnetic field (Marshall et al., 1998).  
Another common mass analyzer is the quadrupole, which was invented at the same 
time as ion trap mass analyzers in 1953 (Paul & Steinwedel, 1953). A quadrupole 
consists of four parallel rods, with a varying RF and a constant DC voltage applied. 
Depending on the voltages applied, only ions of a certain m/z will hold a stable 
trajectory through the quadrupole, and therefore altering the voltage applied 
provides a filter, and applying a range of voltages provides separation of ions, by 
allowing only certain ions through at any time. 
Tandem mass spectrometry is a way of increasing the separation of ions by joining 
two or more mass analyzer steps, which can be tandem in time or tandem in space. 
In tandem in space mass spectrometry a number of mass analysers, of the same or 
different types can also be joined in sequence, to provide increased separation of 
ions, and higher resolution. In tandem in time mass spectrometry, multiple 
separations are performed in sequence by the same mass analyser.  In addition to 
separation of gas phase ions, tandem mass spectrometry allows an increased level 
of analysis, in that fragmentation of ions can be performed, meaning that peptides 
can be matched to a protein based on sequence as well as peptide mass. Common 
tandem mass spectrometer examples include the quadrupole time of flight (Q-TOF) 
and triple quadrupole systems (TQ). Q-TOFs provide enhanced resolution (Morris et 
al., 1996) while TQs provide the ability to isolate peptides, fragment them and then 
isolate particular fragments, providing extra selectivity (Yost & Enke, 2008). 
LC-MS and LC-MS/MS can be applied to many areas of proteomics experiments for 
protein identification, sequence determination, protein interaction identification, 
function determination and quantification. Large numbers of proteins can be 
identified simultaneously from complex protein mixtures by the use of shotgun 
proteomics methods. In this technique a protein sample, which can contain a 
complex mixture of proteins, is first subjected to enzymatic digestion to break down 
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the proteins into peptides. The complex mix of peptides is then separated by liquid 
chromatography (LC) and analysed in a data dependent acquisition mode using 
tandem MS, where the most abundant peptides in MS mode are isolated for 
fragmentation in MS/MS. The instrument cycles between MS mode, where the 
precursor ions are scanned, and MS/MS mode to gather product ion spectra, either 
for a set amount of precursor ions defined by the user, or for those that go above a 
set threshold. The fragments identified by MS/MS are used to identify the amino 
acid sequence of the peptides, and the peptides identified are then matched to 
those of known proteins in a database to identify the proteins in the sample. The 
analysis is performed by a database search engine such as MASCOT 
(www.matrixscience.com) (Perkins et al., 1999) or SEQUEST 
(www.fields.scripps.edu/sequest/)(Eng et al., 2014). Continuing advances in 
instrumentation and shotgun proteomics methods have allowed the identification 
of thousands of proteins in a single run (Olsen et al., 2009; Michalski et al., 2011; 
Hebert et al., 2014).  
A further level of analysis was provided by the development of these proteomic 
techniques into quantitative methods. Quantitative proteomics aims at not just the 
identification, but the quantification of the protein complement of a given 
biological system. It can be subdivided into relative quantification, for the 
comparison of the proteome under two or more varying conditions, or absolute 
quantification, the accurate count of the specific amount of a protein present in a 
certain sample. The field of quantitative proteomics is evolving rapidly, and in 
recent years has moved from a focus on 2D gel analysis and western blots, to mass 
spectrometry (MS) based experimental workflows. It is now possible to quantify 
thousands of proteins in a single run, and as instrumentation and software advance, 
the information gained from each MS run can increase. 
Both relative and absolute quantification can be achieved in a number of ways, 
either with an isotopic label (label mediated quantification) or without a label 
(label-free quantification). Label mediated quantification arose from the design of 
isotope dilution strategies, in which a standard peptide sequence identical to an 
analyte is isotopically tagged (Barr et al., 1996). The standard peptide is then mixed 
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with unlabelled sample, and the ratio of labelled to unlabelled peptide used to 
calculate the amount of protein, either relatively or in absolute values. In label free 
quantification the analyte proteins are simply analysed via MS/MS without prior 
labelling, and statistical analysis is used to infer protein concentration from the 
peptides present. There are both advantages and drawbacks to each quantification 
method which must be considered in designing an experimental workflow. 
1.5 Quantitative proteomics 
1.5.1  Label mediated relative quantification 
A wide variety of methods have been developed to compare samples by differential 
labelling, where relative quantification is achieved by stable isotope labelling of 
standard peptides or proteins which are pooled with differentially labelled, or 
unlabelled analyte peptides or proteins prior to MS analysis. The counterpart 
proteins are isotopically different, but chemically the same, and therefore behave 
the same experimentally, and co-elute from a chromatography system. MS is then 
used to compare the peak intensities of heavy isotope labelled and light 
(unlabelled) peptides. 
A common early method was isotope coded affinity tagging (termed ICAT). In this 
approach, cysteine residues in the sample are labelled using ICAT reagent, which 
consists of a compound with the ability to specifically bind sulfhydryl groups linked 
to a compound containing a stable isotope, and an affinity tag (Gygi et al., 1999a). 
Heavy and light isotope ICAT reagents are used to label two samples for 
comparison, which are then purified by affinity chromatography and analysed using 
MS. The mass difference between the isotopes is used to calculate the relative 
abundance of the analyte (Kito & Ito, 2008).  
A method of tagging amino acid N terminal and side chain amino groups has also 
been developed, termed isobaric tags for relative and absolute quantification 
(iTRAQ). iTRAQ reagents consist of an amino reactive group coupled to a charged 
reporter group, and a neutral balance group which maintains a mass of 145 daltons 
for each reagent. Each has the same mass, but gives rise to a different reporter ion 
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when analysed by MS/MS. There are 8 types of iTRAQ reagent available, to quantify 
up to eight different samples in one run (Boehm et al., 2007).  
Another approach to labelling is the incorporation of heavy isotopes into the 
cellular proteome during cell culture. This method is termed SILAC, for stable 
isotope labelling by amino acids in cell culture. Cells of interest are grown in 
medium containing stable isotope labelled amino acids, and pooled with unlabelled 
cells prior to analysis (Geiger et al., 2011). Unlike the other techniques, this allows 
labelling of all proteins in a sample, and permits the evaluation of larger data sets.  
All of these isotopic labelling strategies use differential labelling of two or more 
sample types, and the ratio of the intensities of the labelled and unlabelled analyte 
is used to calculate the relative amount of the target proteins. These approaches 
have an advantage over label free approaches in that the quantification information 
can be obtained by combining differentially labelled analytes and performing the 
MS in a single run, therefore eliminating any liquid chromatography (LC) or MS 
variability between runs. A further advantage to these techniques is that the two 
labelled peptides are chemically identical, and there should be no variation in 
ionisation efficiency during MS. The drawback to using these relative quantification 
methods is that the labelling procedure adds time, expense and complexity to the 
experimental workflow, thereby increasing the potential for error. Also, the analysis 
is limited solely to only those analyte proteins that have been labelled, so in 
techniques such as ICAT and iTRAQ labelling, the scope of the experiment is limited. 
1.5.2 Label mediated absolute quantification 
Absolute quantification techniques using stable isotope dilution strategies (Barr et 
al., 1996; Stöcklin et al., 1997) involve the use of an isotope labelled protein 
standard, such as AQUA peptides or QconCAT to label at the peptide level, or PSAQ 
to label at the whole protein level, prior to proteolysis to derive the peptides. These 
isotopically labelled peptides or proteins are mixed with the analyte, before or after 
proteolytic digestion, where they will perform the same in chromatographic 
separations due to being chemically identical, but will be differentiated by MS due 
to the difference in mass. Absolute quantification using these methods has the 
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advantage of being able to compare proteins from a number of different 
experiments, as opposed to relative quantification, which is limited to just those 
proteins compared in a single experiment.  
AQUA peptides are synthesised with incorporated stable isotopes, with the same 
sequence as an analyte peptide (Gerber et al., 2003). They are made individually 
and therefore at high cost. For the use of AQUA peptides it is vital to achieve 
complete proteolysis, as the standard is spiked in after the digest and therefore 
analyte peptides must be completely proteolysed to be identical to the standard 
peptide and allow accurate quantification. 
A QconCAT is an artificial peptide construct, which consists of a number of short 
peptide sequences termed Qpeptides, derived from a number of analyte proteins 
(Beynon et al., 2005; Pratt et al., 2006). The peptide gene sequences are assembled 
into a recombinant protein sequence, which is then heavy isotope labelled during 
culture. The QconCAT protein is then enzymatically digested, to yield an equimolar 
mixture of standard peptides. Because every QconCAT can quantify multiple 
proteins, it is more cost effective for large scale analysis, purchasing one plasmid 
rather than a number of individual peptides. The QconCAT is quantified and mixed 
with the analyte sample prior to digestion, and the mixture is then analysed by MS. 
The ratio between analyte and QconCAT can then be used to quantify 
corresponding analyte peptides (Pratt et al., 2006). Running a number of standard 
and analyte peptides at the same time reduces the potential for error between 
runs, which is useful if a set of related proteins are to be analysed, however to 
enable large studies comparing many proteins a number of QconCAT constructs 
may be necessary. In this case reliable comparison between different MS runs will 
be possible only where QconCAT proteins are accurately quantified. The design of a 
QconCAT must also be carefully considered, as certain peptides are unsuitable for 
use as Qpeptides, for example poorly ionising peptides, or those containing PTM 
sites, and some small proteins may not contain any suitable Qpeptides, although in 
some cases it may be improved with the use of an alternative enzyme for 
proteolysis (Al-Majdoub et al., 2014).  
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PSAQ standards are an alternative strategy which may be more appropriate for 
some proteins, as these are full length labelled proteins, which will therefore have 
the same properties as the analyte protein throughout the experimental process 
(Dupuis et al., 2008). PSAQ standards are mixed with analyte prior to any 
processing, and can therefore also be included for any purification or 
prefractionation steps in the analysis, and also downstream proteolysis steps, 
resulting in increased accuracy (Kaiser et al., 2011). Peptides derived would 
therefore behave in a similar fashion during chromatography and ionisation in MS, 
providing an analytical advantage, despite the high cost of generating an entire 
labelled protein. 
1.5.3 Label free relative quantification 
There are two main approaches to label free relative quantification, which take 
advantage of either peak intensities or spectral counting to quantify proteins using 
MS. Label free quantification by peak intensities exploits the correlation between 
peptide concentration and MS signal. In this method the chromatographic peak 
areas of the peptides ions are used to calculate the amount of each protein (Old et 
al., 2005; Silva et al., 2006). This technique takes advantage of the fact that the 
intensity of the ions are representative of the peptide concentration (Silva et al., 
2006). As runs are performed separately, computer programs are necessary for the 
normalisation of data to account for any variability in chromatography between 
runs, and software such as Progenesis LC-MS (Nonlinear Dynamics) is available for 
aligning runs and calculating relative protein quantification of protein in two 
samples using peak intensities (Gonzalez-Galarza et al., 2012). Label free relative 
quantification using peak intensities has been performed using a variety of sample 
types (Huang et al., 2007; Fatima et al., 2009). This approach is advantageous in the 
limited workflow in comparison to label mediated strategies. However, as the 
peptide intensities for each protein are used in the calculation, it is imperative to 
have excellent sample preparation, in order to achieve complete proteolytic 
cleavage of each sample, as any miscleaves in the sample will affect the amount of 
peptide present and cause inaccurate quantification. In addition, for small proteins 
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it may be difficult to produce a sufficient number of peptides, which may affect the 
accuracy of quantification.  
The alternative label free approach, protein quantification by spectral counting, 
quantifies analyte protein according to the number of MS/MS spectra 
identifications of fragments generated from the parent protein. This is based on the 
concept that spectral count (the number of MS/MS spectra obtained) is directly 
influenced by the amount of protein (Liu et al., 2004), therefore comparing the 
number of MS/MS spectra for two samples can provide relative quantification. The 
number of spectral counts can differ depending on the size of the parent protein, 
although a procedure has been recommended for normalising spectral counts to 
the protein length (Florens et al., 2006). It has been suggested that relative 
quantification is less accurate than label-free quantification by peak intensities, 
although it has still been successfully applied in the study of a range of protein 
samples (Old et al., 2005; Florens et al., 2006). 
1.5.4 Label free absolute quantification  
Label free quantification using peak intensities can also be used in the absolute 
quantification of an analyte. This can be achieved by the addition of a known 
quantity of a specific protein to each sample for use as an internal calibrant by the 
MS analysis software. This is achieved by comparing the peak intensities of a given 
amount of calibrant to those of analyte proteins to give an accurate count, in 
moles, of each protein identified. The quantification can be calculated using a top 3 
protocol, where the top three highest intensity peptides are summed for each 
protein, which is the method used by ProteinLynx Global Server (PLGS) software 
(Silva et al., 2006).  Or alternatively, quantification can be achieved using all of the 
peptides. Software such as MaxQuant can calculate the intensity using iBAQ 
(intensity based absolute quantification), which uses the sum of all the intensity 
values divided by the theoretically observable peptides (Schwanhausser et al., 
2011), and can use some or all of the peptides identified. 
Absolute quantification can also be achieved by spectral counting software, such as 
emPAI or APEX. The quantification can be achieved using protein abundance index 
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(PAI), which is calculated from the number of identified peptides divided by the 
number of theoretic tryptic peptides for each protein (Rappsilber et al., 2002), or 
using exponentially modified PAI (emPAI values), which show a linear relationship 
to protein concentration (Ishihama et al., 2005).  Another method successfully used 
in absolute quantification is termed absolute protein expression profiling (APEX). 
This measures the absolute amount of protein from the relationship between 
protein abundance and the number of peptides observed (Lu et al., 2007). Various 
label free software approaches are reviewed in (Gonzalez-Galarza et al., 2012). 
All label free methods are based on the idea that peptide intensities are 
representative of the total amount of protein. It has, however, been observed that 
the intensity observed can differ as a result of the physiochemical properties of the 
peptides (Mallick et al., 2007; Sanders et al., 2007). The nature of a shotgun 
proteomics approach, in loading all of the peptides in a sample for simultaneous 
analysis, and therefore displaying a wide range in size and amino acid composition, 
may mean some peptide exhibit less propensity for ionisation than the standard 
protein peptides, giving an inaccurately low quantification (Craig et al., 2005; Kuster 
et al., 2005). This discrepancy in signal would therefore be reflected in an 
inaccurate quantification, which may lead to a disadvantage for label free methods 
in that they may therefore be less accurate than label mediated quantification.  
On the other hand, the advantage posed by label free quantification is in the 
simplification of experimental workflows, in the elimination of sample preparation 
steps necessary in labelling. Provided the sample preparation and software 
calculation is good absolute label free techniques provide the added advantage that 
information from any number of experiments can be compared, whereas relative 
quantification is limited only to those samples that have been assessed in a single 
experiment.   
1.6 Quantitative proteomics in the analysis of S. cerevisiae proteome organisation 
While the technological advances in mass spectrometry towards accurate and 
reliable quantification of proteins provide vast amounts of information, simply 
understanding the identity and quantity of proteins in a cellular environment does 
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not provide an accurate picture of its role within a cell. There is a far greater level of 
functionality in the cellular environment than there are protein coding genes in the 
genome, due in part to protein-protein interactions and their subsequent 
organisation into protein complexes. Despite the complex nature of protein 
interactions, by building up an organisation map of the protein machinery of a cell, 
it will be possible to understand the interactions occurring, and perhaps build a 
complete picture of the role of each protein within a cell, and monitor interactions 
over time or in changing environments. It is contradictory then, that many 
traditional proteomics techniques are destructive, breaking down the cellular 
proteome into constituent proteins, and then in widely used shotgun experiments, 
digesting the proteins into peptides prior to MS analysis. 
Advances are being made in the study of proteome organisation using a range of 
proteomic techniques. A range of methods have been developed to study the 
interactions within a cell, as are detailed in various review papers (Collins & 
Choudhary, 2008; Rajagopala et al., 2012; Ngounou Wetie et al., 2013; Ngounou 
Wetie et al., 2014). These include yeast two hybrid (Y2H) systems, co-
immunoprecipitation, tandem affinity purification (TAP tag) studies, blue native 
PAGE (BN PAGE) and size exclusion chromatography (SEC) coupled to MS.  
An early technique used for the analysis of multiple binding partners is blue native 
PAGE (BN-PAGE). In this type of electrophoresis, denaturants are not used, and 
therefore protein complexes should remain associated, as samples are separated in 
one dimension, using native electrophoresis, and then in a second dimension, using 
SDS-PAGE, where the protein complex subunits should separate (Schagger & von 
Jagow, 1991). However, Coomassie Brilliant Blue dye is used to charge the protein 
complexes for the native electrophoretic separation, and this may disrupt the 
protein interactions. The technique has been used to separate complexes from 
yeast mitochondria, but is generally a low throughput technique (Grandier-Vazeille 
& Guerin, 1996), and is not suitable for all protein complexes. 
Yeast two hybrid (Y2H) systems have been used extensively in the study of protein-
protein interactions. They provide an assay for the potential for two proteins to 
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interact, the ‘bait’ and the ‘prey’ proteins. As only two proteins are assessed, in 
order to provide information on larger protein assemblies a number of experiments 
must be performed. The ‘bait’ protein is fused to the DNA binding domain of a 
yeast reporter protein. The ‘prey’ protein is fused to the transactivation domain of 
the reporter protein, and interaction between the two proteins is then assessed by 
the presence of the reporter (Fields & Song, 1989). GAL4 is commonly used as the 
reporter gene. This technique has been used in large scale studies examining almost 
6,000 yeast proteins to identify thousands of interactions (Uetz et al., 2000; Ito et 
al., 2001; Parrish et al., 2006). Ito et al (2001) reported the finding of over 4,000 
interactions in their large scale study. Data from these experiments is used to 
visualise the protein interaction network (figure 1.2, (Jeong et al., 2001), 
highlighting the complexity of the proteome. However, the reliability of Y2H data 
has been questioned, as the method produces a high false positive rate, estimated 
to be as much as 50% (Sprinzak et al., 2003). 
TAP tag purification is also a common method used in protein complex analysis. In 
this technique a protein is fused to an affinity tag, which is used to isolate the 
protein using affinity chromatography, under sufficiently gentle conditions in which 
any interacting proteins remain in complex (Rigaut et al., 1999). Though the 
technique is low throughput, and a new affinity fusion protein must be designed for 
the discovery of each interaction, the system has an advantage over Y2H in that 
more than one interaction partner can be studied at a time. The method has been 
implemented successfully in a number of large scale studies to yield lists of protein 
interactions numbering over 4000 (Gavin et al., 2002; Krogan et al., 2006; Collins et 
al., 2007). It has also been found to give fewer false positive results than other 
methods (von Mering et al., 2002) and isolation of protein complexes can be 
followed by quantitative mass spectrometry to yield protein complex stoichiometry 
information (Guerrero et al., 2006). However, analysing a number of different 
complexes via this method is challenging, in needing the design of individual fusion 
proteins. In addition, the presence of the tag may interfere with protein binding 
and if the interaction is weak there is a possibility the complex will dissociate during 
chromatography. 
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Figure 1.2 Protein-protein interaction map of S. cerevisiae  
The interaction map is generated from early Y2H experiments. The colour of the 
node for each protein represents the phenotpic effect of removing that gene, 
red are lethal, green non-lethal, and yellow unkown Taken from Jeong, H., S. P. 
Mason, A. L. Barabasi and Z. N. Oltvai (2001). "Lethality and centrality in protein 
networks." Nature 411(6833): 41-42.  
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In co-immunoprecipitation (Co-IP) techniques a protein complex is precipitated out 
of a cell lysate using an immobilised antibody that specifically binds one of the 
protein subunits. The method has been applied to yeast, and from using 10% of 
predicted yeast proteins as bait, 3,617 interactions were observed (Ho et al., 2002). 
An advantage of this technique is that it is possible to precipitate proteins 
associated with the antigen (Kaboord & Perr, 2008), and in some cases cross-linkers 
can be included to stabilize weaker interactions. Associated proteins can be 
identified using mass spectrometry or electrophoresis. However, only specific 
proteins can be targeted, meaning the technique is only useful in the analysis of 
known, targeted complexes, and not in screening for complexes.  
Protein microarrays are another technique developed to study protein interactions, 
by loading proteins onto a slide, onto which the protein probes are loaded 
(MacBeath & Schreiber, 2000). Functional protein microarrays spot all of an 
organisms encoded proteins and can be used in the analysis of protein function and 
interactions (reviewed in Chen & Zhu, 2006; Reymond Sutandy et al., 2013). The 
protein bound to the array can be visualised by a number of methods, such as 
fluorescence of enzyme based assay (for example using horseradish peroxidise, 
although label free methods are also being developed (reviewed in Reymond 
Sutandy et al., 2013). The technique has been developed into a high throughput 
strategy which has been used to find novel protein interactions in yeast 
(Hesselberth et al., 2006; Tsvetanova et al., 2010). 
Another emerging method for analysis of protein complexes is the use of 
chromatography to fractionate cell lysates prior to MS analysis. Chromatographic 
techniques separate proteins based on their physico-chemical properties such as 
size, isoelectric point or hydrophobicity. If the separation is performed under non-
denaturing conditions, it is possible to separate interacting partners. Size exclusion 
chromatography (SEC) has been used to successfully separate protein complexes 
and analyse the interactions of hub proteins (Li & Giometti, 2007; Gao et al., 2010). 
Coupling of chromatographic separations to MS requires less preparation prior to 
experiments, there is no modification of the proteins, thereby proteins are analysed 
closer to their natural state, eliminating the possibility of protein interactions being 
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affected by a tag.  In addition, it can analyse more protein complexes in one data 
set, and in theory, if a crude cell lysate is separated it would be possible to analyse 
all interacting proteins from a sample in one experiment. As well as looking at 
numerous complexes, this method can simultaneously provide data on all proteins 
in a complex, as opposed to just two interacting partners, enabling the high 
throughput analysis of proteome organisation. SEC is generally a low resolution 
form of chromatography, but it has been coupled to other types of chromatography 
to improve resolution (Liu et al., 2008). Another advantage of teaming native 
protein chromatographic techniques and mass spectrometry for the investigation of 
protein complexes is that quantitative proteomics strategies can be applied to not 
only identify complex subunits, but to accurately calculate the amount of each 
present. In quantifying all of the interacting partners in a protein assembly, it is 
possible the protein stoichiometry of the complex will then be elucidated. The 
technique may also hold potential for the high throughput study of protein 
dynamics, if two sample types are separated and analysed, and if label free analysis 
can be used, there will be limited sample preparation involved.   
In addition to identifying the subunits of protein complexes, quantitative 
proteomics techniques have an application in the study of protein complex 
dynamics. Label mediated quantitative proteomics in the form of mixing after 
purification SILAC (MAP)-SILAC was developed for this purpose (Wang & Huang, 
2008). The technique involves differentially labelling two cell types, purifying out 
the protein complexes, and then mixing before analysis. The complexes from the 
two differentially labelled samples can then be simultaneously analysed. It has been 
applied in the study the dynamics of a number of complexes, including the yeast 
complexes eIF2B-eIF2 and cyclin-Cdc28 (Kito et al., 2008). SILAC studies such as 
these are complicated, labelling of the cells under two different conditions are 
necessary, which adds expense and time to workflows, in comparison to non-
labelling techniques. 
There have therefore been a number of studies in recent years attempting to build 
large scale protein-protein interaction (PPI) maps of proteome organisation in 
yeast. These have been numerous and varied, and have gathered data on 
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thousands of interactions. It isn’t possible to predict the number of interacting 
proteins, nevertheless attempts have been made to calculate the value, and the 
yeast proteome has been estimated to contain anywhere from 10,000 to 60,000 
interactions (Hart et al., 2006). It is not possible to know when the PPI network map 
is complete, but the results of numerous proteome organisation studies are 
displayed in various databases, such as BIOGRID (Chatr-Aryamontri et al., 2013), 
IntACT (Kerrien et al., 2012) and MINT (Chatr-aryamontri et al., 2007). The next 
phase in understanding protein interactions on a proteome wide scale is to build 
this data into a network of interacting proteins, which yields information on protein 
complexes. A range of bioinformatics strategies are employed in this endeavour 
and progress in building and analysing the PPI network maps has been reviewed 
(Clancy & Hovig, 2014). By integrating data from numerous studies, the reliability of 
the protein complex predictions is also improved (Xu et al., 2013). 
1.7 Proteomics in the exploration of the dynamic range of complex proteomes 
The dynamic range of a sample is another problem faced in proteomics, and an 
important consideration in designing a quantitative proteomic worklflow. In an MS 
analysis of complex samples, the most abundant proteins can sometimes dominate 
the results, as current mass spectrometers are capable of reaching across up to four 
orders of magnitude in concentration, while samples can reach up to 12 (Hortin & 
Sviridov, 2010; Zubarev, 2013). In order to explore less abundant proteins, samples 
must therefore be subjected to a preparation step prior to analysis. This usually 
involves the fractionation of proteins in a sample to separate the proteome into 
subsets, or depletion strategies, to remove the most abundant proteins, leaving the 
less concentrated behind. 
Fractionation of a sample is based on simplifying protein mixtures in order to divide 
the components into subsets based on an inherent property of the proteins, and 
can be based on centrifugation and chromatographic or electrophoretic techniques. 
In centrifugation techniques cellular organelles are separated at different 
centrifugation speeds. Chromatographic techniques can involve size exclusion or 
ion exchange methods to split a proteome into subsets depending on size or iso-
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electric point. Electrophoretic prefractionation techniques such as iso-electric 
focusing separate proteins according to their isoelectric point (pI). These techniques 
are put to widespread use in the analysis of proteomes and are reviewed in a 
number of papers (Righetti et al., 2005a; Righetti et al., 2005c).  
Immunodepletion strategies are based on the removal of the most abundant 
proteins. Specific antibodies, dye-ligands  or affinity chromatography can be used to 
bind and remove abundant proteins, and these are discussed in various review 
papers (Bjorhall et al., 2005; Moser & Hage, 2010). These techniques are all based 
on the removal of proteins, leading to loss of information.  
Combinatorial bead library technology is an alternative technique designed to 
reduce the dynamic range of biological samples while retaining all of the proteins, 
by simultaneously reducing the concentration of abundant proteins while 
increasing the amount of the less abundant proteins. This is achieved by 
normalising all of the proteins to a similar level of abundance, rather than reducing 
the complexity of the sample. Combinatorial hexapeptide library technology was 
designed to address the issues concerning proteome dynamic range in plasma, one 
of the most extreme examples of asymmetry (Righetti et al., 2005b; Thulasiraman 
et al., 2005). The libraries consist of a set of ligands bound to spherical, porous 
beads. Combinatorial hexapeptide ligands are formed from the 20 naturally 
occurring amino acids, using the Merrifield approach split, couple, recombine 
method (Furka et al., 1991). In this method, a batch of beads is split into 20, and to 
each subset an amino acid is bound, following which the beads are pooled, and 
then split again before attaching another amino acid. The process is repeated six 
times, to yield a hexapeptide ligand on each bead, and the method leads to a 
potential 206 (64 million) different ligands. A large enough aliquot of beads with a 
unique ligand on each bead would therefore, potentially possess the capacity to 
bind every protein in the complex proteome. This allows an aliquot of beads to 
simultaneously bind the same amount of the highly abundant proteins and the less 
abundant, when a sample is added, leaving a normalised solution when the excess 
protein is removed. The method has been used extensively to enable the analysis of 
low abundance proteins in plasma (Beseme et al., 2010), urine (Petri et al., 2009), 
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chicken skeletal muscle (Rivers et al., 2011) and has recently even been applied to 
bevarages (Fasoli et al., 2011; D'Amato et al., 2012).  
Combinatorial bead library technology can also be combined with various 
proteomic strategies, including electrophoresis and mass spectrometry methods to 
analyse the proteins present (Guerrier et al., 2007; Tu et al., 2011). It has been 
combined with SRM for the analysis of S. cerevisiae to increase the amount of 
proteins identified in comparison to untreated sample (Di Girolamo et al., 2013). 
Combining bead library normalisation with LC-MS offers advantages over 
fractionation or immunodepletion approaches, as the entire proteome should still 
be present in the sample. This, in theory, enables the analysis of the entire 
proteome in one experiment. This not only reduces the workflow time, but 
eliminates the potential for variability between experiments introduced when 
analysing a sample in separate fractions. Allowing the study of all analytes 
simultaneously allows the possibility of analysing an entire proteome in a sample. 
1.8 Aims 
The overall objective of this thesis is to explore the use of quantitative proteomics 
in the exploration of the S. cerevisiae proteome. Specifically, the areas that will be 
examined here are the organisation of proteins into complexes, and the 
examination of the entire dynamic range of proteins. 
The organisation of protein complexes will be examined by pairing native protein 
ion exchange chromatography with LC-MS. The hypothesis is that ion exchange 
chromatography will provide a method of fractionating S. cerevisiae cell lysate 
while some protein assemblies remain intact. Label free quantification will be used 
in identifying the members of protein complexes. The application of label free in 
studying the stoichiometry of protein complexes will then be tested, and compared 
to using a QconCAT based SRM approach for the quantification. 
The final part of this thesis will focus on the reduction in the dynamic range of S. 
cerevisiae cell lysate using combinatorial hexapeptide library technology. This will 
examine the hypothesis that bead libraries are an effective method of 
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simultaneously reducing the concentration of abundant proteins while increasing 
that of the less abundant analytes. The idea of teaming normalisation with 
quantitative proteomics will also be examined. This is based on the theory that 
there will be a range in which binding to the beads will occur in a linear fashion, up 
to the point where a protein will saturate the beads. Therefore any protein below 
this saturation amount can be assumed to represent the total amount of protein 
present in the sample.  
In combining the two approaches, the possibility of using quantitative proteomic 
strategies to build a complete picture of S. cerevisiae will be examined. 
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2. Methods   
2.1 Saccharomyces cerevisiae culture 
 
S. cerevisiae (BY4743 ΔARG3 strain) cells were streaked onto YPD agar plates 
(containing 200 mg/l of G418 antibiotic) and incubated at 30°C. After approximately 
40 hours a single colony was used to inoculate 5 ml YPD media with G418 antibiotic 
and incubated at 30°C with shaking at 150 rpm overnight. The following morning, 
the OD 600nm of this overnight culture was taken, and used to calculate the amount 
to inoculate a 200 ml culture. The inoculation amount was based on 20 hours of 
incubation, with shaking, at 30°C, and estimating a maximum growth rate at 
OD600nm of 0.3 per hour in order to reach a final OD of 2.5. After 20 hours, the 
culture was decanted into 15 ml aliquots, centrifuged (32706 RCF for 10 minutes at 
4°C) and then pellets were stored at – 80 °C until needed. 
2.2 S.cerevisiae cell lysis 
 
Lysis of S. cerevisiae cell pellets was performed using a Minilys homogeniser 
(Precellys). Cell pellets generated from 15 ml culture are suspended in 250 µl of the 
relevant lysis buffer containing protease inhibitors (one Roche complete EDTA free 
protease inhibitor cocktail tablet per 20 ml buffer, 20 mM sodium phosphate for 
equaliser experiments, 50 mM HEPES pH 7.4 for fractionation). Each cell pellet was 
then transferred to a microtube containing glass beads (Precellys) and the cells 
disrupted by 15 rounds of shaking using a Minilys homogenizer (Precellys) on the 
top speed setting for 30 seconds, followed by one minute on ice. The cell lysate was 
then centrifuged at 9542 RCF for 5 minutes, and the supernatant collected and 
combined. The lysate was then stored at 4°C until used. 
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2.3 Coomassie protein assay  
 
For assay of protein concentrations using coomassie bovine serum albumin (BSA) 
was used as to create a standard curve in concentrations of 10 mg/ml, 20 mg/ml, 30 
mg/ml, 40 mg/ml and 50 mg/ml. Appropriate dilutions of the analyte protein 
solution were made so that the concentration fell in the range of the standard 
curve. Coomassie PlusTM protein assay reagent was mixed 2:1 with standards and 
analyte samples in duplicate. The absorbance at 620 nm was measured using a 
Labsystems Multiscan Ascent colourimetric scanner and the concentration of the 
analyte solution was calculated by the software. 
2.4 Fast process liquid chromatography (FPLC) fractionation 
 
2.4.1 Mixed bed ion exchange 
 
Protein concentration of samples was assessed by coomassie protein assay and 
dilutions prepared. These were centrifuged at 12,100 RCF for 10 minutes and 
filtered using a 0.22 µm filter. The sample (0.5 ml) was then loaded onto a 2 ml 
capacity mixed bed ion exchange chromatography column (PolyLC) in start buffer 
(50 mM HEPES pH 7.4). Fractionation was performed on an AKTA purifier (GE life 
sciences) system at a flow rate of 0.5 ml per minute using gradient of 0-85% buffer 
B (50 mM HEPES, 1 M NaCl). A total of 35 x 1 ml fractions were collected. These 
were transferred into 1.5 ml eppendorf tubes before being concentrated and 
desalted using strataclean resin. 
2.4.2 Anion exchange 
 
S. cerevisiae cell lysate was diluted to 15 mg/ml and 0.5 ml loaded onto a 6 ml 
Resource Q column with an AKTA purifier (GE life sciences). A starting buffer of 50 
mM HEPES pH 7.4 was used, and fractionation was performed at a flow rate of 3 ml 
per minute using gradient of 0-45% buffer B (50 mM HEPES, 1 M NaCl) over 8 
column volumes. A total of 50 x 1 ml fractions were collected. 
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2.5 StrataClean resin concentration 
 
For SDS PAGE or LC-MS analysis, the fractions were also concentrated using 
strataclean resin, by transferring 500 µl of each fraction to a 0.5 ml eppendorf with 
20 µl of StrataClean hydroxylated silica beads (StrataCleanTM resin, Agilent 
Technologies). This was then vortexed for 1 minute, and centrifuged at 430 RCF for 
2 minutes. The supernatant was removed, and the remainder of the fraction added 
to the strataclean pellet. This was vortexed for a further minute, and then 
centrifuged at 430 RCF for 2 minutes. The supernatant was removed, and the 
protein bound to the beads was extracted using in solution proteolysis or SDS 
PAGE. 
2.6 SDS PAGE of protein fractions 
 
SDS sample buffer (1 ml 0.5M Tris buffer, pH 6.8, 1 ml glycerol, 0.02 g sodium 
dodecyl sulfate, 0.01 g bromophenol blue, 0.154 g dithiothreitol),  was added to an 
appropriately diluted sample, or protein bound StrataClean resin, vortexed briefly 
to mix and then incubated at 95°C for 10 minutes before loading onto a 12% 1D SDS 
PAGE gel. Electrophoresis was performed at 200V for approximately 40 minutes, 
using BIORAD mini gel series equipment (Biorad-laboratories, UK) and the protein 
bands were visualised by staining in coomassie blue.    
2.7 In solution proteolysis  
 
Sample was first made up to a volume of 160 µl with 25 mM ammonium 
bicarbonate solution (at an approximate amount of 100 µg protein if known),  then 
10 µl of a 2% Rapigest suspension (Waters) was added and incubated at 80°C for 10 
minutes using an eppendorf thermomixer with rotation at 950 rpm. After 10 
minutes the solution was returned to room temperature, centrifuged briefly and 10 
µl of a 9.2 mg/ml solution of DTT was added, and incubated at 60°C with 950 rpm 
mixing. Following this, 10 µl of a 33 mg/ml solution of iodoacetamide was added 
and incubated at room temperature in the dark for 30 minutes before 10 µl of (200 
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µg/ml) trypsin was added (Promega trypsin resuspended in 50 mM acetic acid). 
Digests were then incubated at 37°C with shaking at 90 rpm for 4 hours, before a 
further 10 µl of trypsin was added. This was then incubated at 37°C overnight. The 
following morning, 1 µl of TFA was added to the solution before returning to the 
thermomixer at 37°C for 45 minutes. The digests were then centrifuged at 4°C, 
17135 RCF for 15 minutes, and the supernatant removed. The centrifugation was 
repeated twice more, and the peptide solutions were stored at 4°C until LC-MS.  
2.8 LC-MS using a Waters Synapt G2 Q-TOF system 
 
Proteolysed samples were diluted 1:1 with a 50 fmol/μl solution of rabbit glycogen 
phosphorylase B to act as a standard protein for the label free software, and 2 µl 
was then injected onto a nanoACQUITY system (Waters, UK). Peptide samples were 
introduced in aqueous solvent (buffer A: HPLC grade H2O, 0.1% TFA) at a flow rate 
of 5 µl/min and passed through a 180 μm by 20 mm, 5 μm bead C 18 trap (Waters) 
at a flow rate of 5 µl/min. The peptides are then introduced to a 20 cm long 1.7 µm 
C-18 column at 75 μm by 150 mm, initially at 97% buffer A, followed by separation 
using a 110 minute gradient rising to 85% buffer B (HPLC grade ACN, 0.1% TFA) at a 
flow rate of 300 nl/min. A capillary voltage of 3 kV was applied to ionise samples 
before introduction the mass spectrometer.  Samples were acquired using a data 
dependent acquisition (DDA) mode, resolution 20,000, using a parent mass survey 
range of 50-2000 m/z using HDMSE and a scan time of 1 second, with a trap 
collision energy of 4V. Precursors were then fragmented at a trap collision energy 
of 15-40 V and MSMS spectra obtained. During acquisition the instrument switches 
to a lockspray of Glufibronopeptide (m/z 785.84) infusion every 30s for use as a 
calibrant. 
2.9 LC-MS using a Thermo QExactive Quadrupole-ion trap     
 
Chromatography was performed using an Ultimate 3000 nano system 
(Dionex/Thermo Fisher Scientific). Samples were introduced in buffer A (HPLC grade 
H2O, 2% ACN, 0.1% TFA) and loaded onto a C18 3 m trap column (Acclaim PepMap 
100, 2 cm x 75 m inner diameter) run on a 90 minute linear gradient from 3.8% to 
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50% buffer B (90% ACN, 0.1% TFA), followed by 5 minutes at 99% buffer B, at a flow 
rate of 300 nl/min, using a Thermo Scientific EASY-Spray(TM) PepMap® RSLC 15 cm x 
75 m inner diameter 2 m C18 column. Samples were run on the QExactive in a 
DDA method. Full scan survey was performed by the Orbitrap at resolution 70,000, 
and a target ion accumulation of 1 x106. The scan range was 300 to 2000 m/z and 
the top ten precursor ions with a charge of two or above were isolated for 
fragmentation, dynamic exclusion 20s. The typical spray voltage was 2 kV, capillary 
temperature 250 °C, no sheath or auxiliary gas. The MS/MS ion selection threshold 
was set to 1 x 104 counts and a 2 m/z isolation width. 
2.10 QconCAT expression 
 
The QconCAT gene is synthesised in the pET21 vector, for expression using the T7 
expression system. Plasmid DNA (5 µg) was solubilised in 50 µl TE buffer (10 mM 
Tris/1 mM EDTA), pH 8.0. A 1 ng/µl solution of the plasmid was prepared, and 5 ng 
added to 200 µl of E.coli BL21 cells. The cells were mixed and held on ice for 30 
minutes, before heat shock treatment at 42°C for 30 seconds. Cells were then 
placed back on ice for 2 minutes, 1 ml LB broth added, and incubated 37°C for 1 
hour. Transformed cells were then plated onto LB agar plates with 50 µg/ml 
Ampicillin, and incubated 37°C overnight. Transformed cells were then re-streaked 
onto LB Ampicillin plates, and incubated at 37°C overnight. A single colony was used 
to inoculate 10 ml of LB broth, incubated for four hours, and 100 ul used to 
incoulate 5 ml minimal media without amino acids (20% M9 salts, 0.2% 1 M MgSO4, 
2% glucose(20%), 0.01% 1 M CaCl2), at 37°C overnight, and then 4 ml of this culture 
used to inoculate 200 ml of minimal media with amino acids (as above with 20 mg 
each amino acid, [13C6]arginine and [13C6]lysine). The OD600nm was measured every 
60 minutes and when an OD600nm of 0.6 was reached expression was induced by the 
addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). After incubating for 
6 hours at 37°C, with shaking, cultures were centrifuged at 25040 RCF 4°C for 15 
minutes, and cell pellets are stored at -20°C. 
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2.11 Nickel affinity column purification 
 
QconCATs were purified using Nickel affinity purification columns (Ni-MAC), which 
bind the QconCAT using the hexahistidine tag included in the sequence.  Solubilized 
inclusion bodies were loaded onto the Ni-MAC column, which were then washed 
using 10 ml of bind buffer (6 M guanidine, 1.2 M NaCl, 200 mM  Na3PO4, 40 mM 
imidazole, pH 8.0), followed by 6 ml wash buffer (6 M guanidine, 1.2 M NaCl, 200 
mM Na3PO4, 80 mM imidazole, pH 8.0). The QconCATs were then extracted from 
the column using elution buffer (6 M guanidine, 1.2 M NaCl, 200 mM Na3PO4, 1 M 
imidazole, pH 8.0) and 10 x 0.5 ml fractions collected. Eluted fractions were treated 
with strataclean resin to remove guanidine HCl and samples were run on SDS PAGE. 
The two fractions with the highest concentration of QconCAT were combined and 
dialysed against 1500 ml 50 mM ammonium bicarbonate 1 mM DTT overnight. 
Purified QconCAT was protein assayed using a standard protocol Coomassie Plus 
Protein Assay, and stored at -20°C until use.      
2.12 In gel Proteolysis of QconCAT bands 
 
Suspected QconCAT bands were excised from the gel using a glass Pasteur pipette, 
added to 25 µl 25 mM ammonium bicarbonate, and incubated 37°C for 15 minutes. 
The ammonium bicarbonate was then removed and replaced with 50 µl 50% 
acetonitrile/ammonium bicarbonate, and incubated at 37°C for 15 minutes. This 
step was repeated as necessary until the gel plug was thoroughly destained. 
Following this, 25 µl of a 1.5 mg/ml solution of DTT is added and the plug is 
incubated for 60 minutes at 60°C. After discarding the DTT solution, 25 µl of a 10 
mg/ml iodoacetamide solution was added and incubated at room temperature in 
the dark for 45 minutes. The plug was then washed in 25 mM ammonium 
bicarbonate for 15 minutes at 37°C, and 10 µl acetonitrile until the plug was 
dehydrated. The dried gel plug was then incubated 37°C overnight in 10 µl 12.5 
ng/ml trypsin. The tryptic digest solution was then pipetted off the gel plug into a 
0.5 ml microfuge tube and stored at -20°C until MS analysis. 
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2.13 MALDI TOF mass spectrometry on Bruker UltrafleXtremeTM 
 
Samples (1 µl) were dried onto a stainless steel anchorchip target plate (Bruker) and 
mixed on the plate with an equal volume of α-cyano-4- hydroxycinnaminic acid 
(HCCA) matrix (10 mg/ml solution in 50% ACN, 0.1% TFA).  Analysis was carried out 
in reflectron mode using laser energy of approximately 30%, over a range from 
approximately 800 – 4000 m/z. Spectra were analysed using Bruker FlexAnalysis 
software, processed by baseline subtraction, smoothing and generate a peak list 
based on a S/N threshold of 6. 
 
2.14 SRM using a Waters Xevo triple quadrupole system  
 
QconCATs were diluted to 0.25 fmol/µl, 1 fmol/µl and 10 fmol/µl using the relevant 
fraction digests. Samples were introduced to a nanoACQUITY in aqueous solvent 
(buffer A: HPLC grade H2O, 0.1% TFA) at a flow rate of 5 µl/min and passed through 
a 180 μm by 20 mM, 5 μm bead C 18 trap (Waters) at a flow rate of 5 µl/min. The 
peptides are then introduced to a 20 cm long 1.7 µm C-18 column at 75 μm by 150 
mm, initially at 97% buffer A, followed by separation using a 60 minute gradient 
rising to 40% buffer B (HPLC grade ACN, 0.1% TFA) at a flow rate of 300 nl/min. 
Cone volts were set to 35 kV while collision energy was optimised for each peptide. 
Required points per peak were set to 30 and a peak width of 15 seconds, with an 
optimal dwell time of 0.05. 
 
2.15 ProteominerTM bead library experiments 
 
Proteominer beads (Biorad) were supplied in dried form and prepared according to 
manufacturer instructions. Beads (525 mg) were reswelled by adding 10 ml of 20% 
ethanol and incubated overnight at 4 °C with shaking at 50 rpm. Beads were then 
stored at 4 °C until use. S. cerevisiae cell lysate was diluted to the relevant 
concentration using 20 mM sodium phosphate buffer (pH 7.4). Bead aliquots (80 µl) 
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were allowed to equilibrate for ten minutes on a rotating mixer using the relevant 
buffer, and then loaded with 1 ml of sample. After 120 minutes on a rotating mixer 
at room temperature the beads were left to settle before the beads were allowed 
to settle for 5 minutes, and the excess sample removed. The protein bound beads 
were then washed 5 times in 20 mM sodium phosphate buffer (pH 7.4), and the 
amount of protein bound to the beads was determined via SDS-PAGE or LC-MS.   
 
62.1  Software used 
 
2. 61 .1 PLGS 
Waters PLGS (V 2.119) software was used in the analysis of data generated from 
the Synapt G2. Peptide identifications were performed by searching against a 
database of yeast proteins obtained from Uniprot (2010_01). Database searching 
was done using an FDR of 4%, a minimum of 1 peptide per protein, minimum 
fragment ions matched 3 per peptide and 7 per protein, with 1 miscleave, 
carboamidomethyl (C) as a fixed, and oxidation of methionine as a variable 
modification. Label free quantification is performed on the identified proteins using 
Hi3 methodology, where the average MS signal is calculated for the standard 
protein (glycogen phosphorylase B) and this is used to calculate the fmol of each 
protein identified, using the top three most intense peptides.  
 
2. 61 .2 MaxQuant 
QExactive generated data was processed with MaxQuant (V 1.3.0.5) with peptide 
identification using the default settings and the Andromeda search engine with a 
yeast database. Carbamidomethylation of cysteine was set as a fixed modification, 
and oxidation of methionine as a variable modification. FDR was set to 1%, with 
minimum unique and razor peptides set to 1. Maximum missed cleavages were set 
to 2 and a maximum charge state of 4. Label free quantification was performed by 
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calculating the iBAQ intensity of all of the peptides identified for each protein. The 
iBAQ intensity of the standard protein (glycogen phosphorylase B) is then used to 
calculate the quantity of each protein.           
                                                                                                               
62.1 .3 Skyline 
Skyline software V2.1.0.4936 was used in the design of transition lists and the 
processing of SRM data. PeptideAtlas and ETH spectral libraries were used in 
conjunction with libraries designed from Synapt G2 data (QconCAT digests analysed 
by PLGS) to chose optimal transitions.  QconCAT peptide lists were imported into 
Skyline, and transition lists generated were filtered to include only 1+, 2+, or 3+ 
charges and Y ions. The three optimal transitions for each peptide were chosen, and 
exported as an excel file for use with Masslynx software. 
 
62.1 .4 Masslynx 
Masslynx software V4.1 was used in the processing of Xevo generated SRM data. 
Data was first imported into Masslynx and visually inspected to determine the 
peptide Type (A, B or C). For calculation of peptide quantities chromatograms were 
integrated using the mean smoothing method, number of smooths 2, window 2, 
baseline start and end thresholds 10%. The intensity contributed from the 
unlabelled QconCAT, calculated from either the G2 data (YEW1) or the SRM 
negative control (YEW3) was then subtracted from the analyte peak intensity 
before the fmol amount was calculated based on the QconCAT dilution used. 
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Chapter 3: Analysis of Saccharomyces cerevisiae proteome organisation using ion 
exchange chromatography and LC-MS/MS 
3.1 Introduction 
 
While technological advances towards accurate and reliable quantification of 
proteins provide key information on the cellular proteome, simply understanding 
the identity and quantity of proteins in a cellular environment does not provide an 
accurate picture of their role within a cell. The proteome is a complex, diverse and 
dynamic environment, with a complexity partly achieved because there is a far 
greater level of functionality in the cellular environment than there are protein 
coding genes in the genome. It has been estimated there are an order of magnitude 
more functional proteins in the cell than are encoded (Fields, 2001). The product of 
a protein encoding gene can be altered by events such as alternative splicing and 
post translational modification. In addition to the wide variety of proteins, some 
proteins can also play a variety of roles within a cell, and performing multiple 
functions is known as protein moonlighting (reviewed in Gancedo & Flores, 2008; 
Flores & Gancedo, 2011).  
A further level of complexity in the proteome is created from protein-protein 
interactions leading to the organisation of proteins into complexes. It has been 
estimated that some proteins can have hundreds of different interactions within 
the cell, meaning that individual proteins can therefore be found as part of a 
number of different complexes which are essential to a cells functionality (Jeong et 
al., 2001; Song & Singh, 2013). The current estimate for the number of protein 
coding genes in the S. cerevisiae genome is 5070, as listed by the Saccharomyces 
genome database, SGD (Cherry et al., 2012).  More than a third of these can exist at 
some stage as part of a complex, and over 400 different complexes have been 
identified so far (Gavin et al., 2006) (Liu et al., 2008). Multi-subunit complexes are 
responsible for much of a cells functionality, such as RNA polymerase for the 
transcription of the genome, the exosome for RNA degradation or the proteasome 
for the removal of unwanted or unnecessary protein. By building up an organisation 
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map of the protein machinery of a cell it may be possible to further understand the 
interactions occurring and perhaps build a complete picture of the role of each 
protein within a cell. 
A variety of methods have been implemented in the study of S. cerevisiae protein-
protein interactions, including yeast two hybrid (Y2H) systems, TAP tag studies and 
co-immunoprecipitation, which have all been used in large scale studies discovering 
numerous interactions.  S. cerevisiae two hybrid systems are an assay of the 
potential for two proteins to interact, where the ‘bait’ protein is fused to the DNA 
binding domain of the S. cerevisiae protein Gal4. The ‘prey’ protein is fused to the 
transactivation domain of Gal4, and interaction between the two proteins is then 
assessed using a reporter (Fields & Song, 1989). This technique has been used in 
large scale studies to discover almost 1000 protein-protein interactions in S. 
cerevisiae (Uetz et al., 2000). In TAP tag purification a protein is fused to an affinity 
(TAP) tag, and the tagged protein is then isolated using affinity chromatography, 
under gentle conditions in which any interacting proteins remain in complex. This 
system had been implemented successfully to yield information on over 500 
protein-protein interactions (Gavin et al., 2002). In co-immunoprecipitation 
techniques an antigen is precipitated out of solution using an antibody that 
specifically binds that protein, and if sufficiently non-denaturing buffers are used 
during this procedure, it is possible to precipitate proteins associated with the 
antigen (Ho et al., 2002).  
These are low throughput methods, as in Y2H and TAP tag a new fusion protein 
must be designed for a single proteins interaction partners to be found, adding time 
and complexity to the experiment, and the presence of the tag may interfere with 
protein binding. In immunoprecipitation techniques, if the interaction is weak there 
is a possibility the complex will dissociate during isolation. All of these techniques 
involve the small scale study of individual protein-protein interactions, but have 
enabled the development of big data sets in large scale studies. However, many 
proteins in the cell associate into large, multi-subunit complexes, which can contain 
large numbers of proteins, and the small scale affinity purification or yeast two 
hybrid approaches do not provide stoichiometric information on the assembly of 
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these complexes. In addition, the large number of interactions within some 
assemblies can lead to variation in results, and some studies have shown a poor 
overlap between results, indicating a high degree of false positives (Cornell et al., 
2004). Although low throughput, there have been many studies using these 
technologies, and a plethora of information of yeast protein interactions have been 
gathered, and assembled into databases such as MINT (Chatr-aryamontri et al., 
2007), CyC2008 (Pu et al., 2009), BioGRID (Chatr-Aryamontri et al., 2013) or IntAct 
(Kerrien et al., 2012). The incorporation of information into databases enables the 
construction of interactome networks and the prediction of protein complexes 
(Clancy & Hovig, 2014).  
In addition to the protein interaction studies, entire S. cerevisiae protein complexes 
have been visualised using techniques such as X ray crystallography, NMR 
spectroscopy, or cryo-electron microscopy (cryo-EM). X ray crystallography involves 
the crystallisation of a protein, or complex, and the subsequent diffraction of x rays 
through the crystal enables the visualisation of protein structure. The technique has 
been successfully used to characterise a number of yeast complexes, such as the 
eukaryotic exosome and Ccr4-not complexes (Basquin et al., 2012; Makino et al., 
2013a). Cryo-EM techniques are based on electron microscopy and have been used 
to characterise the helicase core MCM2-7, and the sub-discipline of electron 
crystallography has also been used to image yeast RNA polymerase II (Poglitsch et 
al., 1999). NMR spectroscopy exploits the magnetic field around atomic nuclei to 
provide information on the surrounding structure, and allows the imaging of 
complete multisubunit complexes in some situations where X ray crystallography is 
unable to (Gross et al., 2003). However, both of these techniques require the 
isolation of large amounts of purified protein complexes.  
Mass spectrometry can also be used for the analysis of whole protein complexes in 
the form of native, intact protein mass spectrometry. Native mass spectrometry 
involves the use of native electrospray ionisation (ESI) in an attempt to preserve the 
quaternary structure of the protein interactions, to elucidate the stoichiometry of 
the complex and in the analysis of the exact mass of each of the individual subunits, 
and offer advantages in high sensitivity, reduced sample size, and high throughput 
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analysis, reviewed in a number of papers (Heck, 2008; Lorenzen & van Duijn, 2010). 
Native MS techniques have been applied to the study of protein complexes such as 
the yeast exosome complex (Synowsky et al., 2006) and RNA polymerase III 
(Lorenzen et al., 2007). 
Alternatively, native protein chromatography followed by LC-MS/MS can be used in 
the analysis of protein complexes. This technique involves retaining the quarternary 
structure for the first chromatographic stage of the analysis, following which the 
subunit composition of the separated complexes can be analysed by shotgun 
proteomics. This provides a method of combining protein complex subunit 
identification with the quantification of each subunit. Various forms of 
chromatography can be used in the study of protein complexes, including size 
exclusion chromatography (SEC), ion exchange chromatography (IEX), and 
hydrophobic interaction chromatography (HIC). 
Size exclusion chromatography, also known as gel filtration, involves the separation 
of proteins, peptides or protein complexes on the basis of size. The 
chromatography column is packed with porous beads, into which the sample 
proteins or peptide can diffuse, depending on size. The sample is loaded onto the 
chromatography column, and the proteins which are of a small enough size to enter 
the porous beads take longer to travel through the column. This technology has 
been used to successfully separate S. cerevisiae protein complexes, prior to 
proteolytic digestion and LC-MS, which enabled associated proteins to be identified 
(Li & Giometti, 2007; Gao et al., 2010). Size exclusion chromatography is the 
gentlest of these chromatographic methods, as it uses samples suspended in simple 
non-denaturing buffers, however, it usually offers poor resolution, with a column 
packing material separating a fairly narrow size range of proteins. Protein 
complexes within the cell range from 2 subunits in structures such as 
phophofructokinase and fatty acid sythetase, up to more than 70 subunits in larger 
assemblies such as the ribosomes, and can consequently cover a wide range of 
molecular weights and contain a wide range of components (Robinson et al., 2007; 
Ban & Egelman, 2010). Therefore, this method is not ideal for the high throughput 
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methodology required for the study of all of the complexes in the whole cellular 
proteome. 
Hydrophobic interaction chromatography separates proteins on the basis of 
hydrophobicity. The exposed hydrophobic sections of the protein are encouraged 
to interact with the hydrophobic column material by loading the sample in a high 
ionic strength solution. This type of chromatography has also been coupled to MS 
methods for the study of protein interactions (Liu et al., 2008).  
Ion exchange chromatography separates protein samples on the basis of charge, 
either by the use of positively charged medium (anion exchange chromatography or 
AEX), or negatively charged medium (cation exchange chromatography or CEX). The 
chromatography media interacts with sample proteins carrying the opposite 
charge, and the protein can later be eluted from the column by displacement with a 
solution of high ionic strength, generally with the use of a buffer solution containing 
NaCl. A gradient of increasing strength NaCl can be used to increase the time 
between the elution of proteins of different charge (and therefore different affinity 
for the column material), giving this type of chromatography a higher resolution 
than SEC, and it has also been used in the study of protein complexes (Liu et al., 
2008; Gao et al., 2010). Combining chromatographic separation of native proteins 
with subsequent LC-MS methods provides the potential to analyse all of the 
available protein complexes in a cell lysate in one set of experiments. It allows the 
study of proteins in their natural conformation, eliminating any potential for 
alteration in secondary structure, as is possible in other techniques. 
The process of breaking a protein down into peptides and analysing the peptide 
fragments by MS-MS to build information on the parent protein is termed bottom 
up proteomics (Armirotti, A., 2009). The use of bottom up proteomic methods 
following chromatography allows not just the identification, but the quantification 
of each subunit using label-free methodologies. Label-free methods allow the 
quantification of protein samples without generating specific labelled protein 
standards, meaning the experimental workflow is simplified in comparison to label 
mediated methodologies. This method of quantification takes advantage of the 
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correlation between the intensity of a peptide and the concentration of the protein. 
There are various software tools for the calculations, some of which use just a 
subsection of the peptides identified, such as the top three most intense, and some 
of which use more peptides (Old et al., 2005; Silva et al., 2006; Schwanhausser et 
al., 2011). These label free methods apply data that has been gathered from a mass 
spectrometer using data dependent acquisition, a mode of running whereby 
MS/MS fragmentation of peptides is triggered for the most intense peptides the 
mass spectrometer detects in a set time window. Coupled with HPLC for the 
separation of the complex mixture of peptides, this non targeted mode of 
operation means that data is potentially gathered for all of the proteins in a sample, 
depending on the dynamic range of the sample, and the sensitivity of the mass 
spectrometer.   
3.2 Aims 
 
The primary aim of this chapter was to develop an efficient, high throughput 
method for the fractionation and quantification of S. cerevisiae protein complexes. 
This was attempted using anion exchange chromatography and mixed bed ion 
exchange chromatography systems to separate a clarified yeast cell lysate solution 
into a discrete set of fractions. This is based on the hypothesis that the separation 
will be sufficient to fractionate protein complexes, while maintaining their 
quaternary structure.  
There are numerous types of interactions found in protein-protein interactions, 
such as ion-ion, hydrogen bonds, dipole-dipole, dispersion and hydrophobic 
interactions. Owing to the ionic strength required for the elution of proteins from 
the  ion exchange columns, it is possible that some electrostatic interactions will be 
affected, as it is known these interactions can be weakened in the presence of salt 
(Bertonati et al., 2007). However, higher ionic strength conditions can sometimes 
support the maintenance of protein structure, suggesting the importance of 
hydrophobic interactions in protein complex structure, so it is possible that many 
interactions will be unaffected (Gao et al., 2010).  
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The protein content of the fractions, potentially including all of the cellular protein 
complexes, will then be analysed using LC-MS/MS. The protein content of each 
fraction will be calculated using label-free quantification, in which the correlation 
between peptide intensity and protein concentration is exploited to calculate the 
quantity of each protein present in the sample. This method will potentially provide 
a high throughput method for the analysis of the stoichiometry of protein 
complexes. Conversely, the stoichiometry of the protein complexes will also provide 
a test of the accuracy of the label-free methods, as a number of known protein 
complexes should be observed, where the relationship between the subunits is 
already characterised.   
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3.3 Results and Discussion 
 
3.3.1 Anion exchange chromatography 
 
S. cerevisiae cell lysate was prepared according the protocol outlined in section 2.2. 
The cell lysate was centrifuged to remove insoluble material prior to loading on the 
chromatography column. Anion exchange chromatography was performed using a 
6 ml ResourceTM Q column (GE Life Sciences), with protein loading and gradient 
length adjusted to optimise the separation between complexes, with the aim of 
identifying the maximum number of proteins. The optimised method consisted of a 
0.5 ml load of 15 mg/ml cell lysate run on a gradient of 0-85% buffer B over 8 
column volumes. Buffer A consisted of 50 mM Hepes, pH 7.4 while elution buffer B 
was composed of 50 mM Hepes, 1 M NaCl, pH 7.4. The long gradient and high 
elution buffer was designed to fractionate the majority of yeast proteins. Due to the 
delay in fraction collecting on the AKTA, protein began to elute at fraction 5 and 
continued, according to the UV trace, until approximately fraction 50 (figure 3.1 a), 
therefore fractions 5-50 were taken to be analysed by SDS PAGE and mass 
spectrometry.  
Two sets of fractions were prepared, one of which will be analysed by SDS-PAGE 
and the other by mass spectrometry. The two sets of fractions were prepared from 
the same cell lysate dilution, and run on the same day, using the same buffers. In 
doing so, the chromatographic profile of the two separations remained the same 
(figure 3.1 b). 
SDS PAGE of the fractions collected (figure 3.2 a) show that at a neutral pH of 7.4, 
many proteins do not bind to the column, and are eluted in the initial fractions, 
before the gradient. This is because any protein with an isoelectric point below 7.4 
will carry a positive charge, and therefore be unable to bind the anion exchange 
resin. A protein with an isoelectric point above this will carry a negative charge, and 
therefore will remain bound with the column material until it is displaced by the 
gradient. However, despite the unbound material not undergoing separation during 
the gradient, it has still undergone a form of fractionation, an isocratic separation,  
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Anion exchange resource Q chromatography
a)
b)
7.5 mg/ml S. cerevisiae cell lysate run 1
7.5 mg/ml S. cerevisiae cell lysate run 2
7.5 mg/ml S. cerevisiae cell lysate run 1
50 x 1 ml fractions collected
50 x 1 ml fractions collected
Figure 3.1 S. cerevisiae cell lysate fractionation by anion exchange 
chromatography  
S. cerevisae cell pellets generated from 15 ml of culture where lysed by bead 
beating, and diluted to 15 mg/ml in starter buffer, 50 mM HEPES, pH 7.4. A 0.5 
ml aliquot of the dilution was injected onto a Resource Q anion exchange 
column, and separated at 2 ml/min on an AKTA chromatography system, with 
elution using a gradient of 0-0.85 M NaCl. 50 X 1 ml fractions were collected. 
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Anion exchange fractionation gels
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Figure 3.2 Protein fractionation by anion exchange results 
Protein content of the 50 anion exchange fractions was analysed  a) by SDS-
PAGE, where the fractions have been concentrated using 20 μl of StrataClean 
resin, mixed 1:1 with sample buffer, and run on 1D SDS PAGE, and in b) the 
total proteins identified per fraction and c) the fmol per fraction calculated by 
PLGS using label free analysis, FDR 4%, after tryptic digestion and running 1 µl 
(from a 200 µl digest) on the Waters Synapt G2 Q-TOF mass spectrometer.  
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and it has been separated from the material that has bound. The material will 
therefore be used in the analysis, to add to the overall number of proteins 
quantified. The SDS PAGE also shows that many proteins are eluting across a wide 
range of fractions, indicating they show a broad elution from the column, which 
may be due to the long gradient length. The protein content of the fractions was 
analysed by label free analysis using the Waters Synapt G2. Each fraction was 
treated with StrataClean resin and digested as described in section 2.6, before 
spiking in glycogen phosphorylase B to use as a standard protein prior to loading 
onto the mass spectrometer. The proteins were quantified by label free analysis 
using PLGS software, and a total of 781 proteins were identified (FDR 4%) across all 
52 fractions. The number of proteins identified in each fraction reach a peak at 
approximately 100-200 hits in fractions 20-40, while the total amount of material 
identified peaks at 1000-2000 fmol between fractions 22-32 (figures 3.2 b and c). 
The amount (in fmol) of each individual protein eluted in each fraction is plotted as 
a heat map in MulitExperiment Viewer (MeV) software (Saeed et al., 2003), after 
undergoing hierarchical clustering (HCL) by Pearson correlation. This highlights 
whether there is a linear correlation between two proteins, and measures if the 
two numbers diverge and by how much. The HCL map does show that a number of 
proteins are co-eluting across the fractions (figure 3.3). This could indicate that 
protein complex subunits are eluting together. There are situations where the 
clusters are formed from the subunits of a known complex, for example the 20S 
proteasome, which elutes over fractions 37 to 39 (figure 3.4 a). However, the heat 
map also supports what is indicated by the SDS PAGE, that some proteins are 
eluting in broad peaks over a wide range of fractions (figure 3.4 b). Higher 
resolution chromatography might offer increased separation between complexes, 
and support the hypothesis that in some cases co-eluting proteins are doing so as 
part of a larger assembly. 
3.3.2 Mixed bed ion exchange chromatography 
 
Fractionation was also performed using a mixed bed chromatography column, 
packed with a 50/50 mixture of a weak cation exchange resin (PolyCAT ATM) and a 
Chapter 3 
 
 Page 46 
 
 
 
 
 
 
 
 
 
 
  
HCL 
clustering 
P
ro
te
in
s
n
 =
 7
8
2
Figure 3.3 Hierarchical clustering of AEX fractionated proteins identified by LC-
MS/MS 
A 1 µl aliquot of a 200 µl  volume digest of each fraction was run on the Waters 
synapt G2 and quantified by label free using PLGS software. The fmol amounts 
of each protein identified in each fraction were imported into Multi Experiment 
Viewer (MeV) software. A heat map was generated from the data using 
hierarchical clustering by Pearson correlation.   
 
Fractions 5-52 
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a)
b)
PRE3
PRE8
PRE9
PRE6
SCL1
PUP2
PRE5
PRE7
PRE1
PUP1
PRE2
PRE10
PRE4
PUP3
Figure 3.4 Anion exchange chromatography of the 20S proteasome and 
individual protein examples. 
Digested fractions run on the Waters Synapt G2 are processed using PLGS. The 
fmol amount of each protein, arranged in tabular format, are imported into MeV 
to generate  a heat map. Cluster analysis is performed using Pearson correlation 
a) 20S proteasome cluster, and the fmol amount of each 20S proteasome subunit 
identified, b) some individual proteins eluting across a wide range of fractions. 
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weak anion exchange resin (PolyWAX LPTM) (PolyLC inc). Mixed bed 
chromatography offers the advantage of binding the majority of cellular proteins at 
a neutral pH, at which point there will be some proteins retaining a positive charge, 
some a negative charge (el Rassi & Horvath, 1986). Only those with an isoelectric 
point at the pH of the buffer (pH 7.4) will have a net charge of zero, and could 
therefore be eluted in the flow through fractions, prior to the gradient. Therefore 
this type of chromatography may offer the opportunity of binding the majority of 
protein, which may enable the separation and quantification of more protein 
complexes. This method offers increased resolution to the anion exchange 
chromatography, as all proteins should interact with the column, and mixed bed ion 
exchange has proved applicable in the study of proteomes (Le et al., 2011; Zhang et 
al., 2012).   
The PolyLC chromatography column is smaller than the ResourceQ, with a bed 
volume of 2 ml, so the capacity of the column is therefore reduced, and a cell lysate 
dilution of 4 mg/ml was used, meaning a total load of 2 mg/ml. The smaller bed 
volume also means the gradient length is 0-85% B over a total of 30 fractions (figure 
3.5). The chromatography appears to be at a higher resolution, with more peaks 
than the anion exchange. The SDS PAGE of the 30 fractions showed less material in 
the flow through fractions than in the AEX fractionation, however there are still 
some protein bands observed, indicating these proteins have an isoelectric point of 
7.4, and therefore do not bind either ion exchange resin. The gels also support the 
idea that this is higher resolution chromatography, as individual protein bands 
appear in fewer fractions than in the anion exchange chromatography gels.  
The fractions were concentrated with StrataClean resin, digested and analysed by 
label free quantification using a Waters Synapt G2 followed by PLGS, and by this 
process the mixed bed ion exchange fractions yielded 791 proteins. The number of 
proteins identified per fraction peaked at 100-200 proteins between fractions 10-
20, and the amount of material identified peaked at 1000-2000 fmol in fractions 10-
20. While there was a similar amount of proteins identified to the anion exchange 
chromatography, the fractionation was achieved over a total of 30 fractions as  
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Volume eluted (ml)
Figure 3.5 Mixed bed ion exchange chromatography results 
Centrifuged cell lysate was diluted to 4 mg/ml before loading 0.5 ml onto a 
PolyLC mixed bed chromatography column and a) separation with a gradient of 
0-85% 1M NaCl. b) The 30 x 1 ml fractions  were concentrated using Strataclean 
resin and run on SDS PAGE. A second set of fractions were concentrated, 
digested and run on the Synapt G2, with label free quantification by PLGS (FDR 
4%). c) the total material quantified, and d) the number of proteins identified.   
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opposed to 50. The higher resolution of the mixed bed chromatography was further 
supported when the data was plotted as a heat map (figure 3.6). The hierarchical 
clustering showed that proteins were still eluting as part of complexes, but in 
sharper chromatographic peaks. The 20S proteasome elutes sharply in one fraction, 
compared to across two fractions in the anion exchange chromatography (figure 3.2 
a). A comparison of some individual proteins also indicates they elute across a 
narrower range of fractions, ENO2, SSA1 and 2 and GLN1 all show narrower peaks 
in comparison to the anion exchange (figure 3.7 b). However, despite the 
improvement in resolution when using this method of chromatography, the SSA1 
and SSA2 proteins still elute over a wide range of fractions, approximately ten 
fractions, a third of the gradient. This indicates the protein has a higher affinity for 
the column, possibly due to having more potential binding sites. One possibility is 
the protein exhibiting interactions with other proteins, which results in more 
possible binding sites. SSA1 and SSA2 are chaperones of the HSP70 family, 
functioning in binding other proteins and assisting folding, and would therefore 
have a propensity for binding other proteins, possibly in various conformations. 
According to the IntAct database, 2816 interactions have been reported for SSA1.   
A direct comparison of some of the protein complexes observed indicates the 
resolution was improved in mixed bed chromatography. ARC1 protein binds both 
methionyl and glutamyl tRNA synthetases, and the three proteins co-elute in both 
types of chromatography (figure 3.8 a). The three proteins are spread across fewer 
fractions when mixed bed chromatography is used. The same effect is seen in 
succinyl CoA ligase (figure 3.8 b) and the nascent polypeptide associated complex 
(figure 3.8 c). Despite the improved chromatography, there are a similar number of 
proteins identified, however the mixed bed chromatography offers the potential for 
increased resolution and was used in all further fractionation experiments. 
3.3.3 Mixed bed chromatography replicates 
 
Five separate replicates of the mixed bed chromatography fractionation were then 
run using separate cell lysates generated from five individual yeast cultures. The   
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Figure 3.6 Hierarchical clustering of mixed bed ion exchange fractionated 
proteins. 
The fraction digests run on the Waters Synapt G2 were analysed using label-
free quantification by PLGS software. The fmol amount of each protein 
identified in each fraction was imported into Multi Experiment Viewer (MeV) 
software. A heat map was generated from the data using hierarchical clustering 
by Pearson correlation. 
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Figure 3.7 Mixed bed ion exchange chromatography of the 20S proteasome and 
individual protein examples 
Digested fractions were run on the Waters Synapt G2 and processed using PLGS. 
The fmol amount of each protein were arranged in tabular format and imported 
into MeV for the generation of a heat map. Cluster analysis was performed using 
Pearson correlation a) 20S proteasome cluster, and the fmol amount of each 20S 
proteasome subunit identified by PLGS, b) the elution of some individual proteins. 
 
20S proteasome 
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Anion exchange Mixed bed ion exchange
a)
b)
c)
Figure 3.8 Protein complex chromatography by anion and mixed bed ion exchange 
Both anion and mixed bed fractions were concentrated using strataclean resin, and 
digested using trypsin, and 1 µl of a 200 µl total volume digest was run on the 
Waters Synapt G2 on a 2 hour HDMSe method. The resulting data was analysed 
usign PLGS, and label free quantification was performed. Results are compared for a) 
ARC1/GUS1/MES1 complex, b) succinyl CoA ligase, and c) the NAC complex. 
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five replicate yeast cultures were grown at five different times, cells were lysed by                                                                    
bead beating and then the protein content was calculated using a coomassie plus 
protein assay. The cell lysates were each diluted to 4 mg/ml, loaded onto the mixed 
bed column and separated using the same 10 column volume, 0-85% B gradient as 
above. Fractions 3-30 from each replicate were digested, run on both the Waters 
Synapt G2 and the Thermo QExactive and quantified by label free analysis. The label 
free quantification from both instruments gives a result in fmol injected, which is 
then corrected for digestion volume. The sum of the amount of protein in each 
fraction would therefore give the total amount of that protein in the original cell 
lysate.   
The chromatograms generated by the AKTA show some differences in the profile 
between the five replicates, though much of the curves follow the same pattern, 
with a number of discrete peaks eluting in fractions 3 to 33 across the length of the 
gradient (figure 3.9). The differences between the chromatograms are likely due to 
variation between the five cultures and preparation of separate dilutions. SDS PAGE 
analysis of the five replicates showed a good correlation, and the fractions in each 
replicate appeared to contain similar amounts of protein bands, despite the 
amount of material varying between replicates (figure 3.10). To quantify this 
protein, the five replicates were run on the Synapt and analysed using PLGS to give 
a total of 786, 790, 543, 692 and 822 hits. As the number of hits varies, the amount 
of material identified does, with a total of 136, 117, 57, 70 and 77 pmol quantified 
by PLGS in the injected material in replicates 1 – 5 (figure 3.11). As expected, there 
are differences between these replicates as there are a number of points where 
variation can occur, due to them originating from five individual cultures, and cell 
lysis of cell pellets on five separate occasions, which are quantified by protein assay, 
with separate dilutions prepared. However, variability in the amount of protein 
identified did not prevent the primary goal in this analysis; to assess the 
fractionation of protein complexes.  
The five replicates were also run on the QExactive, a quadrupole ion trap mass 
spectrometer, with data analysis using MaxQuant (V 1.3.0.5) software, using a  
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Figure 3.9 Five replicates of S. cerevisiae cell lysate mixed bed ion exchange 
fractionation 
Five  separate cultures of S. cerevisiae were prepared on five separate occasions. 
Cell pellets generated from 15 ml of culture were used to prepare a cell lysate by 
bead beating. Lysates were clarified by centrifugation and diluted to 4 mg/ml 
before loading 0.5 ml onto a PolyLC mixed bed chromatography column and 
separating on a gradient of 0-0.85 M NaCl. 30 x 1 ml fractioned were collected. 
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Figure 3.10 SDS PAGE of five mixed bed ion exchange replicates 
S. cerevisiae  cell pellets generated from 15 ml of culture were used to prepare 
a cell lysate by bead beating. Lysates were clarified by centrifugation and 
diluted to 4 mg/ml before loading 0.5 ml onto a PolyLC mixed bed 
chromatography column and separating on a gradient of 0-0.85 M NaCl. 30 x 1 
ml fractioned were collected, concentrated via StrataClean resin and run on SDS 
PAGE. 
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G2 total proteins
G2 total fmol per fraction
QExactive total proteins
Qexactive total fmol per fraction
b)
d)
Figure 3.11 LC-MS/MS results of mixed bed ion exchange fractions 
The 30 x 1 ml fractions generated from mixed bed ion exchange 
chromatography were concentrated via StrataClean resin, digested and run on 
the Synapt G2 or QExactive. Label free quantification was done using PLGS (FDR 
4%), and MaxQuant software (FDR 1%). Results are reported as a) total fmol of 
material and b) total number of hits in each fraction in the G2 data, c) total fmol 
material and d) total hits in each fraction in QExactive data. 
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default setting of 1% FDR (Cox & Mann, 2008). Label free quantification was 
achieved by calculating the iBAQ intensity using MaxQuant and calculating the fmol 
of each protein by comparing the intensity of the 50 fmol of glycogen 
phosphorylase B. In replicates 1-5 respectively there were 1868, 1810, 1636, 1574 
and 1746 proteins identified (figure 3.11). The mode of function of the two 
instruments, and the data processing are not directly comparable, however the 
QExactive yielded more than double the hits of the G2 for each replicate. Within 
these replicates there were 1241 common proteins identified on the QExactive, and 
a total of 2282 proteins identified at least once when all replicates are combined 
while in the G2 data there were 480 common proteins and 1051 in total. There 
were also different amounts of protein in each replicate, and the total amount of 
material identified by label free varies from 38 nmol in replicate 4 to 110 nmol in 
replicate 5. As the cell lysate used for each replicate was derived from a different 
batch of yeast culture a certain amount of variation in the protein content would be 
expected. However, the total protein load onto the chromatography column was 
calculated at 2 mg in each run. There are a number of potential sources of this 
error, either prior to fractionation, in the protein assay of the cell lysate, or the 
sample dilution, or error could also come from the pipetting of the StrataClean 
resin. Despite the difference in protein content of the replicates however, a 
comparison can still be made of the results of individual proteins, as the protein 
load is sufficient to observe individual protein behaviour in each replicate. Also, the 
protein in each replicate follows the same pattern, with the majority of the material 
for each replicate eluting in fractions 10-15.    
3.3.4 Chromatographic effects on abundant glycolytic proteins 
 
Some of the most abundant proteins in the yeast cellular proteome are the 
enzymes involved in the glycolysis pathway. These proteins are involved in the 
conversion of glucose into pyruvate, regenerating ATP. It has been suggested that 
they associate into a multi-enzymatic complex, or metabolon (Araiza‐Olivera et al.; 
Araiza-Olivera et al., 2013). Some of the enzymes, including three isozymes of 
glyceraldehydes-3-phosphate dehydrogenase (TDH1-3), four isozymes of  
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Figure 3.12 Chromatographic elution of glycolytic enzymes. 
The S. cerevisiae cell lysate, 4 mg/ml dilution, loaded onto mixed bed ion 
exchange and fractionated on a gradient of 0-85% 1M NaCL. The 
chromatographic elution profile is shown of some of the enzymes of the 
glycolytic pathway. 
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enolase (EN01-2), phosphoglycerate kinase (PGK1), phosphoglucose isomerise 
(PGI1), enolase 1 (ENO1), two isozymes of hexokinase (HXK 1-2) and three of 
alcohol dehydrogenase (ADH 1-3) elute between fractions 8 and 14 (figure 3.12). 
The isozymes of a protein possess similar structures, and may elute in similar 
position due to this similarity, however the co-elution of many different proteins 
may indicate some level of interaction. 
3.3.5 Investigating protein interactions  
 
Protein complexes in the yeast cellular environment are abundant and varied, and 
hundreds of different complexes are reported in the literature, and assembled into 
databases such as MIPS, BIOGRID, and CYC2008 (Guldener et al., 2006; Pu et al., 
2009; Chatr-Aryamontri et al., 2013). They vary in size and structure from just 2 
subunits to more than 70 in large organelles such as ribosomes. It is therefore 
expected that a variety of different elution profiles will be observed. To provide a 
visual representation of the elution of proteins across all 5 replicates heat maps 
have been generated in MeV. These show the fmol amounts of each protein, and 
for each replicate the normalised data is also displayed as a heat map. To 
normalise, the amount of an individual protein in each fraction has been calculated 
as a percentage of the total amount of that protein identified across all of the 
fractions. Hierarchical clustering was performed using Pearson correlation to 
arrange the results according to co-eluting proteins. The normalised data for each 
replicate shows much tighter clustering, which indicates the fmol amount of protein 
in each cluster varies, although the same total percentage is eluted. The elution of 
the proteins in these tight clusters was repeated across all five replicates (figures 
3.13 to 3.17). Analysis of the clusters showed that a number of known protein 
complex subunits are eluting together. 
One such example of a complex where all subunits are clustering together is the 
LSm (like-sm) proteins assembly. LSm are RNA binding proteins which are 
assembled into ring structures (Zhou et al., 2014), and there are eight proteins in 
eukaryotes, all of which are identified in the QExactive data. All of the subunits 
elute in fraction 17 (figure 3.18), however the cluster analysis groups them into two  
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3.13 Hierarchical clustering of mixed bed ion exchange fractionation replicate 1 
The fmol of each protein in each fraction was imported into Multiple Experiment 
Viewer (MeV) software, and a heat map was generated of the cluster proteins. 
Hierarchical clustering of a) the fmol amounts was achieved using Pearson 
correlation. A second heat map was also generated b) of the normalised data. 
Normalisation was achieved by calculating the percentage of each protein found in 
each fraction, and a heat map generated as before. 
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3.14 Hierarchical clustering of mixed bed ion exchange fractionation replicate 2 
The fmol of each protein in each fraction was imported into Multiple Experiment 
Viewer (MeV) software, and a heat map was generated of the cluster proteins. 
Hierarchical clustering of a) the fmol amounts was achieved using Pearson 
correlation. A second heat map was also generated b) of the normalised data. 
Normalisation was achieved by calculating the percentage of each protein found in 
each fraction, and a heat map generated as before. 
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3.15 Hierarchical clustering of mixed bed ion exchange fractionation replicate 3 
The fmol of each protein in each fraction was imported into Multiple Experiment 
Viewer (MeV) software, and a heat map was generated of the cluster proteins. 
Hierarchical clustering of a) the fmol amounts was achieved using Pearson 
correlation. A second heat map was also generated b) of the normalised data. 
Normalisation was achieved by calculating the percentage of each protein found in 
each fraction, and a heat map generated as before. 
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3.16 Hierarchical clustering of mixed bed ion exchange fractionation replicate 4 
The fmol of each protein in each fraction was imported into Multiple Experiment 
Viewer (MeV) software, and a heat map was generated of the cluster proteins. 
Hierarchical clustering of a) the fmol amounts was achieved using Pearson 
correlation. A second heat map was also generated b) of the normalised data. 
Normalisation was achieved by calculating the percentage of each protein found in 
each fraction, and a heat map generated as before. 
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3.17 Hierarchical clustering of mixed bed ion exchange fractionation replicate 5 
The fmol of each protein in each fraction was imported into Multiple Experiment 
Viewer (MeV) software, and a heat map was generated of the cluster proteins. 
Hierarchical clustering of a) the fmol amounts was achieved using Pearson 
correlation. A second heat map was also generated b) of the normalised data. 
Normalisation was achieved by calculating the percentage of each protein found in 
each fraction, and a heat map generated as before. 
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a)
b)
LSM8
LSM6
LSM5
LSM3
LSM2
LSM4
LSM7
LSM1
Side view
Top view
Figure 3.18 Clustering of the Like-SM (LSM) protein complex subunits 
Hierarchical clustering of the mixed bed fractionation normalised to percentage protein was 
performed in MeV software using Pearson correlation.  An example a) of the LSM complex 
subunits clustering in two subsets is shown, and b) the structure of the LSm complex, as 
shown in Zhou et al., 2014, and visualised using PyMOL software. c) the graphical 
representation of the fmol amount of each protein identified. 
 
b) 
c) 
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subsets, one group of five proteins, one smaller group of three proteins. This is 
because the proteins in the smaller subset, consisting of LSM1, LSM4 and LSM7, are 
all identified in fraction 13 in addition to fraction 17. The data from replicate 1 is 
shown, for other replicates see supplementary material. There are two known 
complexes of LSm proteins, LSM 2-8, which interacts with U6 snRNA, and LSM 1-7, 
associated with mRNA degradation, so it is possible that two structures are forming 
(Bouveret et al., 2000). However, LSM1 was actually found in both locations of the 
gradient, in fraction 13, and also in fraction 17, where LSM8 is also identified.  
Other examples of protein complexes showing sharp elution profiles and clustering 
together include RNA polymerase II transcription inititation factor TFIIA and the 
HAT1-HAT2 histone acetyltransferase complex. TFIIA consists of two subunits, 
TOA1, the large subunit, and TOA2, the smaller subunit. The two proteins cluster 
together in fraction 22, but elute over a number of fractions, indicating the complex 
has a high affinity for the chromatography media (figure 3.19 a & b). The 
chromatography of the heterodimer HAT1-HAT2 histone acetyltransferase complex 
is much sharper, with both subunits eluting together in fraction 22. The difference 
in the chromatographic profile of these two complexes is reflected in both the 
graphical representation, and the heat map generated (figure 3.19 c & d). Replicate 
1 data is shown for these complexes, for additional replicates, see supplementary 
material. 
Some variation in the chromatographic behaviour of the different protein 
complexes is to be expected, due to the structural variation in the wide range of 
protein assemblies identified. Many of the complexes identified show a sharp peak 
in the chromatography, eluting in just one fraction, for example the ARP2/3 
complex, which has seven subunits eluting in fraction 15 (figure 3.20 a). Other 
protein-protein interactions appear to remain stable under these experimental 
conditions, but elute in more than one fraction, and at different times in the 
gradient, such as phosphofructokinase, an octameric complex consisting of four 
heterodimers of an α subunit, PFK1, and a β subunit, PFK2.  The two subunits have 
the same elution profile, indicating the complex remains intact, but both have a  
Chapter 3 
 
 Page 68 
 
 
  
Figure 3.19 Heirarchical clustering of complexes in fractionation results 
Hierarchical clustering of normalised LC-MS/MS results of the mixed bed 
chromatography fractions. Clustering of a) TOA1 and TOA2 subunits of transcription 
factor II A complex and b) the fmol amount identified, and c) the clustering of HAT1 
and HAT2 subunits of the histone acetylase complex, and d) the fmol amounts of each 
identified in the fractions. 
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Figure 3.20 Examples of protein complex elution in mixed bed fractions 
QExactive data was analysed by MaxQuant, and the iBAQ intensity calculated 
for each protein. The amount of each protein was calculated and results shown 
for a) the ARP2/3 complex, b) a complex of methionyl and glutamyl-tRNA 
synthetases bound to ARC1, c) phosphofructokinase, d) the nucleosome e) the 
structure of the complete nucleosome octamer, from White et al., 2001 f) 
trehalose-6-phosphate synthase/phosphatase, and g) the fatty acid synthase. 
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double peak (figure 3.20 b), suggesting some of the protein is remaining attached to 
the column while the first peak is eluting. This either suggests that there are two 
different conformations of the complex observed, that one or both of the proteins 
has been partially phosphorylated, or that the heterodimer is interacting with 
another protein, or complex. There is evidence for PFK1 interacting with 172 other 
proteins, according to the IntAct database, and 152 for PFK2, the majority of which 
are gathered from TAP tag studies, so other interactions are possibly the reason for 
the double peak observed here. Another example is the mitochondrial processing 
protease, the two subunits of which (MAS1 and MAS2) elute in the same fractions, 
and peak in concentration in two separate positions (figure 3.20 c). The MAS1 
subunit can undergo phosphorylation, and therefore the two peaks may be caused 
by the two forms of MAS1, phosphorylated and unmodified. Another example of a 
complex exhibiting double peaks is the nucleosome complex, which consists of 
multiple copies of four histone proteins. There are six nucleosome associated 
proteins identified, four core proteins H2A, H2B, H3 and H4, the linker histone H1, 
and also the H2A variant H2AZ. When the fmol amounts of these proteins are 
plotted, they separate into two distinct peaks, which elute at two positions in the 
gradient (figure 3.20 d). The complete complex is an octamer, composed of two 
copies of each of the core histones, which assemble into subcomplexes. A tetramer 
forms, consisting of two H3 and two H4 proteins, which binds DNA and then 
recruits two copies of H2A and two copies of H2B (White et al., 2001) (figure 3.20 
e). A single copy of histone H1 then binds the assembled octamer. The peak 
observed at fraction 27 consists of the four core histones, while the peak eluting 
earlier in the gradient, at fractions 19-20 also includes H1. This could indicate the 
addition of the linker histone alters the isoelectric point of the complex, or the 
completed assembly may be in two forms, one of which is bound to a strand of 
DNA, which carries a negative charge, and would therefore alter the affinity of the 
complex proteins to the chromatography medium. In addition, there are 57 
interactions listed for histone H1 in the IntAct database, so other interactions are 
possible. 
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Despite the improvement in resolution observed when using mixed bed 
chromatography, some complexes elute in wide peaks. This indicates that these 
complexes have a higher propensity to bind to the column. Some elute over a wider 
range of fractions, such as trehalose-6-phosphate synthase/phosphatase, which has 
three subunits eluting across almost 20 fractions, although the third, regulatory 
subunit, TPS3 eluted over just 7 of the middle fractions (figure 3.20 f). The three 
subunit chromatograms of this protein do not show as good a correlation as some 
other complexes, possibly indicating they have dissociated, are partially assembled, 
or are eluting as individual proteins. Fatty acid synthase also shows a wider peak 
elution the two subunits of which elute from the column sharply in fraction 18 and 
then the peak tails off slowly (figure 3.20 g).  
There are also other examples of complexes showing similar behaviour, such as the 
ribosome complexes, which elute across a wide range of fractions, spanning a large 
part of the gradient. The ribosomes are made up of a large (60S) and small (40S) 
subunit, and are both relatively large structures (Ben-Shem et al., 2010). There 
were 38 subunits identified from the 40S ribosome across fractions 12 to 22 (figure 
3.21 a), and 59 subunits associated with the 60S ribosome identified across 
fractions 15 to 28 (figure 3.21 c). For both complexes subunits were identified in 
different fractions, eluting at different parts of the gradient, indicating that the 
complex was dissociated, or partially assembled. Hierarchical cluster analysis sorted 
the 40S ribosome proteins into seven distinct clusters (figure 3.21 b), while the 60S 
ribosome sorts into approximately 6 clusters (3.21 d), each containing three or 
more proteins, which may indicate that there was some level of organisation in the 
ribosome proteins. Growing yeast cells must produce large numbers of ribosomes 
to enable transcription, and the cellular ribosome proteins can undergo rapid 
turnover (Pestov & Shcherbik, 2012). The spread of the subunits across multiple 
fractions and in a number of clusters may, therefore, represent ribosome proteins 
partially assembled into complexes. On the other hand, the ionic conditions used in 
eluting proteins from the mixed bed chromatography column may cause disruption 
to some electrostatic interactions within the protein complexes. The assemblies are 
so large and subunits so numerous that multiple interactions occur for each  
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a)
b)
d)
f)
40S ribosome
60S ribosome
c)
e)
Figure 3.21 Chromatographic elution of the subunits of the ribosome 
complexes. 
QExactive data was analysed by MaxQuant software, to find the iBAQ intensity 
of each protein, used to calculate the fmol, and a) the fmol of 40s ribosome 
subunits plotted, and b) the structure of the complex, from Ben-Shem et al., 
2010  and c) the clustering of complex subunits. d) the quantification of the 60s 
ribosome subunits, e) the structure and f) the hierarchical clustering. 
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protein.  Therefore the dissociation of some protein interactions, particularly in 
large systems such as the ribosomes, may be expected. There are also examples of 
proteins that are present in multiple complexes, such as the RNA polymerase 
subunits. There are three types of RNA polymerase in yeast, termed RNA 
polymerase I, II and III. Each complex has some unique subunits, and some shared 
subunits. RNA polymerase I contains 14 subunits, 7 of which are unique, and 7 are 
also constituents of RNA Polymerase II or III. RNA polymerase II consists of 12 
proteins, 7 of which are unique, and RNA polymerase III contains 16 subunits, 9 are 
unique, and 7 are shared with the other two complexes. The graphs of each 
complex had multiple peaks, while the unique proteins elute in just one peak (figure 
3.22). Hierarchical cluster analysis shows at least two distinct clusters, one in 
fraction 27-29 containing the RNA polymerase I subunits, and a clear cluster in 
fractions 22-26 for the RNA polymerase II subunits (figure 3.23 a). There was also a 
third, less distinct cluster in fractions 26-27 containing those subunits unique to 
RNA polymerase III. Examining the unique subunits to each complex gives three 
distinct peaks, while picking out the subunits that can be present in multiple 
complexes, many had multiple peaks (figure 3.23 b-f). Those subunits that are 
unique to RNA polymerase III were present at lower concentrations than those 
from the other complexes, supporting the clustering of the heat map, showing a 
less intense cluster in this position.   
There are also indications of other proteins forming multiple interactions, such as 
zuotin (ZUO1), a chaperone which interacts with Hsp70 chaperone SSZ1 and SSB1/2 
(Gautschi et al., 2001).  ZUO1 elutes from the mixed bed column in two distinct 
peaks, one of which co-elutes with SSZ1 and the other with SSB2 (figure 3.24). This 
indicates the chaperone is partly associated with each protein, either because they 
are partly assembled, or partially dissociated.  
3.3.6 The exosome complex 
 
The eukaryotic exosome is a multi-subunit complex required for the degradation of 
3’-5’ RNA. It consists of nine non catalytic subunits, Rrp40, Rrp4, Rrp41/Ski6, Rrp42, 
Rrp43, Rrp45, Rrp46, Csl4, and Mtr3 arranged into a ring structure, and one  
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a) b)
c) d)
e) f)
RNA polymerase I
all subunits
RNA polymerase I
unique subunits
RNA polymerase II
all subunits
RNA polymerase II
unique subunits
RNA polymerase III 
all subunits
RNA polymerase III
unique subunits
Figure 3.22 Quantification of RNA polymerase subunits in mixed bed fractions. 
Results are analysed by MaxQuant software, which reports the iBAQ intensity 
of each protein, used to calculate the fmol. The fmol in each fraction is 
calculated by multiplying by the total fraction volume, and results are shown for 
a) each RNA polymerase I subunit, b) each unique RNA polymerase I subunit, c) 
each RNA polymerase II subunit, d) each unique RNA polymerase II subunit, e) 
RNA polymerase III subunits, and f)  unique RNA polymerase III subunits. 
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b) c)
d) f)
RPA10 
RPA12
RPC40
RPC19
RPA135
RPA190
RPA42
RPA14
RPO26
RPC53
RPC82
RPC37
RPO31
RPC17
RPB4
RPB7
RPB3
RPB11
RPO21
RPB2
RPB9
RPB5
RPC10
RPB8
RPA34
c) e)
Figure 3.23 Hierarchical clustering of RNA polymerase subunits and 
quantification of the subunits with roles in multiple complexes. 
a) hierarchical clustering  of the normalised results of RNA polymerase subunit 
quantification. Normalisation is achieved by calculating the percentage of each 
protein found in each fraction. The fmol results for those subunits that are 
present in all three complexes are plotted for b) RPB5, c) RPB8, d) RPB10, e) 
RPC10 and f) RPO26. 
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  Figure 3.24 LPD1 (Dihydrolipoamide dehydrogenase) protein quantification in 
mixed bed fractions 
The quantities of protein (fmol) in each sample injected was calculated from 
the Qexactive data by processing with MaxQuant software. The total protein 
per fraction was then calculated by multiplying by the total volume, and the 
result is displayed for ZUO1, SSZ1 and SSB2. 
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catalytic subunit, Rrp44/DIS3, at the top of the ring (figure 3.25 b)  (Makino et al., 
2013b). In the nucleus, the catalytic subunit Rrp6 is also associated with the 
complex, although this subunit is not identified in this data. All 10 of the cytosolic 
exosome complex subunits are quantified in the fractionation replicates, with just 
one subunit, CSL4, missing from replicate 4 (figure 3.25 a). The structure of the 
complex is stoichiometrically equal, and therefore, if the complex remains whole, 
there will be equal amounts of each subunit identified. However, the label free 
quantification does not reflect this. In all replicates, the 10 subunits are identified in 
one fraction, indicating that they remain in complex, but they are apparently 
present at different concentrations. In the most extreme example, replicate 5, 
there is a 31 fold difference in the amount of the highest subunit, DIS3, and the 
lowest subunit, RRP46. In each replicate, DIS3 is the most abundant exosome 
subunit, and when all 10 subunit quantities are plotted against each other as 
scatter graphs (figure 3.26 a & b), there is a general linear trend. Therefore, the 
proteins that are identified at lower concentrations are consistently lower, while 
the higher abundance proteins are consistently higher, indicating there is an 
experimental reason why these proteins perform differently under LC-MS.  
Not all of the exosome subunits are identified in samples run on the G2 and 
processed using PLGS. This is to be expected, since the G2, on average, returned 
almost half of the hits of the QExactive runs. In replicate 1 only 8 proteins were 
identified, replicate 2 there were only 3 proteins identified, and replicate 3 there 
were 2 proteins. In replicate 4, only the highest concentrated protein DIS3 is 
identified. Four proteins were also missing from replicate 5, but a comparison of 
the G2 and QExactive data was possible by looking at the common peptides 
identified in replicates 1 and 5. The comparison of the fmol amounts of each 
protein found using both instruments (figure 3.27 a-d) does show a somewhat 
linear relationship, with adjusted R2 values (calculated in origin) of 0.7 for replicate 
1 and 0.5 for replicate 5. This indicates that the proteins are quantified similarly in 
both types of mass spectrometer, with the lower abundance proteins consistently 
low, and the differences observed in the quantification of the subunits are due to 
the properties of the protein, not the mode of analysis. 
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Replicate 1
Replicate 2
Replicate 3
Replicate 4
Replicate 5
b)
a)
Dis3
Dis3
Figure 3.25 Label free quantification results of the exosome subunits 
Label free quantification results  are reported a) for exosome subunits in all five 
replicates. b) the structure of the S. cerevisiae exosome complex, with Dis3 
arranged at the top of a round structure formed from a single copy of each 
other subunit, obtained from Makino et al., 2013. 
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a)
b)
Figure 3.26 The exosome subunits quantities in five replicates calculated by 
MaxQuant processing 
The QExactive data was processed using MaxQuant software, and a) the fmol 
amount of each of the exosome proteins in the five replicates of mixed bed 
fractionation, and b) a scatter matrix of the five replicates of protein 
quantifications plotted against each other.  
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a) b)
c) d)
R = 0.66
R = 0.46
Figure 3.27 Exosome label free results calculated from G2 data 
G2 data was processed by PLGS software, which gives a result in fmol per injection, 
which was then corrected for digest volume.  a) line graph representing the amount 
of each subunit in replicate 1, and b) the fmol amount of each subunit in the PLGS 
processed data  against the MaxQuant processing. c) the fmol amount of each 
exosome subunit in replicate 5, and d) the fmol amount of each subunit in the PLGS 
processed data plotted against the MaxQuant processed data. 
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The proteins that were quantified at the lowest concentrations do so repeatedly 
across all of the replicates. In the QExactive data CSL4 is quantified at the lowest 
amount in all replicates, however it is not identified at all in replicates 4 or 5. MTR3 
is quantified as the second lowest subunit in four replicates, from just 1 to 5 
peptides in each replicate, a total of 7 peptides in 5 replicates, with just one of 
which is present in all replicates. In the third lowest concentration subunit, RRP46, 
which has 5 peptides identified, only two are found in all replicates. This may mean 
the low concentration of these subunits is due to a lack of peptides that are 
consistently observable on a mass spectrometer (figure 3.28 a). In label free 
quantification, the intensity of the peptides is taken to represent the quantity of the 
protein. Therefore, any errors in protein quantification must be due to differences 
in the peptides intensities observed. Of 56 peptides identified in total, there are 21 
common to all 5 replicates. If the intensities of these are plotted against each other 
on a scatter matrix, they show a somewhat linear relationship, indicating that less 
detectable peptides perform consistently poorly across all replicates (figure 3.28 b). 
If this is the case, the reason for the low quantification of some subunits could be 
that the iBAQ based label free analysis has used less intense peptides in the 
quantification. There are only two replicates of G2 data that have enough peptides 
to perform a comparison, but in both of these there is a somewhat linear trend, 
although much less than the protein quantification (R2 values 0.1 and 0.04) (figure 
3.28 c and d). This indicates a wide variation in peptide intensity. The observation of 
a peptide on a mass spectrometer depends on the peptide performance in the 
chromatography, and ionisability in the mass spectrometer, both of which are 
dependent on the physicochemical properties of the peptide. These properties can 
cause peptides to behave differently in different mass spectrometers (Mallick et al., 
2007). The two mass spectrometers differ in design; the Waters Synapt G2 is a 
quadrupole-time of flight instrument, while the Thermo QExactive is a quadrupole 
orbitrap. The design of an orbitrap mass spectrometer means that ions are trapped, 
and accumulate prior to their release into the detector. This increases the chance of 
acquiring all the peptides, which means there will be a difference in the number of 
peptides observed by the two instruments. The less linear effect observed when the 
intensities from both mass spectrometers are plotted indicates that peptides are  
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a)
d)c)
b)
R2 = 0.1 R2 = 0.04
Figure 3.28 Qexactive reported intensities of the exosome peptides identified. 
The Qexactive data is processed by MaxQuant software, a) the number of 
peptides identified in each replicate, b)the common peptides found in all five 
replicates plotted as a scatter matrix, and c) the replicate 1 intensities of the 
peptides common to both the G2 and Qexactive data sets plotted against each 
other, and d) the replicate 5 common peptide intensities plotted against each 
other. 
 
R2 = 0.1 
C) d) 
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not performing the same in the two instruments. In addition, the data from the two 
instruments is processed differently, with PLGS using the top three most intense 
peptides to calculate the fmol amount of protein, while MaxQuant uses IBAQ, 
taking into account all of the peptides found, and the theoretical probability of 
observing the peptides from a protein. However, the fmol amount plotted against 
each other does show a linear relationship, which indicates that the variation in 
peptide intensities is somewhat accounted for in the processing, however the 
variation in the exosome quantification shows that the label free processing does 
not overcome all of the differences in peptide observation.   
3.3.7 The 20S proteasome 
 
The 20S proteasome is another example of a protein assembly whose subunits co-
elute using mixed bed ion exchange chromatography. The complex is responsible 
for degradation of proteins within the cell, and consists of 14 proteins, 7 β subunits 
arranged in a ring structure, with two rings stacked on top of each other, encased 
on either side by another ring structure, consisting of 7 α subunits (figure 3.29) 
(Groll et al., 1997). Therefore, the complex consists of two copies of each of the 14 
different subunits, which should be equimolar.  
All 14 subunits are identified in all five replicates of the MaxQuant data (figure 
3.29). There are differences in the amount of each subunit quantified, in the most 
extreme case up to a five fold difference in replicate 1, between PUP1 at 6 fmol and 
SCL1 at 32 fmol. Although there is a difference in the amount of protein quantified 
in all five replicates, those at a higher concentration are higher in all replicates. 
SCL1 is among the top three proteins in all replicates (figure 3.30 a). When the fmol 
amount of each protein in the five replicates are plotted as a scatter matrix, it 
supports the idea that the proteins quantified at a higher concentration do so 
repeatedly (figure 3.30 b). 
The number of peptides identified differ for each protein, and the three lowest 
concentration proteins, PUP1, PUP3 and PRE4, have the least number of peptides 
identified (figure 3.31 a), therefore, the low concentration calculated for these  
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20s label free
b)
a)
α αβ β
Figure 3.29 Quantification of the 20S proteasome in 5 replicates of mixed bed 
ion exchange 
a) QExactive data was processed using MaxQuant, and the fmol amounts of 
each protein were calculated based on the iBAQ intensity reported. b) the 20S 
proteasome structure, obtained from Groll et al., 1997. 
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Figure 3.30 The total material quantified for all 20S proteasome subunits in all 
five replicates. 
The label free quantification of each protein is calculated using MaxQuant 
processed data, and a) the fmol of each protein plotted in descending order, 
and b) a scatter graph depicting the total fmol identified across all fractions, 
plotted against the material in the other four replicates.   
 
a) 
b) 
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Number of peptides identified Total intensity of peptides identified
b)
Figure 3.31 Peptide intensities of 20S proteasome subunits identified in all 
five replicates. 
a) The number of peptides identified from each protein by MaxQuant 
processing of QExactive data, and b) the total peptide intensity for each protein 
in each replicate, c) the intensities of common peptides to all replicates, plotted 
against each other. 
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proteins may be due to a lack of observable peptides. The difference in the number 
of peptides also influences the total peptide intensity (figure 3.31 b), which 
increases as more peptides are identified. When the intensity of each individual 
peptide are plotted against the other replicates, there is a less obvious trend in the 
peptide intensities than was observed at the protein level (figure 3.31 c), however 
there is still a positive relationship. This indicates that peptides which ionise poorly 
do so consistently, and if these peptides are used to calculate the protein 
concentration, it may result the variation in protein quantification observed. In 
most replicates there is a positive relationship between the peptide intensities in 
the G2 data and the QExactive (figure 3.32). The two data sets are processed using 
different types of software, the G2 data by PLGS which uses the top 3 most intense 
peptides, while the QExactive data is processed using MaxQuant and the iBAQ 
intensity. The trend between the two data sets may indicate that the proteins 
which are quantified at lower concentrations are due to lower intensity peptides.  
3.4 Conclusions 
 
The method developed for the fractionation of S. cerevisiae cell lysate using mixed 
bed ion exchange chromatography has successfully separated a number of protein 
complexes, which show a variety of elution behaviours. Despite some protein 
interactions being disrupted, it has been possible to quantify some protein 
complexes. However, it is possible that, had a gentler method of fractionation been 
used, such as gel filtration, more complexes, and more transient interactions, would 
have been observed. An added advantage in SEC is that it is relatively easy to define 
if a protein is forming an interaction, as it appears in the gradient at a higher mass 
than its own. A comparison of the two methods would have been an interesting 
addition to this chapter, and in the case of additional complexes found using SEC it 
would have been possible to define the interactions occurring as electrostatic. The 
resolution of SEC separations could have been increased by using a sequence of 
columns, enabling a wide range of molecular masses to be separated. 
Another useful addition to this chapter would have been the use of some control 
samples, to find a method of disrupting protein complexes, however it would be  
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Replicate 1 Replicate 2
Replicate 3 Replicate 4
Replicate 5
R2 = 0.5
R2 = 0.7 R2 = 0.2
R2 = 0.5
R2 = 0.1
Figure 3.32 Peptide intensities of 20S protein subunits. 
The Qexactive data is processed by MaxQuant software, which reports the 
intensity of all of the 20S peptides identified, while the G2 data is processed by 
PLGS. The intensities of the peptides common to both the G2 and Qexactive data 
in all five replicates are plotted against each other. 
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difficult to disrupt the protein-protein interactions without also affecting the 
tertiary structure of the protein, and therefore there would be no guarantee that 
any effects observed are not the consequence of denaturing the protein and not 
just the interactions. However, a control would have provided support for the fact 
that the proteins are chromatographing as part of complexes, and not just because 
they have similar isoelectric points, although all of the complexes seen here are 
supported in literature.  
Some complexes elute in single, sharp peaks, while others are spread across 
multiple fractions, or elute in multiple, discrete peaks. In some cases, this may 
indicate that there are multiple conformations, post translational modifications, or 
there may be more interactions occurring. 
The data presented here indicates that label free analysis may not provide a 
suitable method of analysing the stoichiometry of proteins within a complex. The 
quantification relies on the availability of quantotypic peptides, which for some 
proteins are less available. The mode of analysis used here applies data dependent 
acquisition, which targets only a selection of the peptides available within the 
sample, thereby eliminating some proteins from the analysis. There are more 
accurate methods of quantitative proteomics available, which will be examined in 
the next chapter.  
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Chapter 4: Quantification of protein complexes using Selected Reaction 
Monitoring  
4.1 Introduction 
Large scale protein interaction studies, implementing techniques such as Y2H 
experiments, or TAP tag projects, have over the years gathered a plethora of 
information about protein-protein interactions occuring within the S. cerevisiae cell 
(Uetz et al., 2000; Gavin et al., 2002; Yu et al., 2008; Rajagopala et al., 2012). In 
addition, a number of other techniques have been used to extend the study of 
individual interactions to the analysis of entire multi-subunit protein complexes. 
Traditional methods of studying protein complexes include gel electrophoresis and 
size exclusion chromatography (Camacho-Carvajal et al., 2004; Rivers et al., 2007; 
Liu et al., 2008), while in more recent years mass spectrometry methods have also 
been implemented. Native mass spectrometry techniques have been used in the 
successful study of both the yeast proteasome and exosome complexes (Loo et al., 
2005; Synowsky et al., 2006), however these techniques require large sample 
amounts, purified complexes, and the complex must remain stable under ESI 
conditions. Although these techniques yield valuable information, alternative 
approaches can be used to yield much more accurate results for quantitation of the 
protein subunits, and may also provide a more detailed view of complex 
stoichiometry. 
Chapter 3 focused on the quantification of protein complexes using mass 
spectrometry followed by label free analysis. As discussed in Chapter 3, for some 
protein complexes identified by label-free quantification, the concentration of the 
individual proteins does not conform to the expected relationship between 
subunits (figures 3.25, 3.29). Examples of this behaviour included the 20S 
proteasome, a complex responsible for degradation of proteins within the cell, 
which consists of 14 protein subunits, seven β subunits arranged in a ring structure, 
with two rings stacked on top of each other, encased on either side by another ring 
structure, consisting of seven α subunits (see figure 3.29) (Groll et al., 1997). 
Therefore, the complex consists of two copies of each of the 14 different subunits 
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and the label-free quantification results should be equal. Although the structure of 
the complex has been confirmed in numerous studies (Groll et al., 1997; Beck et al., 
2012), the label free data obtained from both the Waters Synapt G2 and the 
Thermo Scientific QExactive do not reflect the protein complex stoichiometry, as in 
some instances there were relatively large differences in the quantity of some 20S 
proteasome subunits.  
These inaccuracies in the quantification could indicate that label-free proteomics is 
not an appropriate method for the study of protein complex stoichiometry. Label-
free absolute quantification relies on spiking a known quantity of a standard 
protein into the sample to be analysed. The standard protein peptide intensities are 
then taken to represent the amount of protein that was spiked in, and the 
quantification of all other proteins in the sample are calculated based on the ratio 
of sample peptide intensity compared to the intensity of the standard peptides 
(Silva et al., 2006). In this case the ratio is calculated either by comparing just the 
top three most intense peptides using PLGS to analyse the Synapt G2 data, or when 
using MaxQuant for the QExactive data used in chapter 3 the ratio is calculated by 
intensity based absolute quantification (iBAQ), using the sum of all the peptide 
intensities divided by the number of theoretically observable peptides for each 
protein (Schwanhausser et al., 2011). These methods are based on the concept that 
the intensities observed are representative of the total amount of protein, 
however, the intensity observed can differ as a result of the physiochemical 
properties of the peptides, and can vary with experimental conditions (Mallick et 
al., 2007; Sanders et al., 2007). The nature of a shotgun proteomics approach, in 
loading all of the peptides in a sample for analysis at the same time, can cause a 
bias in the results towards the highly abundant, well ionising peptides. Therefore, 
there may be inaccuracies in quantification due to less abundant proteins failing to 
be identified. In addition, the peptides generated from a complex sample, differing 
in size and amino acid composition, may mean some peptides exhibit less 
propensity for ionisation than the standard peptides, giving an inaccurately low 
signal (Craig et al., 2005; Kuster et al., 2005). 
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Absolute quantification of proteins can also be achieved by label mediated 
quantification using a stable isotope labelled protein standard using a number of 
techniques, which potentially provides a more accurate method of quantitation 
(reviewed in Brun et al., 2009). In this technique anything from an individual 
peptide to an entire recombinant protein can be labelled with heavy radioactive 
isotopes, to be mixed with the sample of interest, analysed by mass spectrometry 
and an accurate quantification can be determined from the ratio of heavy labelled 
standard to the analyte protein or peptide. These label mediated methodologies 
are potentially more accurate than label free quantification, as the standard 
peptides or protein will be physicochemically identical apart from the small 
difference in mass introduced by the label, and therefore standard and analyte 
should behave in the same manner in all aspects of the experiment, including both 
the enzymatic digestion, and in the chromatography system, but will be resolved 
during analysis in the mass spectrometer.   
The heavy isotope  labelled standards used can be synthesised in the form of a 
whole recombinant protein in PSAQ technology (Picard et al., 2012), or as individual 
peptides in the form of AQUA peptides (Gerber et al., 2003) for a small scale study. 
Alternatively, a recombinant protein consisting of a number of tryptic peptides can 
be designed, to act as standards for the quanitification of numerous proteins, 
termed a QconCAT (Beynon et al., 2005; Rivers et al., 2007). Targeting a number of 
peptides makes this technology useful in the design of a larger scale study. All of 
these methods have been successfully implemented in the absolute quantification 
of individual proteins for many studies, and AQUA peptides in combination with 
MRM have been successfully used to quantify human spliceosomal subcomplexes 
(Hochleitner et al., 2005; Schmidt et al., 2010). 
A QconCAT consists of a number of proteotypic peptides (Qpeptides) from 
approximately 20 different proteins concatenated into one recombinant protein 
sequence. If more proteins are to be quantified, a series of QconCATs can be 
designed. Generally, two or more peptides for each protein would be included to 
provide both increased accuracy, and a provision in the case of an unusable 
Qpeptide. Included in each QconCAT is a hexahistidine tag sequence for 
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purification, and a standard glufibrinopeptide sequence for the quantification of the 
QconCAT protein itself. Once the recombinant protein gene sequence is designed, it 
is expressed in a heavy labelled form (usually [13C6]-arginine and [
13C6]-lysine for 
tryptic Qpeptides), quantified, mixed with the analyte and then the sample is 
tryptically digested. This yields a sample containing a mixture of heavy labelled 
Qpeptides, and the light analyte peptides. This sample mixture is then analysed 
using a LC-MS, and the quantity of sample protein can be calculated using the ratio 
of the heavy labelled peptide to light sample peptide (figure 4.1). The technology 
has been successfully implemented in the quantification of proteins from a number 
of different samples (Carroll et al., 2011; Bislev et al., 2012; Peffers et al., 2013; Al-
Majdoub et al., 2014).  
When designing a QconCAT it is important to carefully consider the choice of 
Qpeptides, in addition to being proteotypic they must be quantotypic, representing 
the quantity of the protein being targeted. The peptide selected must be unique to 
that single protein of interest, and it is also preferable to select peptides that have 
been observed in previous proteomics experiments. There are a number of mass 
spectral libraries available to verify this, such as PeptideAtlas or PRIDE (Jones et al., 
2006; Deutsch et al., 2008). The sequence context of the peptides chosen should be 
carefully considered, as certain sequence contexts can make the C terminus of the 
arginine or lysine residues less susceptible to digestion (Thiede et al., 2000; Lawless 
& Hubbard, 2012). Dibasic residues can be cleaved at the C terminus of either 
residue, and an acidic residue immediately following the arginine or lysine may 
impair cleavage, as will a proline in the same position (Thiede et al., 2000). It is also 
advisable to avoid any peptides that are potential sites for post translational 
modifications, as the signal can be split between the two forms. Methionine or 
cysteine residues should be avoided, as the sulphur containing side chains can 
undergo oxidisation reaction, adding 16 Da to the mass of the peptide, and a 
glycine residue immediately following an asparagine can allow a deamidation 
reaction to occur, causing a 1 Da mass shift. There are various software tools 
available to assist in selecting peptides for QconCATs, including MC:pred (Eyers et 
al., 2011) for predicting how well the peptide will undergo enzymatic digestion, and  
Chapter 4 
 
 Page 94 
 
  
Candidate peptides from each
protein are assessed for PTM
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Qpeptides are assembled into
one recombinant protein
sequence, which is then
expressed in E.coli
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standard are mixed and
digested with trypsin to give
a mixture of standard and
analyte peptides
Standard and analyte mixtures
are analysed by mass
spectrometry, where the ratio
of standard to analyte ion is
used to quantify the sample
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Figure 4.1 Quantifying a complex protein sample using QconCAT technology 
The protein sequences are analysed to decide on the optimum target peptides. 
These are then concatenated into one recombinant protein sequence, which is 
expressed in E.coli, with heavy isotope labelling. The QconCAT is then quantified, 
tryptically digested, and standard and analyte peptides are then mixed, and 
analysed at the same time using mass spectrometry. The analyte is then 
quantified by calculating the ratio of the standard to analyte ions.  
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CONSequence (Eyers et al., 2011; Lawless & Hubbard, 2012), a tool for predicting 
the potential for observing a peptide in a mass spectrometer.  
Once a QconCAT has been designed, expressed, mixed with analyte proteins and 
digested the mixture of peptides can be co-analysed by LC-MS. Selected reaction 
monitoring (SRM) may prove a more accurate method of analysing a Qpeptide and 
analyte pair. In this approach, the standard and analyte mixtures are loaded onto a 
triple quadrupole instrument. A quadrupole mass analyzer consists of four parallel 
rods that have fixed DC and alternating RF voltages applied. Ions pass through the 
quadrupole, focused between the four rods, and depending on the RF applied, only 
ions of a particular m/z will pass through. In a triple quadrupole instrument, the 
first quadrupole is used to isolate a predicted precursor ion, the second quadrupole 
acts as a collision cell to fragment the precursor ions, following which specific 
fragment ions are selected in the third quadrupole. This offers higher selectivity 
than shotgun methods, in that two levels of mass selection are used, which also 
enables the reduction of noise, allowing greater sensitivity. A series of 
precursor/fragment pairs (transitions) are selected, and both the heavy and light 
versions are targeted. The intensity of the peptides are then used to calculate the 
quantity of the light peptide, based on the known concentration of the heavy 
standard peptides. This type of mass spectrometry overcomes the bias towards 
abundant peptides seen in a shotgun experiment, and also the standard, heavy 
labelled peptide and unlabelled peptides should exhibit the same behaviour under 
the experimental conditions, potentially leading to increased accuracy of 
quantitation. The technique provides an accurate method for protein quantification 
(reviewed in Gallien et al., 2011; Picotti & Aebersold, 2012).  
4.2 Aims 
The aim of this chapter is to design QconCATs to accurately quantify the subunits, 
and thereby analyse the stoichiometry, of some of the protein complexes found in 
S. cerevisiae cell lysate fractionated by ion exchange chromatography in Chapter 3. 
A QconCAT will be designed to target all of the subunits in the 20S proteasome. The 
QconCAT and analyte mixtures will be quantified using a selected reaction 
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monitoring (SRM) approach on a Waters Xevo triple quadrupole instrument. This 
method will be compared to label free quantification for the complex subunits.   
Eukaryotic translation initiation factor 2 complex will also be quantified using 
QconCAT technology. The eukaryotic initiation factor (EIF2) is responsible for the 
recognition of start codons and the recruitment of initiator tRNA to the 40s 
ribosome to begin translation (Shin et al., 2011). The complex is a heterotrimer that 
consists of three subunits which should therefore be stoichiometrically equal, two 
of which, SUI2 and SUI3 are identified in separate fractions, while the third subunit, 
GCD11, is found alongside both of the other subunits.   If the label free data is 
correct, the complex could be partially dissociating, SUI2 and SUI3 dissociating from 
each other, while GCD11 is still partially bound to each. The stoichiometry of the 
complexes and behaviour of the subunit proteins will be confirmed via SRM.   
When analysing the composition of these protein complexes, the increased 
accuracy of the label mediated strategies and SRM approach may provide an 
advantage over label free analysis. Whereas label free methods scan mixtures of 
ions and select the most intense ions for MS/MS, the targeted nature of the 
QconCAT method, coupled with the advantages offered by using selected peptides, 
which should behave identically to the analyte peptides could provide a more 
accurate method for analysing protein complex stoichiometry. 
The design of the experimental workflow for the QconCAT based quantifications is 
shown in figure 4.2.   
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Design of QconCAT: find 
optimal peptides
Transform and express 
QconCAT plasmid in E. coli
Purification using Ni affinity 
column, check expression 
using  mass spectrometry
Digest and quantify QconCAT 
using LC-MS 
Spike QconCAT into relevant 
fraction digests
IEX chromatography of S. 
cerevisiae cell lysate replicate 6
Fractions concentrated using 
strataclean resin, and digested 
with trypsin
LC-MS using Q Exactive, and 
label free quantification using 
MaxQuant, find fractions 
containing protein complexes
Quantify complex subunits 
using SRM
Figure 4.2 Experimental workflow 
Workflow depicting the design of the experiment to compare the quantitation 
of protein complexes from ion exchange chromatography fractions.  
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4.3 Results and discussion 
4.3.1 Design of a QconCAT encoding peptides from the 14 subunits of the 20S 
proteasome 
A QconCAT was designed for the quantification of all of the subunits in the 20S 
proteasome. The complex consists of 14 subunits, all approximately the same size, 
ranging from 22.5 kDa to 31.6 kDa. In order to choose appropriate Qpeptides, first a 
theoretical tryptic digest was performed on the sequence of each protein. The N 
and C terminal peptides were immediately discarded, due to the propensity for 
modification, such as N terminal acetylation (Soppa, 2010) or C terminal prenylation 
(Zhang & Casey, 1996). The remaining peptides were then examined using a set of 
criteria for choosing optimal peptides. Firstly, they must be at an optimal size for 
detection by a mass spectrometer, and therefore, any peptides less than 6 amino 
acids in length were discarded (Brownridge & Beynon, 2011). They were then 
filtered for peptides containing an NG sequence which can undergo deamidation, 
an M residue which can undergo oxidation, or an N terminal Q, which is prone to 
partial conversion to pyroglutamic acid, dibasic residues because the C terminus of 
either of the amino acids could be cleaved, or any peptides with an acidic residue 
immediately following the tryptic cleavage site, as these are prone to miscleavages 
(Thiede et al., 2000; Brownridge et al., 2013). Any peptides with a KP or RP were 
filtered, as these will not be digested by trypsin, and any peptides containing C 
residues, which can form disulfide bridges and impair digestion. Following all of 
these filters, the resulting peptides were then analysed using the MC:Pred and 
CONSequence tools. MC:Pred predicts the likelihood of a peptide being miscleaved 
by trypsin. The tryptic peptides were searched using the SVM prediction type 
option on the MC:Pred software, and the results were filtered on a score 0.4. 
CONSequence predicts detectable peptides using four machine learning algorithms, 
and scores each peptide 1-4 according to the number of algorithms that predict 
that peptide will be observable. The filter applied was a CONSequence score of 3 or 
4. It was also attempted to choose Qpeptides that were observed in previous label 
free experiments, reported by the Q Exactive generated data in Chapter 3, as it is 
known these peptides are observable in LC-MS experiments. There are therefore a 
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number of criteria, and despite starting with 19-32 peptides for each protein, due 
to the stringent criteria, the majority of subunits did not have two peptides which 
meet all of these criteria, and the peptides eliminated by filters are shown in table 
4.1. 
 Table 4.1 Filtering of 20S proteasome tryptic peptides 
 
The aim was to include two peptides to represent each subunit, in order to increase 
both the likelihood of observing at least one, and to enable the averaging of the 
two peptide scores to increase reliability, so some of the filters then had to be 
relaxed. In these instances, firstly the MC:Pred score filter was raised to 0.5, and 
then peptides containing C, M or NG sequences had to be included, or in some 
cases, peptides that had not been previously observed in label free experiments. 
For example, the smallest protein, PUP3, at only 22.5 kDa, has only 19 tryptic 
peptides, and less than half are of sufficient length to be observable in a mass 
spectrometer. None of the tryptic peptides for PUP3 met all of the selection 
criteria, and it was necessary to choose peptides that were not observed in 
previous label free experiments, but that met other criteria. Other compromises 
made include four peptides with ‘NG’, for PUP1, FNNGVVIAADTR, for PRE7 
NQYEPGTNGK, for PRE10 AVENGTTSIGIK, and for PRE4 YDNGVIIAADNLGSYGSLLR. 
There are also three peptides included that contained methionine residues, for 
PRE3 MVVLTAAGVER, for PUP1 VVSALQMLK, and for PUP2 SMIEHAR. The final 28 
peptides chosen were then BLAST searched against the S. cerevisiae proteome to 
check they were unique to that protein before being assembled into one 
recombinant protein sequence.  
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One of the most important considerations in SRM experiments is the aim of keeping 
the standard and analyte peptide conditions as alike as possible. An important 
aspect of this is the tryptic digestion, and if there is any discrepancy between the 
digestion efficiency of the two peptides, it will result in an error in the 
quantification results. Even in situations where the two peptides are co-digested, 
there is still a discrepancy in the sequence context of the two peptides, as the 
standard peptide is concatenated with several other peptides originating from 
different proteins. This can cause discrepencies in digestion efficiency, as the 
QconCAT protein does not form a secondary structure, as the original protein 
would, which may alter the availability of some peptides to proteolytic attack, and 
this lack of secondary structure can cause QconCAT proteins to digest at a much 
faster rate than the analyte proteins (Rivers et al., 2007). Providing the digest has 
gone to completion, however, this should not affect the final results, as if the 
QconCAT and the original protein are both completely digested, all peptides should 
be exposed. A second issue with the difference in sequence context is the effect the 
surrounding amino acids have on the propensity for trypsin to cleave at a K or R 
residue. Trypsin cleaves at the C terminus of a K or R residue, except where it is 
followed by P, but the efficiency of the enzyme reaction differs depending on the 
sequence context (Brownridge & Beynon, 2011). The amino acids on either side of 
the trypsin specificity site affect the digestion efficiency (Siepen et al., 2006). With 
the aim of reducing any discrepencies in digestion efficiency between standard and 
analyte peptides, it was decided that each Qpeptide should be flanked by the three 
amino acids at the N and C termini in the original sequence context of the protein. 
In some cases, this involved the inclusion of sequences that were suboptimal for 
digestion. However, the aim is to ensure the standard and analyte peptides behave 
in the same manner, so if the analyte peptide is miscleaved, the standard should be 
to the same extent, to reduce the likelihood of a false result.  The final QconCAT 
sequence consisted of 28 Qpeptides, flanked by 3 amino acid linker sequences 
(Table 4.2).  
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 Table 4.2 20S proteasome peptides included in the QconCAT 
 
4.3.2 Design of a QconCAT encoding peptides from the eIF2 complex  
Another QconCAT, termed YEW1, was designed to encode all the subunits from the 
translation initiation factor 2 complex. Theoretical digests were performed using 
Pepmapper software and the resulting list of tryptic peptides was filtered using the 
same criteria as above (Table 4.3). Once again there are few peptides which pass all 
of the filters applied. The criteria again had to be relaxed so that two peptides per 
protein could be incorporated.  
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Table 4.3 Filtering of eIF2 tryptic peptides 
 
For the translation initiation factor 2 subunits SUI2 and SUI3 there were some 
suboptimal peptides included. SUI2 contains both FQIPLEELYK, which has a low 
CONSequence score, indicating it may not be observable in a mass spectrometer, 
however the other most suitable option, YGGVCNITMPPK, contains a methionine. 
As the QconCAT construct size will allow the addition of extra peptides, in this case 
both options were included, taking the SUI2 Qpeptide count up to three. For SUI3 
one of the peptide options, EGTPSANSSIQQEVGLPYSELLSR, contains an acidic 
residue following the tryptic cleavage site, which may result in a missed cleavage, 
so an additional peptide, LFFMVCK, was again included, taking the peptide count to 
three. This increases the chances of at least two peptides being observed.  
After the filter criteria were relaxed, there were a total of eight EIF2 Qpeptides for 
incorporation into the QconCAT (table 4.4). In addition to these eight peptides, 12 
peptides were included from proteins of the elongator complex, however data from 
these is not shown in this thesis.  
Table 4.4 eIF2 peptides included in the QconCAT 
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The three amino acids at the N and C terminus of the peptides were included to 
provide the same sequence context as in the original protein. In some cases, the 
sequence context was not optimal for digestion, and several of the three amino 
acid sequences contain an acidic residue before the trypsin cleavage site. Also, the 
inclusion of the tripeptide sequences involves incorporating more tryptic cleavage 
sites than necessary, as there were a number of additional K or R residues. This 
could cause higher numbers of miscleavages, but as the original sequence context 
was preserved as far as possible, any miscleavages should be to the same extent as 
the analyte peptide, preserving the relationship between analyte and standard 
signals, and preventing any error in quantification. This approach is based on the 
PCS strategy derived by Kito et al. (2007). 
The design of both YEW1 and YEW3 QconCATs included an mApple sequence at the 
N terminus of the Qpeptides (figure 4.3). The mApple protein is a fluorescent 
monomer which was included with the aim of quantifying the QconCATs by 
absorbance. Unfortunately, it was not possible to pursue this concept in the time 
frame of this thesis. At the C terminus of the Qpeptides a glufibrinopeptide 
sequence was included for quantification by mass spectrometry, and a hexa-
histidine tag for purification.  
4.3.3 Expression of YEW1 and YEW3 QconCATs 
YEW1 and YEW3 constructs were expressed in E.coli in minimal media containing 
heavy isotope labelled arginine and lysine as described in section 2.11. Expression 
of the QconCAT was confirmed by gel electrophoresis (Figure 4.4 a and b), where an 
additional band was visible in the post induction lanes of both cultures, at 
approximately 90 kDa, close to the molecular weights of the full QconCAT 
constructs. The suspected QconCAT proteins were then purified using the hexa-
histidine tag built into the construct, by Nickel affinity chromatography (for method 
see section 2.12). Purification of the protein was confirmed using gel 
electrophoresis (figure 4.4 c and d), where there was one major protein band in the 
elution lanes. To provide confirmation of the expression of the correct QconCAT 
sequence, the gel bands of the suspected QconCATs were excised, and in gel  
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pET21a
mApple Qpeptides
Glufibrinopeptide
Hexa-histidine tag 
T7 
promoter
Figure 4.3 QconCAT construct design 
Each construct consisted of the pET21a plasmid with genes inserted 
downstream of the T7 promoter. Genes  inserted were mApple sequence, 
followed by the chosen Qpeptides, a glufibrinopeptide sequence for 
quantification and a hexa-histidine tag for purification.  
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Figure 4.4 SDS PAGE of expression and purification of YEW1 and YEW3  
Plasmids were transformed into E.coli and cultured in minimal media with 
heavy isotope labelled lysine and arginine. Samples  were collected until an 
OD 600nm of 0.6, when 1 mM IPTG was added, and culture continued for 4 
hours. Samples from a) YEW1 and b)YEW3 time points are run on SDS 
PAGE. Potential QconCAT bands are highlighted. Cultures were purified 
using Ni affinity columns and a band is evident for c) YEW1 and d)YEW3.  
 
Chapter 4 
 
 Page 106 
 
digestions were performed. The digests were checked by MALDI-TOF using a Bruker 
Ultraflextreme, and analysed using Bruker Flexanalysis. For the suspected YEW1 
band, peptides from the entire length of the construct are identified, which 
confirms expression of the complete Qpeptide sequence. Six of the EIF2 Qpeptides 
were identified, and the two that were not identified were both in the middle of 
the construct, and since the presence of the entire construct has been confirmed it 
is unlikely that the peptides are not expressed. In addition, both of the missing 
peptides are lysine terminated, which are less detectable by MALDI-TOF than 
arginine terminated peptides (Hale et al., 2000).  
The purified YEW1 protein also showed a second band, which was confirmed as the 
same protein by the identification of the Qpeptides (figure 4.5). The second band is 
therefore a result of the same protein running at a faster rate through the gel, 
possibly due to the loss of a peptide reducing the mass of the protein, or it could be 
due to a conformational change. Due to the nature of the QconCAT, an artificially 
constructed protein made up of short peptide sequences, the protein will not adopt 
a secondary structure. However, the QconCAT design includes an N terminal 
mApple fluorescent protein sequence, which does adopt a secondary structure. The 
fusion of a monomer with a secondary structure to a sequence of Qpeptides may 
cause conformational changes in the mApple sequence. If any part of this structure 
remains partially folded during electrophoresis, it may manifest as the second band. 
Whether the reason behind the double band is the loss of an N terminal peptide, or 
structural differences, the identification of Qpeptides from the N and C terminus of 
the QconCAT section of the construct indicates the complete sequence is present. 
MALDI-TOF also confirmed the expression of 20 YEW3 Qpeptides from the entire 
length of the construct (figure 4.6).  
The purified protein was then tryptically digested and confirmation of the 
expression was also achieved by LC-MS using a Waters Synapt G2, and analysis 
using Waters ProteinLynx Global Server software (PLGS), which identified the 
protein as YEW1 and YEW3 using a QconCAT database. When YEW1 data was 
analysed using PLGS, all of the EIF2 complex peptides were observed, which 
confirms the expression of the correct QconCAT. All of the peptides were observed  
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Figure 4.5 MALDI TOF confirmation of YEW1 expression 
Peptide map depicts the QconCAT protein,  containing mApple gene (grey), EIF2 
complex genes (pink) and elongator complex genes (blue).  The possible 
QconCAT band was excised from the gel in figure 4.4, and an in gel digestion 
was performed using trypsin. The digest was analysed by MALDI TOF using a 
Bruker Ultraflextreme, peaks corresponding to Qpeptides are highlighted (EIF2 
in blue, elongator in pink), and mApple peptides are marked with *.  
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  Figure 4.6 MALDI TOF confirmation of YEW3 expression. 
Peptide map depicts the QconCAT protein,  containing mApple gene (grey) and 20S 
proteasome genes (green).  The suspected QconCAT band was excised from the gel 
in figure 4.4, and an in gel digestion was performed using trypsin. The digest was 
analysed by MALDI TOF using a Bruker Ultraflextreme, and peaks corresponding to 
20S proteasome complex Qpeptides are highlighted in green. mApple peptides are 
marked with *.  
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as doubly or triply charged ions, and the methionine residues included were 
observed at their original mass, and had not undergone oxidation. There was one 
peptide identified by PLGS in a missed cleaved form, AGLDNVDAESKEGTSNR. This is 
likely the result of having an acidic residue, glutamic acid, following the trypsin 
cleavage site. However, as the Qpeptide is in the sequence context of the original 
protein the analyte peptide would be expected to show the same degree of missed 
cleavage, therefore the QconCAT digest was used in the quantification.  
When heavy labelled QconCATs are generated, it is usual for there to be a small 
amount of unlabelled peptide present. This is the case for each of the YEW1 heavy 
labelled peptides observed, where there are also peaks representing the m/z of the 
unlabelled peptides, indicating the heavy labelling is incomplete (figure 4.7). The 
effect is more pronounced for lysine terminated peptides than arginine. In order to 
use the heavy labelled peptides, it was therefore necessary to calculate the amount 
of signal contribution from unlabelled QconCAT. At the same time as running the 
sample and QconCAT mixture on the mass spectrometer a control sample of the 
QconCAT dilution without sample was run. For each individual peptide the amount 
of unlabelled signal was calculated. The signal contribution from unlabelled 
QconCAT was then subtracted from the quantity of each analyte peptide observed. 
This calculation was done for each individual peptide, regardless of whether lysine 
or arginine terminated.   
For the YEW3 digest, 27 of the 28 Qpeptides were observed in the G2 data, 
IFHYGHVFLGITGLATDVTTLNEMFR was not (figures 4.8-4.11). The presence of 27 
peptides confirmed expression of the correct protein. None of the 20S proteasome 
Qpeptides were seen in miscleaved forms in the PLGS search results. Once again it 
was apparent that some of the peptides were not completely labelled, there were 
peaks observed at the m/z of the light peptide, and the unlabelled peaks were more 
intense in the lysine terminated peptides. Therefore, when the QconCAT and 
analyte mixtures were analysed by SRM, a control sample was also run, and the 
intensity of the light peak in the control sample subtracted from the sample peak 
intensity. One peptide, SGKPFIAGFDLIGCIDEAK, has a proline residue following a  
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Figure 4.7 YEW1 Qpeptide labelling identified by LC-MS 
Purified YEW1 QconCAT was digested using a trypsin in solution digest. The 
digested protein was then analysed by LC-MS using a Waters Synapt G2 to 
check the digestion efficiency  and the heavy isotope labelling. The eight 
Qpeptides encoding EIF2 protein sequences are shown.  
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Figure 4.8 YEW3 Qpeptide labelling identified by LC-MS 
Purified YEW3 protein was subjected to in solution digestion using trypsin and run 
on a Waters Synapt G2 on a 1 hour gradient in MSE mode. Results were analysed 
using PLGS to check coverage and digestion efficiency, and an extracted ion 
chromatogram generated for each Qpeptide.  
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Figure 4.9 YEW3 Qpeptide labelling identified by LC-MS 
Purified YEW3 protein was subjected to in solution digestion using trypsin and 
run on a Waters Synapt G2 on a 1 hour gradient in MSE mode. Results were 
analysed using PLGS to check coverage and digestion efficiency, and an 
extracted ion chromatogram generated for each Qpeptide.  
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Figure 4.10 YEW3 Qpeptide labelling identified by LC-MS 
Purified YEW3 protein was subjected to in solution digestion using trypsin and 
run on a Waters Synapt G2 on a 1 hour gradient in MSE mode. Results were 
analysed using PLGS to check coverage and digestion efficiency, and an 
extracted ion chromatogram generated for each Qpeptide.  
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Figure 4.11 YEW3 Qpeptide labelling identified by LC-MS 
Purified YEW3 protein was subjected to in solution digestion using trypsin and 
run on a Waters Synapt G2 on a 1 hour gradient in MSE mode. Results were 
analysed using PLGS to check coverage and digestion efficiency, and an 
extracted ion chromatogram generated for each Qpeptide, for which the 
spectra are shown, except in the case of the peptide 
IFHYGHVFLGITGLATDVTTLNEMFR, which was not found. 
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lysine. In this instance, the peptide was observed as a triply charged ion, containing 
two lysine residues which have accepted a positive charge.  
4.3.4 eIF2 complex quantification 
A QconCAT targeting the eIF2 complex was designed because the label free data 
indicated the complex, which is a heterotrimer, was not stoichiometrically equal 
(figure 4.12). In addition, the data indicates that there is some dissociation 
occurring, which could be responsible for the lack of stoichiometry observed.  
YEW1 QconCAT dilutions were prepared using fraction 14-22 digests, which, 
according to the label free analysis, contain the eIF2 complex subunits. SRM 
experiments were performed on the Waters Xevo, and analysed in MassLynx 
software. For transitions used see supplementary material.  A control sample was 
run, YEW1 diluted to the same concentration as the analyte sample. However, 
when run on the Xevo there is a difference in retention time between the fraction 
digest diluted QconCAT and the control sample without a yeast background. 
Therefore, the G2 data was used to calculate the percentage of light signal 
contributed by the unlabelled QconCAT. The percentage of light peptide present 
was calculated for each individual peptide. When the SRM data was analysed, the 
peak area contributed by the unlabelled QconCAT was subtracted from the analyte 
peak area before the quantity of analyte peptide was calculated.  
The standard and analyte pairs were placed into three categories. Type A, when 
both the standard and analyte peaks are observed, Type B when just the standard 
is, but not the analyte, and Type C, when neither peptide is observed (Brownridge 
et al., 2013). Prior to quantification, each of the peptides were assessed and 
labelled as one of these categories. Where Type C peptides are observed, it is not 
possible to quantify.  With Type B peptides, it is not possible to obtain an accurate 
quantification, but it is possible to suggest that the analyte protein is at a lower 
concentration than the standard, and therefore set a maximum concentration of 
analyte in the sample.  
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  Eif2 labelfree
Eukaryotic initiation factor 2 complex
Figure 4.12 Label free quantification results for the EIF2 complex subunits in 
five replicates of IEX fractionation 
 Five replicates of IEX fractionation were collected, the protein content of each 
fraction was concentrated using StrataClean resin, and then digested using 
trypsin. The digest was then mixed with standard glycogen phosphorylase B, 
and run on the Qexactive using a top ten data dependent acquisition method.  
The results were processed using MaxQuant software. 
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The peptide YGGVCNITMPPK was discarded from the experiment due to being a 
Type C peptide, as neither the heavy nor light transitions were observed. The 
peptide EGTPSANSSIQQEVGLPYSELLSR was a Type B, the QconCAT peak was 
observed, but not the analyte peak. Where Type B peptides were observed, it is 
indicative of the analyte peptide being present at too low a concentration to be 
observed, possibly because it has undergone some sort of post translational 
modification or poor digestion. As the standard peptide is observed, at a 
concentration of 0.25 fmol, it is then possible to set this as the maximum amount of 
analyte peptide. However, as two other peptides for this protein were included, 
and peaks for these were observed, they were used to quantify SUI3. All other 
peptides were Type A (figure 4.13). 
One thing to note within the peptide quantifications is that the where two peptides 
are observed, there is a difference in the ratio of the two peptides to each other in 
each fraction. Theoretically, the peptide should ionise to the same extent in each 
sample, and maintain a steady ratio across the samples. The difference is likely due 
to ion suppression (or ion-enhancement) effects, where a difference in the sample 
composition can cause a peptide to ionise to a greater or lesser extent. The effect is 
well documented, across a range of sample and instrument types (Buhrman et al., 
1996; Matuszewski et al., 2003; Chambers et al., 2007). As there are different 
numbers of proteins in each fraction, the sample background differs, with a 
variation in peptide content of around 2000-4000 peptides (figure 4.14). As the 
variation in both the size and content of sample background differs, the propensity 
of each peptide to ionise will differ in each digest. This phenomenon is known as 
matrix effects, and theories as to the cause include competition for charges, or 
competition for the surface area of the droplet during the transition into gas phase 
ions (reviewed in Gosetti et al., 2010). Matrix effects can therefore cause variation 
even between replicates, or within sets of the same sample, and can therefore 
cause some differences in the QconCAT results from different fractions presented 
here.   
For the subunit SUI2, two peptides were quantified, AVTATEDAELQALLESK and 
FQIPLEELYK. Both peptides reach the highest concentration in fraction 19, however  
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Number of proteins
Number of peptides
Figure 4.14 Protein and peptides identified in IEX fractions replicate 6 by the 
QExactive 
IEX fractionation was performed on a sixth replicate of S. cerevisiae cell lysate 
for use in SRM experiments. Fractions 10-29 were concentrated using 
StrataClean resin and run on the Q Exactive before label free quantification 
with MaxQuant software. The variation in the number of proteins and the 
number of peptides in each fraction is depicted.  
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FQIPLEELYK is detected at a lower concentration than AVTATEDAELQALLESK, at 1.64 
fmol compared to 5.35 fmol (figure 4.15). In the label free analysis 15 peptides are 
identified from SUI2. These peptides are most intense in fraction 19, so the two 
quantification methods support the fact that the majority of SUI2 is eluting in 
fraction 19. The two peptides included in the QconCAT are both identified in the 
label free data, so it is possible to compare two quantification methods for the 
individual peptides. In the label free data, both of the peptides show a wide 
distribution, eluting across five fractions. AVTATEDAELQALLESK is most intense in 
fraction 22, but is eluted across fractions 17-22, and FQIPLEELYK is most intense in 
fraction 19, and is less abundant than the other peptide. Extracted ion 
chromatograms show the highest intensity of both peptides in fraction 19 (figure 
4.16). In both the label free and the QconCAT data FQIPLEELYK is at a lower 
concentration, which is also supported by the extracted ion chromatogram, 
suggesting it has less propensity for ionisation than AVTATEDAELQALLESK.  Despite 
this discrepancy, the label free and SRM analyses both support SUI2 eluting in 
fraction 19.  
For the subunit SUI3, two peptides were able to be quantified, LFFMVCK and 
AGLDNVDAESK. There is a discrepancy between the results of these two peptide 
quantifications (figure 4.17). The peptide AGLDNVDAESK was identified as a missed 
cleavage in the QconCAT G2 data, possibly a result of having an acidic residue, 
glutamic acid, in the next position to the trypsin site, however, the intensity of the 
non miscleaved form is in the range of an order of magnitude greater than the 
miscleaved (figure 4.18 a). The QconCAT peptide is in the same sequence context as 
the analyte peptide, and therefore in theory both the standard and analyte could 
be miscleaved. However, because in this experiment the two were digested 
separately and the QconCAT is spiked into the fraction digest, it is possible that they 
will undergo varying degrees of digestion. Therefore, one or other of the digests 
may go further towards completion and cause a discrepancy in the results. The low 
amounts of analyte quantified suggest that if there was a discrepancy in the digest 
efficiency, it has caused an abnormally low analyte signal, suggesting a miscleave in 
the analyte peptide. In the original sequence context, the Qpeptide is N terminal to 
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a)
b)
c)
SUI2 label free results – all peptides
SUI2 QconCAT results
label free results – QconCAT peptides
Figure 4.15 SUI2 peptide quantification by both QconCAT and label free 
methods 
The two peptides quantified by QconCAT methodology are shown in a), while b) 
shows the intensity of all of the EIF2α peptides identified by label free analysis. 
c) both of the QconCAT peptides are also identified by MaxQuant processing of 
the Qexactive data. 
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Figure 4.16 Extracted ion chromatograms of SUI2 peptides 
Extracted ion chromatograms of the two SUI2 peptides that were included in 
the QconCAT.  Fractions were run on the Q Exactive in a data dependent 
acquisition mode and extracted ion chromatograms were performed using 
Thermo Xcalibur software. 
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c)
b)
SUI3 QconCAT results
SUI3 label free results – all peptides
SUI3 label free results – QconCAT peptides
Figure 4.17 SUI3 peptide results by both SRM and LC-MS/MS  
The two peptides quantified by QconCAT methodology are shown in a), while b) 
shows the intensity of all of the SUI3 peptides identified by MaxQuant 
processing. c) the peptide LFFMVCK was also identified by MaxQuant software 
in the Qexactive data.  
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Figure 4.18 AGLDNVDAESK standard and analyte extracted ion 
chromatograms 
a) QconCAT digest was run on the G2 and PLGS software used to generate 
extracted ion chromatograms for the limit peptide and the miscleaved form. b) 
Fraction 17 digest was run on the Qexactive and extracted ion chromatograms 
for the limit peptide and miscleaved peptide were performed in Xcalibur 
software.  
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the third Qpeptide included in this QconCAT, meaning the miscleaved analyte 
peptide would be AGLDNVDAESKEGTPSANSSIQQEVGLPYSELLSR, but this is not 
identified in any of the 6 fraction replicates processed by MaxQuant, or by 
extracted ion chromatogram. EGTPSANSSIQQEVGLPYSELLSR was a type B peptide, 
so the analyte signal was not observed, while the standard was. This indicates the 
peptide is observable under the experimental conditions, but the analyte signal is at 
too low a concentration to be observable. The peptide was identified in all other 
replicates of label free quantification, at a retention time of 29.5 - 32.2 minutes (see 
supplementary material), and extracted ion chromatograms on the mass of the 
limit peptide in replicate 6 at that retention time indicate AGLDNVAESK is not 
present (figure 4.18 b). There is no peak at the correct mass for the miscleaved 
peptide (figure 4.18 b). However, the resulting miscleaved peptide is large, at 
3679.7 Da, and large, miscleaved peptides show less signal in MS, and therefore it 
may not be observable (Brownridge & Beynon, 2011). In addition, there is no 
observed peak at the correct mass for EGTPSANSSIQQEVGLPYSELLSR. If there is a 
miscleavage it may render this peptide at too low an intensity for observation, and 
AGLDNVAESK at a false low intensity. The two peptides would not be expected to 
be present at the same intensity, due to differential ionisation, and the lower 
intensity is also supported by comparing the standard peptides, where 
EGTPSANSSIQQEVGLPYSELLSR was observed at a much lower intensity (figure 4.13). 
The low intensity of both of these peptides in the QconCAT data, and the fact that 
neither was identified by MaxQuant in the Q Exactive data,  support the possibility 
that the peptides are miscleaved. The peptide LFFMVCK is identified in the label 
free experiment, and is the fifth most intense peptide (figure 4.17 b). In the label-
free data 14 peptides are identified, and they are most intense in fractions 16 and 
17. Extracted ion chromatograms support the presence of the peptide in fraction 17 
of the label free quantification (figure 4.19). This supports the QconCAT mediated 
quantification of LFFMVCK, at 7 fmol in fraction 16 and 4 fmol in fraction 17.  
Therefore, given the discrepancy between the two peptides, the LFFMVCK 
quantification will be used. This indicates that SUI3 is present in fractions 16-17. 
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Figure 4.19 SUI3 peptide LFFMVCK extracted ion chromatograms 
QconCAT digest was run on the Waters Synapt G2 on a 1 hour gradient in a DDA 
method. a) An extracted ion chromatogram for the peptide LFFMVCK for the 
unoxidised m/z of 475.7. b) Fraction 17 digest was run on the Q Exactive on a 2 
hour gradient, and an extracted ion chromatogram shown for m/z 472.7. 
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For the subunit GCD11 the two peptides quantified were LNPLSAEIINR and 
YNIDAVNEFIVK. Neither were seen as miscleavages or with any modifications in the 
G2 data. The two peptides show a good correlation (figure 4.20). In the label free 
data, there are 27 identified peptides, and they are most intense in fraction 19. 
There is also a peak in the peptide intensity at fractions 15 – 16. The two peptides 
used in the QconCAT also follow this pattern, with peaks in fractions 15-16 and 
fraction 19. This supports the idea that this subunit is eluting in two locations. 
When the peptide results are averaged to yield the protein quantification, in the 
individual fractions SUI3 appears twice as concentrated in the label free results, and 
GCD11 is also found at much higher levels, 1.6 pmol rather than 0.7. When the total 
amount of each subunit is calculated, the SRM data indicates they are more equal 
than is shown by the label free data (figure 4.21 a). As in the label free data, all 
three subunits are identified in fraction 19, SUI2 and GCD11 at similar amounts, and 
SUI3 less concentrated (figure 4.21 b). However, SUI3 is present at higher 
concentration in fraction 16 in both data sets. It is possible that a large proportion 
of the SUI3 subunit has dissociated from the complex during fractionation, leaving a 
complex of SUI2 and GCD11, and a small number of SUI3 subunits, undetected by 
the label free software. It is possible the SUI3 subunits are dissociating due to the 
fractionation process, however the same effect is seen the work of Kito et al (2007), 
in a TAP tag based project. In this project it was noted that SUI3 (EIF2) is present at 
a lower concentration than the other two proteins when the EIF2 complex is 
associated with the EIF2B complex. If this is the case the peak seen in fraction 16 
may just be the single SUI3 protein dissociated from the EIF2-EIF2B complex. There 
are only two subunits of the EIF2B complex identified at low amounts in the label 
free data, but they are identified in fractions 18-19 (figure 21 d). However, as they 
are present at much lower amounts than the EIF2 subunits, this can not confirm the 
theory presented by Kito et al. 
4.3.5 20S proteasome complex quantification 
Due to the absence of a trypsin cleavage site following the glufibrinopeptide 
standard sequence, the QconCAT YEW3 was quantified externally, using a common   
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Figure 4.20 GCD11 peptide quantification by SRM and LC-MS/MS methods 
The two peptides quantified by QconCAT methodology are shown in a), while b) 
shows the intensity of all of the EIF2α peptides identified by label free analysis. 
c) Both of the QconCAT peptides are also identified by MaxQuant processing of 
Qexactive data.  
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QconCAT quantification Label-free quantification
Total protein across all fractions
Figure 4.21 EIF2 complex subunit concentrations by label-free and QconCAT 
quantification 
The amount of each protein calculated in each 1 µl injection was multiplied by 
the total digest volume of 200 µl. The same calculation was performed for 
samples run on the QExactive. a) the total amount of each subunit in all 
fractions, and b) the subunit amount in each fraction. c) the amount of the two 
EIF2B subunits identified by label-free quantification. d) EIF2B complex subunits 
 
a) 
b) c) 
d) 
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peptide in the CopyCAT CC036, obtained from Dr Stephen Holman. The QconCATs 
were digested simultaneously, and run on the Waters Synapt G2. CC36 was 
quantified by spiking into the digest a known quantity of unlabelled 
glufibrinopeptide standard, and comparing the intensity of the heavy to light 
peptides. YEW3 was then quantified by comparing the intensity of the common 
peptide NFSLAIDK in YEW3 against CC036. The calculated QconCAT concentration 
was 0.59 pmol/µl. This method of quantification will be potentially less accurate 
than an internal quantification method, due to variation introduced between 
injections. It should therefore be taken into account, when interpreting the data, 
that the results may contain a higher than usual potential for error. Once 
quantified, the QconCAT digest was run on the Waters Xevo to check the retention 
time of each peptide, the results were processed using Skyline software and three 
transitions were chosen for each peptide. The YEW3 digest was then diluted to 10 
fmol, 1 fmol and 0.25 fmol per µl using the digest of S. cerevisiae IEX fraction 22 
(replicate 6), which was confirmed as containing the 20S proteasome by label free 
quantification using both the Synapt G2 and the Thermo QExactive.  
Due to the large amount of unlabelled QconCAT observed in the Synapt G2 data, a 
control sample was also run at the same time as the samples. The control consisted 
of the YEW3 QconCAT, diluted to the same concentrations using a solution of 97% 
acetonitrile, 0.1% TFA. The dilutions were run on the Xevo using the same methods 
set up to target the heavy and light peaks in the sample dilutions, and the peak area 
of the light peptide in the control was subtracted from the peak area of the sample 
peptides before the quantification was calculated. This method was designed to 
provide a more accurate quantification result, however, as discussed, matrix effects 
may alter the ionisation of QconCAT peptides in the presence of sample.  
The SRM data was assessed for the presence of peptide pairs, and while the 
majority of peptides observed were Type A, some peptide quantifications were 
discarded from the analysis (figures 4.22-4.25). The peptide 
IFHYGHVFLGITGLATDVTTLNEMFR was a type C peptide, neither the heavy or light 
peak was observed.  
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Other peptides had potential modification sites. Four peptides in this QconCAT 
contain the sequence NG, an asparagine residue followed by glycine which can 
allow a deamidation reaction to occur. In the deamidation reaction, the asparagine 
side chain attacks the neighbouring amino acid group forming a succinimide 
intermediate. The intermediate can then be hydrolysed to form either an aspartic 
acid residue, or isoaspartic acid. Therefore, the observed change is an addition of 
0.984 Da to the mass of the peptide.  
When checking the peptide labelling of YDNGVIIAADNLGSYGSLLR using MALDI-TOF 
analysis, it was apparent that the peptide was present at 1 Da heavier than the 
expected mass (figure 4.26 a). There was no evidence in the spectrum of either the 
unlabeled peptide or the succinimide intermediate form. The LC-MS data indicates 
the presence of both the original peptide, and the deamidated form (figure 4.26 b 
and c). SRM data shows two peaks in both the heavy and light transitions (figure 
4.26 d). However, since only the unmodified form of the peptide was targeted it 
was not possible to quantify the peptide. 
The MALDI data indicates AVENGTTSIGIK is also deamidated, with a peak at + 1 Da, 
and no peak at the unmodified m/z or the succinimide intermediate (figure 4.27 a). 
The LC-MS data for both heavy and light versions of AVENGTTSIGIK indicate both 
forms are present (figure 4.27 b and c). When the original mass is targeted by SRM 
the chromatogram shows two peaks, however for the light peptide, only the first 
peak is observed in all three transitions. This indicates the first peak is the correct 
peptide. In this case, the intensity of the heavy peptide is well below that of the 
light. However, as the deamidated mass was not targeted for SRM analysis, it is not 
possible to accurately quantify the peptide (figure 4.27 d).  
MALDI data also indicated FNNGVVIAADTR(H) may be deamidated, by the presence 
of a peak at 1 Da higher than the expected mass (figure 4.28 a). There is no 
indication of a succinimide intermediate in the mass spectrum, although there is a 
peptide peak approximately 1 Da more than the expected succinimide intermediate 
(1266.6), the peak corresponds to another peptide (T37), and the isotope pattern 
shows no evidence of an overlapping peak. In addition, the G2 data acquired shows  
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Figure 4.26 Possible deamidation  of peptide YDNGVIIAADNLGSYGSLLR  
Purified QconCAT protein was subjected to in solution digestion. The digest was 
then analysed by a) MALDI TOF using a Bruker Ultraflextreme, where a peptide 
was identified at approximately 1 Da heavier than the expected mass. b) 
QconCAT digest was also analysed by LC-MS on a Synapt G2, and c) the 
standard and analyte peptides observed in an SRM experiment using a Xevo TQ, 
and d) the SRM peptide data observed in Masslynx and Skyline  
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Figure 4.27 Possible deamidation of peptide AVENGTTSIGIK  
Purified QconCAT protein was subjected to in solution digestion. The digest was 
then analysed by a) MALDI TOF using a Bruker Ultraflextreme, where a peptide 
was identified at approximately 1 Da heavier than the expected mass. b) 
QconCAT digest was also analysed by LC-MS on a Synapt G2, and c) the 
standard and analyte peptides observed in an SRM experiment using a Xevo TQ. 
d) the SRM peptide data observed in Masslynx and Skyline 
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Figure 4.28 Possible deamidation of peptide FNNGVVIAADTR  
Purified QconCAT protein was subjected to in solution digestion. The digest was 
then analysed by a) MALDI TOF using a Bruker Ultraflextreme, where a peptide 
was identified at approximately 1 Da heavier than the expected mass. b) 
QconCAT digest was also analysed by LC-MS on a Synapt G2, and c) the 
standard and analyte peptides observed in an SRM experiment using a Xevo TQ. 
d) the SRM peptide data observed in Masslynx and Skyline 
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two peaks in the extracted ion chromatogram, the spectra of which are 0.5 Da 
apart, corresponding to the 1 Da increase in mass (figure 4.28 b). The analyte 
peptide on the QExactive also shows evidence of modification (figure 4.28 c). 
Unfortunately the transition lists on the Xevo were set up to target only the 
unmodified form of the peptide, not the deamidated version. The SRM for the 
heavy peptide has two peaks eluting approximately 0.5 minutes apart, however the 
light peptide only has one peak, indicating that the first peak eluting is the correct 
peptide. In addition, the heavy and the light peptide have the same fragmentation 
pattern (observed in Skyline), further supporting the fact that the first peak is the 
correct one (figure 4.28 d). The heavy labelled peptide, however, is at a lower 
intensity than the light. Because the deamidated mass has not been acquired it is 
not possible to discern the degree of deamidation in this peptide. Had the 
transition list included the modified form of the peptide, it may have been possible 
to calculate the ratio of the two forms of the peptide, and quantify the peptide 
(Rivers et al., 2008).  
The fourth potentially deamidated peptide, NQYEPGTNGK, was also observed at + 1 
Da in the MALDI and LC-MS data in both heavy and light forms (figure 4.29 a- c). 
The SRM data has single peaks, however, the light peak has eluted approximately 
0.5 minutes earlier than the heavy (figure 4.29 d). 
If the deamidated and intermediate forms had been targeted, it may have been 
possible to isolate the peptides in all four isoforms, the original Asn, isoAsp, Asp, 
and the succinimide intermediate form (Chelius et al., 2005). If this had been 
achieved quantification may have been possible by comparing the ratio but with 
the limited data acquired, quantification will not be possible in this instance. 
Therefore, for quantification of the 20S proteasome using the data gathered here, 
these four peptides won’t be used, and for the four proteins the other Qpeptide 
will be used in the protein quantification. Another problem peptide was 
FQGGIIVAVDSR, for which the retention time put into the method was too early, 
and only half of the peak was acquired. The heavy and light peaks were both 
observed at the same retention time, so the quantification was performed using the 
area of the partial peak acquired. 
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Figure 4.29 Possible deamidation of peptide NQYEPGTNGK  
Purified QconCAT protein was subjected to in solution digestion. The digest was 
then analysed by a) MALDI TOF using a Bruker Ultraflextreme, where a peptide 
was identified at approximately 1 Da heavier than the expected mass. b) 
QconCAT digest was also analysed by LC-MS on a Synapt G2, and c) the 
standard and analyte peptides observed in an SRM experiment using a Xevo TQ. 
d) the SRM peptide data observed in Masslynx and Skyline 
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There are also four peptides that contain methionine residues, which can 
potentially be oxidised to form a peptide of +16 Da in mass. To check if this had 
occurred, extracted ion chromatograms were performed on both the heavy 
peptides, and the light peptides (figure 4.30). All of the peptides in this case were 
observed at the unmodified mass, and no evidence was found of the oxidised 
forms.   
The remaining quantifications were plotted as a histogram and checked for 
discrepencies between peptides from the same subunit. The two PUP2 peptides, 
IYDNEK and SMIEHAR, show a large discrepency, at 3.15 and 12.04 fmol. Neither of 
these peptides have any potential modification listed on the uniprot database. In 
this case, the three transitions for each peptide were compared (figure 4.31 a). Of 
the three transitions for the peptide IYDNEK none of the peaks observed co-elute, 
resulting in a low quantification. On the basis of this the quantification of the 
second peptide, SMIEHAR, will be used for the PUP2 protein subunit.  
There was also a discrepancy in the results for the PRE5 subunit, where the 
peptides were at 28.43 and 10.5 fmol (figure 4.31 b). Neither of these peptides 
have any potential modification sites, and the transitions for each show a good 
correlation. LFQVEYALEAIK was the most concentrated peptide in the analysis, 
calculated at 28.43 fmol. Coincidentally, the next highest concentration calculated 
was 28.34, for NFSLAIIDK, the peptide which is N terminal to LFQVEYALEAIK (figure 
4.32). These are both at almost three times the average peptide quantification of 
10 fmol. A high result in SRM occurs when the analyte signal intensity is higher than 
the standard. Therefore, if the standard intensity is low, for example if there is a 
miscleavage at that point in the QconCAT, it will give a false high result for the 
analyte. As the two high results occur for peptides which are next to each other on 
the QconCAT, it is possible that a miscleavage has occurred. However, the 
miscleaved peptide was not identified by PLGS processing. In addition, it was not 
found in MALDI data or by searching the G2 data for the extracted ion 
chromatogram (figure 4.33). The lack of evidence does not prove that the 
miscleavage does not exist, however, as the peptide would be lysine terminated  
Chapter 4 
 
 Page 142 
 
   
425.22
425.72
426.22
422.21
576.33
576.83
577.33573.32
MVVLTAAGVER(H) 
576.3
VVSALQMLK(H)
497.78
MVVLTAAGVER(L)
573.3
YW_070913_Fraction22a #21075 RT: 67.27 AV: 1 NL: 7.09E5
T: FTMS + p NSI Full ms [300.00-2000.00]
570 571 572 573 574 575 576 577 578
m/z
0
50000
100000
150000
200000
250000
300000
350000
400000
450000
500000
550000
600000
650000
700000
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
573.31
573.82
574.32
576.80574.74
574.82
570.63
577.13
571.60 572.30570.96 572.60 575.63
SMIEHAR (H) 
425.19
RT: 66.55 - 68.01
66.6 66.8 67.0 67.2 67.4 67.6 67.8 68.0
Time (min)
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
67.38
67.41
67.33
67.4867.10 67.25
67.50
67.53
67.59
67.04
67.63
66.97
66.91 67.9667.8767.70
66.88
66.7566.58
NL: 1.48E6
m/z= 572.81-573.81 
F: FTMS + p NSI Full 
ms [300.00-2000.00]  
MS 
YW_070913_Fraction
22a
VVSALQMLK(L)
494.78
YW_070913_Fraction22a #12798 RT: 43.26 AV: 1 NL: 2.94E6
T: FTMS + p NSI Full ms [300.00-2000.00]
493.5 494.0 494.5 495.0 495.5 496.0 496.5 497.0 497.5
m/z
0
200000
400000
600000
800000
1000000
1200000
1400000
1600000
1800000
2000000
2200000
2400000
2600000
2800000
R
e
la
tiv
e
 A
b
u
n
d
a
n
ce
494.78
495.28
493.76
494.26
495.78494.57
494.91
493.60
495.24
493.93
RT: 42.37 - 45.03
42.5 43.0 43.5 44.0 44.5 45.0
Time (min)
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
43.44
43.50
43.42 43.55
43.39 43.62
43.37
43.67
43.31
44.55
43.28 44.5843.75
44.7244.49
43.82 44.26
43.24
44.1743.0742.43 44.7844.1342.98
44.8342.61
42.85
NL: 3.25E6
m/z= 594.28-595.28 
F: FTMS + p NSI Full 
ms [300.00-2000.00]  
MS 
YW_070913_Fraction
22a
SMIEHAR (L) 
422.19
YW_070913_Fraction22a #4625 RT: 18.72 AV: 1 NL: 7.20E6
T: FTMS + p NSI Full ms [300.00-2000.00]
419 420 421 422 423 424 425 426 427 428
m/z
0
10
20
30
40
50
60
70
80
90
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
422.21
422.71
424.24418.23
421.00
423.21 424.74419.23 421.19
425.94425.24
RT: 17.75 - 19.47
17.8 17.9 18.0 18.1 18.2 18.3 18.4 18.5 18.6 18.7 18.8 18.9 19.0 19.1 19.2 19.3 19.4
Time (min)
0
1000000
2000000
3000000
4000000
5000000
6000000
7000000
8000000
9000000
0
100000000
200000000
300000000
400000000
500000000
600000000
700000000
800000000
900000000
1000000 00
1100000 00
1200000000
1300000000
1400000000
1500000000
1600000000
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
18.65
18.67 18.72
18.63
18.74
18.77
18.79
18.1818.11
18.08 18.22 19.0418.3418.02 18.8418.39 19.0617.95 18.43 19.12
17.91
19.1818.87 19.20 19.29
19.33
18.69
18.65
18.63
18.74
18.56
18.79
18.84
18.89
18.53
18.49
19.04
18.43
19.10 19.1418.25 18.4018.20
19.18 19.2918.17 19.33 19.4218.0917.87 17.91
NL: 1.63E9
TIC F: FTMS + p NSI 
Full ms 
[300.00-2000.00]  MS 
YW_070913_Fraction
22a
NL: 9.09E6
m/z= 421.70-422.70 
F: FTMS + p NSI Full 
ms [300.00-2000.00]  
MS 
YW_070913_Fraction
22a
497.81
498.31
498.81
494.79
Figure 4.30 Extracted ion chromatograms of methionine containing peptides 
Heavy labelled QconCAT peptides were run on the Waters synapt G2, and 
extracted ion chromatograms are performed using PLGS software. Fraction 17 
digest was run on the  Qexactive, and extracted ion chromatograms of peptides 
were performed in Thermo Xcalibur.   
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Figure 4.31 The transitions acquired for the two peptides from PUP2 and PRE5 
proteins  
QconCAT digest was mixed with fraction 22 digest, and SRM data was acquired 
on a Waters Xevo triple quadrupole mass spectrometer. Three transitions for 
each peptide are acquired, and displayed in Skyline software. 
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Individual peptide quantifications
Protein quantifications
Figure 4.32 20S proteasome individual peptide and average subunit 
quantifications  
Peptide quantities were calculated using MassLynx. The peak area of the heavy 
and light peptides were calculated, the area of the unlabelled QconCAT was 
subtracted from the analyte peak, and the ratio of the remaining light area to 
heavy peak area was used to calculate the peptide quantification, then corrected 
for volume. For protein quantification the peptide results were averaged. 
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Figure 4.33 Lack of evidence for miscleavage in QconCAT peptides NFSLAIIDK 
and LFQVEYALEAIK 
 QconCAT digest was run on both the Bruker Ultraflex and Waters Synapt G2 
mass spectrometers to check for miscleaves.  No evidence is seen of either a) 
the singly charged peptide in MALDI, or b) the doubly charged peptide in an EIC 
of the G2 LC-MS data. 
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and therefore may not be visible by MALDI, and under LC-MS conditions, it would 
be large, at 3064.9 Da, and a quadruply charged ion, and therefore the miscleavage 
could be unstable under experimental conditions. 
For the protein PRE2 the two peptides are quantified at 18.1 fmol and 1.9 fmol.  
FQGGIIVAVDSR eluted across a wide time frame, and therefore only a partial peak 
was acquired. Although this may affect results, since half of the peak has been 
integrated for both the standard and the analyte, they have both been treated 
equally and the result could be a true reflection of the peptide amount, and it will 
still be included in the analysis.   
For the PUP1 peptide, VVSALQMLK, the quantification of the injected peptide is 
0.25 fmol. This is much lower than the peptides from other subunits, but the 
second peptide included from PUP1 was unused due to the presence of an NG 
sequence. The peptide does contain a methionine, which can potentially undergo 
oxidation, however the QconCAT wasn’t observed in the oxidised form. The analyte 
peptide was observed in the label free quantification, but not in the oxidised form, 
and there were no miscleavages identified by MaxQuant processing. Therefore, the 
result will be included. 
The individual peptides quantified, corrected for digestion volume, ranged from 
0.05 pmol to 5.78 pmol (figure 4.34 a). The averaged protein quantifications are, 
consequently, also spread across a wide range, from 0.05 to 5.75 pmol (figure 4.34 
b). The average quantification of the 14 20S proteasome subunits is 2.11 pmol, six 
of the subunit quantifications fall within 10% of this average, while 9 fall within 
25%. The two furthest outliers, PUP1 at 0.05 pmol and PRE4 at 5.75 pmol, were 
both quantified from just one peptide. Therefore, these results could be less 
reliable than the others. 
The label free quantification obtained for the proteasome proteins in replicate 6 
ranges from 0.85 pmol to 4.19 pmol. When these are plotted against the QconCAT 
results they show a somewhat linear relationship (figure 4.34 c). The MaxQuant 
software used in calculating the label free results uses an IBAQ method, where the 
sum of the observed intensities for each protein is divided by the theoretically  
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Figure 4.34 Comparison of 20S proteasome quantification by QconCAT and 
label free analysis 
QconCAT quantification results a) calculated by peak area ratios, and corrected 
for digest volume. The label free results b) calculated using the MaxQuant 
reported iBAQ intensity and corrected for digest volume. The amount of each 
protein by each method are plotted against each other in c), while d) shows the 
iBAQ intensity against the fmol quantification for each QconCAT peptide. 
 
R2 = 0.01 
R2 = 0.42 
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observable peptides. Therefore, all of the peptides identified using the Thermo 
QExactive will be used in the quantification. When the intensities of just the 
common peptides are plotted against the QconCAT quantification as a scatter 
graph, they show more of a linear relationship, as indicated by a higher R squared 
value (figure 4.34 d). This indicates that the individual peptides are behaving in 
approximately the same manner across both instruments, and poorly ionising 
peptides on the QExactive are also poorly ionising on the Xevo.  
The QconCAT quantification results for the two complexes discussed here, where 
two peptides are identified, generally show a somewhat linear relationship (figure 
4.35). The two peptides originate from the same protein, and should therefore have 
a good correlation. This may indicate that in this analysis the peptides chosen are 
not proteotypic, therefore the QconCAT peptides are not representative of the 
behaviour of the other peptides from the same protein. This is exemplified by the 
results for the subunit PUP1, which was quantified at 0.85 pmol in the total fraction 
digest. This was calculated on the basis of one peptide, VVSALQMLK. However, in 
the replicate 6 label free analysis, there are 9 PUP1 peptides identified, and 6 of 
them are more intense than VVSALQMLK. Of the 9 peptides identified by the 
QExactive the majority were not included in the QconCAT design due to poor 
MC:Pred or CONSequence scores. In the case of this protein, a lack of suitable 
peptides may have forced the use of a peptide that is not quantotypic. The 
quantification of this protein could be checked using the second peptide, 
FNNGVVIAADTR, if an SRM experiment is set up to target the deamidated forms of 
the peptide. The SRM quantification of this protein may have been improved by the 
inclusion of other peptides, such as those found more intense by label free, which 
may therefore be more proteotypic. 
4.4 Conclusions 
The results of the EIF2 complex confirm that there is some dissociation happening, 
and also that the complex appears to not be stoichiometrically equal, although 
there is an improvement in the results using SRM. In order to confirm wether the 
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Figure 4.35 QconCAT peptides comparison for those proteins where two 
peptides are observed 
QconCATs encoding 20S proteasome and EIF2 complexes were run on the 
Thermo QExactive and processed using MaxQuant. For those proteins where 
two peptide quantifications were obtained, the quantification (in pmol) for 
each peptide are plotted against each other. 
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dissociation of the complex is caused by association with EIF2B, the second complex 
would have to be targeted in an SRM experiment, as it is not present in sufficient 
amounts in the label free data. 
For the two complexes quantified here, it was difficult to find ‘quantotypic’ 
peptides, for each complex there were peptides that were not observed in the Xevo 
data. Due to the variable nature of proteins, varying in size, composition, and 
physicochemical properties, it can be difficult to find appropriate tryptic peptides 
for each subunit in a complex. For these proteins, such as the 20S proteasome 
subunit PUP1, or the elongator protein ELP6, it may be more convenient to quantify 
using a PSAQ method. This would enable all the potential tryptic peptides to be 
targeted during one analysis.  
The discrepancy in the data for some proteins appears to be due to the poor 
performance of some peptides, such as the PUP1 peptides discussed, which are 
observed at a low intensity in both the QconCAT and label free data. However, the 
concept behind the use of SRM is that the standard and analyte peptides behave in 
the same manner, so if the analyte peptide is poorly ionised, this will also be 
represented by the QconCAT intensity, and the quantification should therefore be 
accurate. However, this does not appear to be the case with the data presented 
here. Matrix suppression effects may also contribute to any errors in the data. 
Particularly in the case of the EIF2 complex, where multiple fractions are compared, 
it is possible that peptides ionise differently in different fractions. If this is the case 
the quantification of different proteins in different fractions cannot be compared. 
The effect could be examined using a control sample, such as the glufib sequence 
included in the QconCAT sequence. If a known amount of light glufib was spiked 
into each fraction and QconCAT mixture, it may be possible to assess the ionisation 
effect in each fraction. Also, the calculations for the unlabelled percentage may 
introduce an additional source of error, as matrix effects will mean the peptides 
ionise differently without the sample digest background. Any attempt to correct the 
quantification will therefore add error, however, this is much less than the error 
that would be included had no correction been applied. For completely accurate 
results, the heavy labelling of the peptides should ideally be repeated.  
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If the transitions had been improved, the reliability of the data would have also 
been improved given enough time and sample to repeat the experiment. Three 
replicates would give a more reliable quantification, and possibly improve the 
relationship between protein concentrations.  
Error in the QconCAT quantification could also come from the fact that the 
QconCAT was spiked into the fraction digest following label free quantification, 
rather than co-digested. Differences in the proteolysis of the standard and analyte 
peptides would manifest as errors, for miscleavages in the sample, the 
quantification would be a low result, and for a miscleavage in the analyte a higher 
result. The digestion efficiency of both the standard and analyte was tested during 
the experimental workflow using SDS PAGE. However, SDS PAGE is less sensitive 
than SRM, so some miscleavages may still be present.  A better method would have 
been to split the replicate 6 fractions into two aliquots, one for label free analysis, 
and the other for QconCAT quantification. This would have made it possible to co-
digest the QconCAT and the analyte proteins following the label free analysis 
identifying the appropriate fractions. The other potential source of error is in the 
peptides themselves, for example, the four 20S proteasome peptides that contain a 
potential deamidation site, although, again, this issue could be addressed during 
the experimental workflow if the modified forms of the peptides are targeted by 
SRM.  
With regards to the aim of exploring the stoichiometry of protein complexes using 
QconCAT based quantification, the results presented here are inconclusive. Despite 
the advantages of label mediated quantification and SRM methodologies over label 
free methods, for the CCT ring and 20S proteasome complexes, there is no 
improvement to the quantification results. The conclusions, therefore, must be that 
either both complexes contain differing amounts of each subunit, which is unlikely, 
or that the quantification is flawed. Since the inaccurate quantification is likely to 
be due to the use of peptides that are not quantotypic, it must be concluded that a 
PSAQ method may have been more appropriate. 
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Chapter 5: Accessing low abundance proteins using ProteoMiner 
equaliser bead technology 
 
5.1 Introduction 
 
The detection of analyte proteins within proteomics has, historically, been hindered 
by the large dynamic range of samples, sometimes spanning up to 10 orders of 
magnitude (Mitchell, 2010), which make the identification and quantification of 
some of the less abundant proteins difficult. In electrophoresis, the abundant 
proteins can mask the appearance of the less abundant proteins, while in LC-MS, 
using a DDA mode analysis for protein discovery, the more concentrated proteins in 
a sample can dominate the precursor selection, meaning the less abundant samples 
are not fragmented, and therefore not identified. Problems also arise from these 
less abundant proteins, sometimes present in extremely low copy numbers, falling 
below the limit of detection of a mass spectrometer. There are various techniques 
used to counteract the dynamic range issue, the majority of which are based on 
reducing the complexity of the sample either by removing the most abundant 
proteins using depletion strategies or by splitting the entire proteome into subsets 
by fractionation.  
The technique used here, combinatorial peptide ligand library (CPLL) technology, 
aims to reduce the dynamic range of biological samples without reducing sample 
complexity by simultaneously reducing the quantity of high abundance proteins and 
increasing that of less concentrated proteins. This reduction in dynamic range 
should, in theory, bring all of the proteins in a sample into the range detectable by 
the mass spectrometer and, by normalising the proteins to approximately the same 
concentration, should eliminate the problem of a few proteins saturating the mass 
spectrometer. The technology, first applied in proteomics for the analysis of serum 
proteins, consists of a library of hexapeptide ligands covalently bound to spherical, 
porous beads (Thulasiraman et al., 2005). The library is formed from 20 naturally 
occurring amino acids, using the Merrifield approach split, couple, recombine 
method, first implemented to make hexapeptide combinatorial beads by Furka et al 
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in 1991 (Merrifield, 1965; Furka et al., 1991; Lam et al., 1991). A batch of porous 
poly(hydroxymethylacrylate) beads is split into 20 subsets, and to each of these 
subsets a different amino acid is bound via a linker, such as a carboxyl group, and 
then the subsets are pooled, mixed, split into 20 sets again, and the process is 
repeated. The process is repeated six times, forming a different hexapeptide ligand 
on each bead, and leading to a potential 206 (64 million) different ligands, with 
multiple copies of a single peptide sequence covalently attached to a single bead at 
a potential density of 50 µmol/ml (Boschetti & Righetti, 2008). These peptides, 
presented on the surface of the bead and exposed to a sample, are able to interact 
with proteins in the same manner as all naturally occurring protein-protein 
interactions in the cell, such as ion-ion, hydrogen bonds, dipole-dipole, dispersion 
and hydrophobic interactions (Righetti et al., 2006). 
Due to the vast amount of variation in the peptide composition, and the ligand-
protein interactions, an aliquot of beads of sufficient volume would potentially be 
able to interact with all of the proteins in a given proteome. Therefore, the concept 
behind the reduction in dynamic range using these beads is that, when a sample 
containing an asymmetric mixture of proteins is introduced to the library, each 
bead will bind a finite, equal, number of copies of a single protein, up to the 
potential bead capacity of 50 µmol/ml. Any excess of protein above this amount 
will not interact with the beads, and will be removed by a wash step (see figure 5.1 
for a schematic of experimental workflow). Once excess proteins have been washed 
off, the bead bound protein can be removed directly using SDS if the analysis is to 
be done using PAGE.  Alternatively, various elution agents can be used, such as urea 
or CHAPS, however these are not compatible with LC-MS. For an LC-MS based 
workflow, therefore, the protein can be removed from the beads by direct tryptic 
digestion. This yields an equimolar mixture of, in theory, all of the proteins in a 
sample. The highly abundant proteins will saturate the beads, whereas less 
concentrated proteins may be present in such low copy numbers that some peptide 
ligands will remain unbound. To reduce this effect, and to increase the possibility of 
obtaining an equimolar protein mixture, it is necessary to overload the beads with 
protein sample. 
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Hexapeptide ligands covalently 
attached to porous polymer bead 
Each single bead 
consists of a unique 
ligand
Protein mixture is incubated with beads, 
and each ligand binds a different protein
Most abundant proteins washed off 
beads
Bead bound proteins eluted, and analysed
Figure 5.1. Combinatorial bead library normalisation. 
Hexapeptide ligands  are covalently bound to porous beads. Each bead contains 
multiple copies of a unique peptide, and therefore binds a finite number of 
copies of a single protein. Any excess protein is washed off, and the bead bound 
protein is eluted, resulting in an equimolar mixture of proteins.  
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When the technology was first implemented, it was based on the concept that, with 
each individual bead possessing a unique peptide, and each peptide binding a 
unique protein, an individual bead would bind a single, unique protein to maximum 
bead capacity, and the complex protein mixture eluted from the library would be 
equimolar. However, it has since been reported that multiple hexapeptide ligands 
are capable of binding a single protein at different efficiencies, and also that a 
single bead is able to bind multiple proteins (Huang et al., 1996; Boschetti et al., 
2007). These findings indicate that eluate from a bead binding experiment may not 
be the equimolar mixture anticipated, and may contain a high concentration of 
some proteins able to bind numerous peptides, possibly via a number of different 
interactions. Also, in some samples, it is possible for proteins to bind the beads 
asymmetrically, as certain proteins, such as the heat shock proteins in chicken 
skeletal muscle, can bind to each other and form a scaffold effect, with multiple 
layers of protein surrounding one bead (Rivers et al., 2011).   
Despite these potential issues, combinatorial hexapeptide libraries can greatly 
increase the proportion of the proteome it is possible to identify. Although the 
technology was first developed to enable the identification of low abundance 
proteins in blood plasma, it has since been applied to a wide variety of samples, 
from human bile, serum and urine, to animal biological fluids and tissues, and even 
beverages (table 5.1).  
Table 5.1 Examples of the use of combinatorial hexapeptide ligand libraries  
Sample 
Number of 
untreated  
proteins  
Number of 
normalised 
proteins  Reference 
Human urine 134 383 (Castagna et al., 2005) 
Human serum 115 305 (Guerrier et al., 2006) 
Human erythrocytes 535 1524 (Roux-Dalvai et al., 2008) 
Human CSF 476 1149 (Mouton-Barbosa et al., 2010) 
Swine plasma 1708 2657 (Tu et al., 2011) 
Chicken skeletal muscle 35 360 (Rivers et al., 2011) 
Sea urchin coelomic fluid 26 82 (Fasoli et al., 2012) 
Spinach 132 236 (Fasoli et al., 2011) 
Mango pulp 374 2693 (Fasoli & Righetti, 2013) 
Champagne 0 43 (Cilindre et al., 2014) 
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The suitability of the technology for a wide range of sample types also  means the 
method has far reaching applications, in the discovery of potential biomarkers for 
disease, such as cancer (Meng et al., 2011; Monari et al., 2011) or liver disease 
(D'Amici et al., 2012), and even conditions such as preeclampsia (Liu et al., 2011). 
Another application of the technology is in the discovery and removal of 
contaminants or impurities (Fortis et al., 2006; Antonioli et al., 2007). In addition, 
the technology can assist in protein discovery, and has enabled the identification of 
two novel proteins in snake venom (Calvete et al., 2009). 
5.2 Aims 
 
ProteoMinerTM combinatorial hexapeptide beads were exploited here in an attempt 
to simultaneously analyse the entire dynamic range of the S. cerevisiae proteome. 
Currently, the SGD lists 5070 open reading frames as verified, and 750 as 
uncharacterised. Both crude cell lysates and normalised material will be analysed 
by LC-MS to assess the reduction in dynamic range, and potential identification of 
the whole yeast proteome concurrently. 
In addition, the possibility of quantifying these proteins will be examined. Although 
equaliser bead technology is usually used in a qualitative manner, owing to the 
removal of some protein material, quantification may be achievable for the less 
abundant proteins, providing they bind the beads in a linear fashion and the beads 
can be assumed to have bound the total protein present in the sample provided it 
does not reach the full capacity of the bead. In order to test this theory the mode of 
binding was explored using a series of increased loadings on a set amount of beads 
to find the saturation level, and assess the linearity of binding below saturation 
level. There are also a number of ways protein can interact with equaliser beads, 
and in a final series of experiments, the effect of ionic conditions on protein binding 
was investigated in an attempt to elucidate the protein-ligand interactions. 
These experiments will be performed with the aim of accessing low abundance 
proteins, exploring the idea of using the technology to quantify the full dynamic 
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range of yeast proteins, and also examine the potential for entire protein 
complexes to bind to the bead library. 
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5.3 Results and Discussion 
 
5.3.1 S. cerevisiae cell lysate protein normalisation using ProteoMinerTM beads 
 
ProteominerTM beads were purchased from Bio-Rad and prepared according to 
manufacturer instructions. The bead slurry was thoroughly mixed and a 10 µl 
aliquot was taken, and diluted 1 in 10. The bead content of this dilution was then 
counted under a microscope, to an average of 76 beads /µl. Corrected for dilution, 
this corresponds to approximately 60,500 beads in an 80 µl aliquot used for these 
experiments. Theoretically, this amount should be able to bind all of the proteins in 
a complex proteome, provided sufficient quantities are loaded. 
To initially assess the normalising effect of the bead library, a Saccharomyces 
cerevisiae cell lysate was prepared from a cell pellet by bead beating and diluted to 
a 10 mg/ml solution. The cell lysate was centrifuged, then added to an 80 µl aliquot 
of beads and normalisation was performed according to the protocol outlined in 
section 2.16. This was repeated on three separate occasions, with three individually 
prepared cell lysates. On comparing the cell lysate starting material and CPLL 
treated material directly off the beads using gel electrophoresis (see figure 5.2 a for 
an example) there is a visible effect on the protein composition of the sample. The 
yeast cell lysate starting material is less asymmetric than the plasma samples the 
beads were originally designed for, at a dynamic range of five orders of magnitude, 
and the starting material is complex to begin with,  a number of proteins are visible 
by electrophoresis. However, the banding pattern on the gel indicates that the 
normalised material contained more visible protein bands. In addition, there was a 
reduction in the intensity of the strongest bands, indicating some extent of 
normalisation has occurred.  
The bead-bound protein was then  digested and quantified using label free analysis 
on a Waters Synapt G2 in HDMSE mode. In each replicate, there was a clear  
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Figure 5.2 Proteins in cell lysate before and after CPLL treatment 
Three replicates of a 10 mg/ml cell lysate treated with 80 µl beads, a) SDS PAGE of 
centrifuged cell lysate before and after CPLL treatment b) The crossover in the proteins 
identified in the two sample types in three replicates c) The number of proteins 
identified in three replicates of yeast cell lysate starting material and normalised 
protein following tryptic digest and run on the Waters Synapt G2 in HD MSE mode.   
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increase in both the number of proteins identified, and consequently the total 
material identified. In the first replicate, there was an increase from 327 to 623 
proteins identified, replicate 2 showed an increase from 366 to 577, and replicate 3 
from 475 to 622 (figure 5.2 c). This amounts to an average increase of 56% from a 
starting material digest to the bead bound protein. The increase in the number of 
proteins identified indicates that treatment with the CPLL library is bringing more 
proteins into the quantifiable range. In each replicate, there are a number of 
common proteins found in both the starting material and the bead treated material 
(figure 5.2 b). There are also a number of unique proteins found in starting material 
and treated.  Those in the normalised material may have been present in too low an 
amount to be identified in the starting material. However, those unique to the 
starting material should have bound the beads, and still been observed after CPLL 
treatment. The increase in the number of identified proteins also results in an 
increase in the total amount of material quantified (figure 5.3 a), from 8,100 to 
38,600 fmol in replicate 1, 8,200 to 20,800 fmol in replicate 2 and 13,100 to 26,900 
fmol in replicate 3. This corresponds to an average increase in material of 193%, 
much more than the increase in protein numbers, suggesting that a number of 
proteins have shown a big increase in concentration. 
Despite indications that the equaliser technology has indeed normalised the 
sample, and increased the number of hits, the overall dynamic range of the sample 
does not undergo the expected reduction. The aims of using this technology would 
be to bring the less concentrated proteins up in concentration, while reducing the 
more abundant. There is little change in the concentration of the least abundant 
protein identified in each case; however, there is in fact an increase in the amount 
of the most abundant.  
Table 5.2 The lowest and the highest calculated amount, in fmol, of an individual 
protein in the starting and treated material. 
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Figure 5.3 The amount of material in three replicates of starting material and 
normalised sample 
Bead bound protein is tryptically digested, a) the total fmol of protein identified in 
three replicates of starting material and normalised sample analysed by LC-MS using 
the Synapt G2 and b), the protein index plotted against the fmol amount of each 
protein  
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This indicates that the effect the CPLL is exerting on the dynamic range is in fact the 
opposite of that anticipated, there is actually an increase in the range of protein 
concentrations. The beads are only supposed to bind a limited amount of each 
protein, but there are a number of possible reasons why some proteins may bind 
excessive amounts. One explanation is that the ligands are not actually specific, and 
the most abundant proteins are overloading the beads Alternatively some proteins 
may have a higher propensity to bind the beads, which would result in some less 
concentrated proteins in the starting material dominating the normalised material. 
If the former explanation is true, the abundant proteins in the starting material will 
also be the most abundant in the CPLL treated material. In all three replicates of 
starting material, the most abundant protein was enolase II (ENO2), while in the 
normalised material replicates the top protein was pyruvate decarboxylase (PDC1), 
translation elongation factor 1 (TEF1) and elongation factor 2 (EFT2). The most 
abundant proteins were different in the starting material and the normalised, which 
indicates that the highly abundant proteins in the normalised sample were not 
over-saturating the beads simply due to them being the dominant proteins in the 
sample. Therefore, the most concentrated proteins may be present at excessive 
concentrations in the normalised material due to a higher affinity to the beads in 
comparison to other proteins. This was perhaps a result of having more exposed 
surface areas capable of interacting with the bead bound ligands, or a propensity to 
interact with other proteins already bound to beads. This effect will be examined in 
a later series of experiments.   
From these results, it is evident that the use of equaliser bead technology has 
extended the range of identifiable proteins in the yeast cell lysate prepared in these 
experiments.  The increase in proteins calculated as mid concentration indicates 
that more are being brought into the identifiable range. This effect is highlighted 
when the fmol amount of each protein identified are plotted on a logarithmic scale 
(Figure 5.3 b), which shows a shallower incline in the normalised material, as more 
proteins are quantified in the middle of the total dynamic range identified. This 
indicates that, in line with the expected normalisation effect, some proteins have 
been brought up in concentration, from below the limit of detection and therefore  
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not identified in the original cell lysate, to within the range of concentrations 
quantifiable by the mass spectrometer. Some proteins have therefore increased in 
concentration, but some have also been reduced in concentration (figure 5.4). The 
top ten most abundant glycolytic enzymes identified in the starting material 
exemplify this behaviour (figure 5.5), and most are reduced in concentration after 
treatment with the beads, which would be expected of the highly concentrated 
proteins. However, some of these do increase in concentration, for example, 
alcohol dehydrogenase (ADH1) in replicate 1, and pyruvate decarboxylase (PDC1) 
increase in concentration in all three replicates, which indicates they are binding 
well in excess of the expected maximum bead saturation level.  
Gene Ontology (GO) annotation provides a way to group proteins based on 
function, biological process or component. To investigate if particular protein 
subsets show more propensity to bind the beads, GO searches were performed on 
the SGD website, to group proteins according to component, and function. There 
was no indication that a particular component subset showed more propensity for 
binding (figure 5.6). On examining protein function, it appeared the RNA 
polymerase proteins, translation initiation factor, and proteins with nucleotide 
binding activity are concentrated by CPLL treatment (figure 5.7).  
Within the three replicates of starting material there are 251 (43%) common 
proteins, while in the normalised material there are 391 (46%) common proteins 
(figure 5.8 a, b). This indicates that the variation in protein identifications is caused 
by the experimental process, rather than variation introduced by the beads. 
Approximately a third of proteins that were in the starting material did not bind the 
beads (refer back to figure 5.2 c). In theory, all of these should be visible in the 
normalised sample, as they were originally present at sufficient concentration to be 
detected, and most should possess an exposed surface area which has an affinity to 
at least one peptide. Of the 262 proteins that were uniquely identified in the 
starting material across all three replicates, 17% are common across all three 
replicates, and 53.82% of proteins are unique to one replicate (figure 5.8 c). These 
proteins should each possess the ability to bind, but were unable to in that 
replicate. The fact that only 17% of the proteins that did not bind the beads do so  
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Replicate 1
Replicate 2
Replicate 3
Figure 5.4 The change in amount of each protein identified in three replicates 
Scatter graphs depicting the fmol change in each protein from starting material to CPLL 
treated material, in three digested replicates run on the Synapt G2.  
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Figure 5.5 The most abundant glycolytic enzymes in starting material proteins before 
and after CPLL treatment.  
The amount (in fmol) of the top ten glycolytic enzymes found in the starting material 
and CPLL treated sample in a) replicate 1, b) replicate 2, and c) replicate 3 as quantified 
PLGS using Synapt G2 data.  
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Figure 5.8 Venn diagrams depicting the common proteins identified across 
three replicates of untreated and treated material. 
 a)  three replicates of cell lysate starting material and  b) three replicates of 
CPLL treated material. Samples were run on the waters Synapt G2 and label 
free quantification was performed using PLGS, and c) the unique proteins found 
in starting material, common to all three replicates.  
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reproducibly indicates that the unbound protein in each experiment is a random 
effect, and not a result of the proteins inability to bind. This variation could be due 
to the inherent degree of variability in the equaliser beads, the very concept behind 
the equaliser beads relies on the fact that there are a number of different peptide 
ligands. Another explanation for the variability is the number of interactions 
possible, in variation in the ligands available, and a large amount of proteins able to 
bind the beads in different interactions, and different affinities. This could mean 
that, when an aliquot of a complex mixture of peptide ligands is brought together 
with a complex sample, able to interact with each other in a number of different 
ways, the sheer complexity of the binding process may lead to a large degree of 
variability.   
5.3.2 The effect of increased protein loading   
 
To further examine the process of protein binding to the beads, the effect of 
introducing increasing amounts of protein onto the same quantity of beads was 
tested. Centrifuged cell lysate was prepared at 0.05 mg/ml, 0.1 mg/ml, 0.5 mg/ml, 1 
mg/ml, 5 mg/ml and 10 mg/ml.  Three replicates of each loading were performed 
from the same sample dilution, in order to examine the variation derived from the 
beads, and minimise the variation introduced from the sample. The only source of 
variation should therefore be the difference between aliquots of beads. The gel 
electrophoresis of each loading shows additional bands in the normalised material 
when compared to the starting material (figure 5.9), which increase in intensity 
with each loading, up to 1 mg/ml. In the lower loadings, of 0.05 mg/ml and 0.1 
mg/ml, the starting material is not concentrated enough to be visible, however a 
number of proteins are observed in the normalised sample lane. This indicates that 
a number of proteins have increased in concentration at these lower loadings. 
The samples were digested and run on both Waters Synapt G2 Q-TOF and the 
Thermo Scientific Q Exactive Quadrupole Orbitrap mass spectrometers. The total 
number of proteins identified increases with each higher loading, until after the 1 
mg/ml cell lysate, when there is no further increase in number of identifications 
(figure 5.10 a). Data from both mass spectrometers is presented, showing that the  
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Figure 5.9 Gel electrophoresis of increasing CPLL loading experiments 
80 µl bead library aliquots were loaded with clarified cell lysate dilutions 
ranging from a) 0.05 mg/ml, b) 0.1 mg/ml, c) 0.5 mg/ml, d) 1 mg/ml, e) 5 mg/ml 
and f) 10 mg/ml. Following 2 hour incubation periods unbound protein was 
removed by washing with 5 x 1 ml phosphate buffer, and then 10 µl aliquots of 
the normalised bead bound material starting material, unbound protein, and 
washes 1-3 were mixed 1:1 with sample buffer and analysed by SDS PAGE.  
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Figure 5.10 Proteins identified in three replicates of increasing CPLL load 
a) The average number of proteins identified in three replicates of CPLL treated 
material, run on a Thermo QExactive and label free quantification performed 
using MaxQuant, and run on a Waters Synapt G2 and analysed using PLGS and 
b) the overlap in proteins identified in the three replicates. C) the average 
number of peptides identified in three replicates of the loading experiment, and 
d) the average total peptide intensity identified by the G2 and QExactive.  
 
Average number of identified 
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Increased protein loadings analysed by 
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ion trap identified more proteins, although at the higher loadings there is less 
difference in the number of proteins identified between the two instruments, the 
average G2 hits at the top load are 683, and the average QExactive 693. When all 
loadings, run on both instruments, are combined there are 1660 proteins identified, 
and 1008 of these are common to both instruments, 303 unique to the synapt G2 
and 349 unique to the QExactive (figure 5.10 b). The QExactive may have identified 
more at lower loadings because of the ion trap separating ions better, making it 
more likely to identify more proteins by triggering fragmentation of a greater 
number of ions. At higher loadings, it would be expected that more normalisation 
has occurred, the peptides injected would be of a more equal abundance, and 
therefore a wider of range ions are able to be selected for fragmentation in a data 
dependent run and identified by the G2.   The number of peptides identified in each 
loading differs on the two instruments, however, and the G2 returns more peptides 
in total (figure 5.10 c). However, the QExactive returns an increased total peptide 
intensity on average, ranging from 3-6 x1012, in comparison to 3-4 x 108 (figure 5.10 
d). 
 When analysing the total fmol of material identified (figure 5.11 a) there is an 
increasing amount of protein until saturation is reached after approximately 1 
mg/ml. In fact, there is even a slight decrease in the amount of material identified 
by both mass spectrometers at the highest loading in the QExactive data. At all 
loadings there is more material identified by the ion trap mass spectrometer than 
the Q-TOF, despite the similar number of proteins identified. Despite the difference 
in quantity calculated, there is a linear trend in the amount of each protein 
identified between the G2 and QExactive (figure 5.11 b), however this is lessened in 
the higher loadings. The number of proteins identified and the total fmol identified 
show the expected trend across the loading experiments, an increase across the 
successive loads, and little change following the loading at which saturation point is 
achieved. This behaviour is consistent with the idea that each bead will bind a 
specific protein up to capacity, and then any excess will be removed during the 
washing stage. Due to the higher number of identifications, the Q Exactive data will 
be used for the rest of this chapter for comparing the different protein loadings. 
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Figure 5.11 The amount of material identified in the loading experiment 
samples on the G2 and the QExactive 
a) the total amount of material calculated in each CPLL loading when analysed 
by label free quantification using PLGS for the G2 generated data and 
MaxQuant for the QEx generated data, and b) a comparison of the fmol amount 
of the common proteins found in both data sets for each loading.  
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Despite this expected binding pattern there is, again, an increase in the overall 
dynamic range of protein quantifications observed between the normalised 
material at higher loadings and the starting material (figure 5.12 a). However, the 
distribution of proteins within this range differs, and despite the range of protein 
concentrations being wider than the starting material, the distribution does show a 
shallower incline, on account of the additional proteins identified being in the 
middle of the dynamic range. The difference in the dynamic range of proteins is the 
effect of proteins being both increased and decreased in concentration in 
comparison to the starting material (figure 5.12 b). The scatter graphs depict the 
protein concentrations increasing and decreasing in all loadings, and the effect is 
more pronounced in the higher loading, with one protein increasing in 
concentration by over 7000 fmol. 
When the protein binding is investigated on an individual level it indicates that the 
process of equaliser bead normalisation follows the original premise of reducing the 
abundance of some proteins, and increasing others. When the average loading data 
is plotted as a heat map (figure 5.13) it highlights these two effects, some proteins 
bind the beads in increasing amounts at the successively higher loadings, and some 
become less concentrated.  However, in addition to this some appear to bind 
increased amounts at successive loadings, and at later loading decrease. The 
difference in behaviour is indicated by the dual colour system on the heat map, a 
blue colour indicates a decrease in fmol, while red indicates an increase. Some low 
abundance proteins are not detected at all in starting material, but bind the beads 
at successively larger amounts with each loading increase, until a saturation point is 
achieved. This would be the expected behaviour, and examples of this behaviour 
include phosphofructokinase 1 (PFK1p), alpha-ketoglutarate dehydrogenase 1 
(KGD1p) and an ATPase of the HSP70 family (KAR2p) (figure 5.14). 
Other effects are also highlighted, for example some proteins increase in 
concentration at lower loadings, before reaching a maximum and then decreasing 
at higher loads, rather than remaining at saturation level. This may be the result of 
the overloaded proteins competing for specific binding sites as the concentration of  
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Figure 5.12 The quantification for each individual protein 
Label free quantification is achieved by iBAQ processing of QExactive data, and 
a) the average material (in log10 fmol) calculated for each individual protein in 
the loading experiments, arranged in descending order, and b) the change in 
the fmol amount of each protein identified in each loading.  
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Figure 5.13 The average change in fmol of each protein across increasing loadings 
The average fmol of protein in CPLL treated sample was calculated and the starting 
material fmol was subtracted to give the change in amount of each protein. Heat 
map was generated using heirarchical clustering in MeV software. The clusters 
indicate different binding patterns, proteins increasing in quantity across the 
loadings, proteins that reach saturation point at a lower loading, and stay steady at 
successive loadings, and proteins which reduce in concentration at higher loadings.  
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Figure 5.14 Examples of different protein binding patterns across CPLL 
loadings 
CPLL loading experiment digests are run on the QExactive and the amount of 
each protein calculated using MaxQuant. a) - m) examples of individual protein 
behaviours in all three replicates. 
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other proteins also increases. However, some proteins continue to increase in 
concentration throughout the loadings, and bind far in excess of the average 
protein concentration. The average amount of an individual protein identified are 
138, 133, and 127 fmol in the three replicates. The most abundant protein in the 
normalised material, translational elongation factor 1, is present well in excess of 
this average at approximately 7700, 7300, and 5900 fmol in the three replicates. 
The next two top proteins in all three normalised samples are mitochondrial 
aldehyde dehydrogenase (ALD4), and elongation factor 2 (EFT1), which are both 
present at over 2000 fmol. These proteins also appear to be increasing in 
concentration up to the top loading, which indicates that they are binding beyond 
what should be the level of saturation. The vast over-representation of these few 
proteins could be the effect of them having an affinity to more than one specific 
peptide, or the proteins binding each other to form a matrix, with successive layers 
of proteins around a single bead. These are all examples of binding effects of 
proteins that are becoming more concentrated after treatment with the equaliser 
beads, and are showing at least three different binding patterns. 
There is then the opposite effect of the bead library to consider, the proteins which 
are brought down in concentration during the experiment. Here also, there is 
variation in the binding patterns observed. The abundant glycolytic enzymes  
glyceraldehyde-3-phosphate (TDH3) and pyruvate kinase (CDC19), are present in 
both the starting material and the low loadings at high amounts, and the 
concentration decreases over successive loadings (figure 5.14). Since less protein is 
observed after more is introduced to the beads, it indicates the original excess of 
material binding was due to some degree of non specific binding. One possible 
explanation is that these proteins, which are present in high concentrations, are 
binding ligands which may have a higher affinity for other proteins. Therefore, 
when the loading is increased and a greater variety of proteins become available, 
the ligand will preferentially bind another protein, now present at sufficient 
amounts to displace the more abundant protein. 
 With other proteins such as enolase 1 (ENO1p), and triose-phosphate isomerase 
(TPI1p), there is an immediate reduction, the concentration of protein decreases 
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from the first loading and in fact after the 0.1 mg/ml load there is no material 
identified at all. This behaviour may indicate the protein has a very low affinity for 
any of the peptide ligands, so when the availability of other proteins increases, the 
abundant protein is rapidly displaced. Some less abundant proteins, such as 
phosphoenolpyruvate carboxykinase (PCK1p), a HSP70 family ATPase (SSC1p), and 
alcohol dehydrogenase (ADH1p) increase in concentration over the lower loadings, 
but at subsequent loads (above 1 mg), instead of showing a steady concentration to 
indicate they had reached saturation, show a decline in abundance. This could 
indicate there is more competition for binding sites occurring at higher loadings.  
Another possible protein interaction in the CPLL binding is the interaction of 
proteins with each other. The proteins that exist as part of complexes may remain 
part of these assemblies while also binding to the bead library. The 20S proteasome 
subunits all bind the bead library in the same pattern, increasing in concentration 
until the 1 mg/ml load, where saturation is reached, except in replicate three, 
where the quantity of each protein in the 1 mg/ml load is lower than the first two 
replicates (figure 5.15). The same binding effect is observed for the nine subunits of 
the exosome identified in the loading experiment, which also reach saturation 
above a 1 mg/ml total protein load (figure 5.15). The same binding could be seen in 
all of the subunits due to either the proteins all exhibiting the same binding pattern, 
or because the proteins remain part of a complex, or partial complex. Fatty acid 
synthetase is a heterodimeric complex, and both subunits are observed in the 
loading experiment. The two subunits increase in concentration up to a 1 mg/ml 
load, after which the concentration falls (figure 5.16). This binding pattern is also 
seen in two subunits of the ribonucleotide-diphosphate reductase (RNR) complex, 
RNR2 and RNR4, which form a heterodimer (Chabes et al., 2000). The two proteins 
both increase in concentration up to 1 mg/ml, and decrease in subsequent loadings 
(figure 5.16). The fact that the subunits of these two complexes all decrease at 
higher loadings may lend support to the theory that proteins are remaining bound 
to each other while also binding to the CPLL library.   
When the starting material and all three replicates of six loadings are combined, 
there are in total 1360 proteins identified. There is some variation between  
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Figure 5.15 The binding of 20S proteasome complex subunits at increasing 
bead loadings. 
The 14 subunits of the 20S proteasome are quantified by MaxQuant in 
increasing protein loadings on the CPLL aliquots. Nine out of the ten subunits of 
the exosome complex are identified in increasing loadings.  
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RNR complex
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Figure 5.16 The binding of Fatty Acid synthetase and RNR complex subunits 
under increasing loadings 
The heterodimeric fatty acid synthetase complex was quantified by MaxQuant 
in increasing protein loadings on the CPLL aliquots. The two subunits of a 
ribonucleotide-diphosphate reductase subcomplex were identified in increasing 
loadings.  
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replicates, but to a lesser degree than earlier experiments when three separate cell 
lysates were used. Between the three replicates of the highest loading of 
normalised material there was a 72% overlap in protein identifications. However, 
there are still unique proteins found, 18% of proteins identified in the highest load 
of the normalised material are unique to one replicate. In the lowest loading 80% of 
proteins are identified in all three replicates (figure 5.17). As the cell lysate used 
was the same for all three replicates, the variation observed is likely to come from 
the beads. This could be natural variation in the bead aliquot, as each 80 µl aliquot 
of bead slurry may contain a different bead composition, despite repeated mixing. 
Across all of the different loadings each of the 364 proteins identified in the starting 
material was also found in the normalised material. This suggests that the starting 
material proteins which were shown not to bind the beads in section 1.2.2 did so 
due to competing for binding sites, not an inability to bind, and the effect has been 
counteracted by the number of replicates performed in this experiment. 
The variation in binding and the different loading patterns observed indicate that 
the protein-ligand binding is a complex interaction between all of the proteins 
present. The concentration of protein identified is therefore not a true reflection of 
the amount of that particular protein in the cell lysate, but a result of individual 
proteins competing for binding sites that they each have higher or lower affinities 
for. The proteins which are observed to a vast excess in the normalised material 
may then have a structure which provides them with a number of surface binding 
sites, and are therefore capable of binding not only multiple hexapeptide ligands, 
but also possibly other proteins already bound to the beads, resulting in a ‘scaffold’ 
effect of proteins building up in successive layers on the beads.  
The result of the complex binding processes is that is not possible to define the 
saturation point of an individual protein in the beads. Without defining a 
concentration for the saturation of beads with one protein, it is not possible to 
know if all of the protein in a sample has bound to the beads. Therefore it will not 
be possible quantify the less abundant proteins bound to the beads which are 
below saturation level. 
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Figure 5.17 The variation observed in the proteins identified in three 
replicates of CPLL treated sample 
Venn diagrams depicting the variation in the proteins identified in three 
replicates of the lowest CPLL loading (0.05 mg/ml) and the highest loading (10 
mg/ml)  
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5.3.3 Protein normalisation in varying ionic conditions 
 
The next set of equaliser bead experiments was designed to test the binding 
efficiency of the proteins to the ligands under different ionic conditions. There are 
numerous ways the proteins can interact with the bead bound hexapeptide ligands, 
using the same methods as those governing protein folding and protein-protein 
interactions. These include electrostatic forces, hydrogen bonding, hydrophobic 
interactions, and Van der Waals forces. The interactions range in intensity, and will 
differ in strength depending on which exposed amino acid side chains are involved 
in the interaction. Therefore the strength of the protein binding will vary with each 
protein – ligand pair. It was expected that increasing the ionic conditions of the 
environment would affect the protein binding, some electrostatic forces may be 
disrupted, as sodium or chloride ions may interact with the charged areas of the 
amino acids side chains, or the hexapeptide ligands, and any potential hydrophobic 
interactions will be enhanced. 
Sample dilutions were prepared in two different buffers, to a final concentration of 
20 mM sodium phosphate buffer, and 20 mM sodium phosphate, 150 mM sodium 
chloride buffer. The cell lysate was originally prepared in 20 mM sodium phosphate, 
and diluted to 0.2 mg/ml and 20 mg/ml in 20 mM sodium phosphate buffer. Each of 
these was then diluted 1:1 with 20 mM sodium phosphate and 300 mM sodium 
chloride/20 mM sodium phosphate buffers, to a final concentration of 0.1 mg/ml 
and 10 mg/ml. They were then used in equaliser experiments with 80 µl of beads as 
described in section 3.1. The samples were run on the Thermo QExactive.  
The total number of proteins bound to the beads is lower in high ionic conditions in 
all three replicates, 570 proteins identified as opposed to 704 in low ionic 
conditions in replicate 1, 526 compared to 634 in replicate 2, and 498 compared to 
537 in replicate 3 (figure 5.18). The lower number of total proteins identified in high 
ionic conditions indicates that for many proteins, the protein-ligand interaction is 
based on electrostatic interactions, which have been disrupted by the addition of 
salt. The reduction in hits also suggests and there is less propensity for the yeast 
proteins to interact with the beads via hydrophobic interactions, as these would be  
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Figure 5.18 The number of proteins and total material identified in low and 
high ionic strength buffers 
Three replicates of starting material, 0.1 mg/ml load and 10 mg/ml load in low 
and high ionic strength buffers. Samples were digested and run on the 
Qexactive. a)  the number of proteins identified in replicate 1, and b) the total 
fmol of material calculated, c) proteins identified in replicate 2, and d) the total 
material, and e) proteins identified in replicate 3, and f) the total material.  
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increased at the higher ionic strength. However, the total amount of material 
identified is similar or higher in all three instances (figure 5.18), which may indicate 
that those proteins that are able to bind in high ionic conditions are doing so to a 
greater extent. If some proteins bind to a higher extent in the high ionic conditions, 
it may indicate that protein has a propensity for hydrophobic interactions, which 
can be enhanced in the presence of NaCl. There is, in the normalised material in 
each condition, an overlap between the three replicates, with the majority of 
proteins being identified in all three, but also some unique proteins in each (figure 
5.19). 
In all six replicates there is a wide dynamic range of proteins and under both 
conditions the most abundant normalised proteins are found in higher amounts 
than the strongest binding proteins in the starting material. However, in contrast to 
the amount of total material bound, under high ionic strength the most abundant 
proteins identified were less concentrated than in the low salt conditions (figure 
5.20 a). Also, although there was a similar dynamic range identified, when the fmol 
amounts of each protein were plotted (figure 5.20 b, c, d) it showed a shallower 
incline in the low salt conditions, which indicates the proteins undergo more 
normalisation. The most abundant proteins in all three replicates of low salt 
normalised material were translation elongation factor 1 (TEF1), elongation factor 2 
(EFT1) and aldolase 4 (ALD4). TEF1 shows an average increase of 1500% in low ionic 
conditions, and 700% in high ionic conditions, ALD4  1428 % in low ionic conditions, 
and 901% in high, and EFT1 1250% as opposed to 500% in higher ionic conditions 
(figure 5.21).  
In each replicate there were some proteins that were only identified in either 
condition, however, the majority were found in both (figure 5.22 a, b, c), suggesting 
that the majority of protein binding has not been disrupted. Of the normalised 
proteins found in each replicate, 68 %, 61 % and 61 % were common to the low 
ionic buffer normalised material. Between the three replicates of normalised 
material 62.74% of the total proteins identified are common. This suggests that the 
variation between the two conditions is caused by the variability of protein 
normalisation with hexapeptide bead libraries.   
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Figure 5.19 The common proteins identified in CPLL treated samples under 
two ionic strengths  
Venn diagrams depicting the reproducibility of the protein hits identified in all 
three replicates in a) the low ionic strength (20 mM sodium phosphate buffer) 
samples, and b) the high ionic strength (150 mM sodium chloride).  In each 
case, there is a high amount of crossover between the three samples, and there 
are unique proteins identified in the starting material in each replicate.  
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Figure 5.20 The quantification of each protein identified in starting material 
and normalised material at low and high ionic strength 
 a) the quantification of the most abundant proteins (in fmol) found in the cell 
lysate and the normalised material in both high and low ionic strength buffers, 
calculated using MaxQuant and b) the distribution of quantifications for all of 
the proteins identified in replicate 1, c) replicate 2, and d) replicate 3.  
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Figure 5.21. The effect of ionic strength on the most abundant bead bound 
proteins 
The amount of each protein is calculated by label free quantification in 
MaxQuant, and the top three proteins found in the low ionic strength buffer are 
a) translation elongation factor 2, b) elongation factor 1 and c) aldolase 4, 
shown here under both ionic stength conditions.  
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Figure 5.22 Proteins common to bead binding at two different ionic strengths 
a) - c) Venn diagrams showing the common proteins identified between the 
normalised material in low and high ionic strength buffer, in a) replicate 1, b) 
replicate 2, c) replicate 3. d) - f) Scatter diagrams of the log10 fmol amounts of 
common proteins in each conditions plotted against each other in all three 
replicates.  
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A comparison of the behaviour of all of the proteins in both conditions shows that 
the majority exhibited the same behaviour under the two conditions, those that 
increase in concentration did so under both conditions, as shown by the linearity of 
the scatter plot of the fold change in each protein (figure 5.22 d, e, f). However, 
there are some outliers in these scatter plots, showing that there are indeed some 
proteins which exhibit different binding patterns under the two conditions. For 
example, alcohol dehydrogenase isozyme 3 (ADH3), peroxisomal AMP binding 
protein (PCS60), and vacuolar alpha monnosidase (AMS1) are all highly 
concentrated under low ionic conditions, but not higher ionic conditions (figure 
5.23). This indicates that the proteins were interacting with the beads using 
electrostatic interactions at lower ionic conditions, and these have been disrupted 
by the addition of salt. On the other hand, proteins such as ribosomal subunits 
RPL5p, RPL13Bp and RPL10p are all more concentrated in higher ionic conditions 
than low. In fact, of approximately 50 ribosomal proteins identified in the six 
replicates, 98% of ribosomal proteins increase in concentration in higher ionic 
strength buffer in replicate 1, while in replicates 2 and 3 87 % and 80 % increase 
(figure 5.24). This is in comparison to 56 %, 59 % and 70 % of the proteins identified 
overall. An increase in the ability to bind the beads in higher ionic conditions may 
suggest these proteins are binding using hydrophobic interactions, which are 
encouraged in the presence of salt. On the other hand, some of these proteins 
could be binding as part of a sub-complex, or the propensity to form interactions 
may mean these particular proteins have more available interactions with ligands. 
5.4 Conclusions 
 
When considering the concept of the equaliser beads, a library of hexapeptide 
ligands, with a vast amount of variation, able to interact with proteins in a sample 
by any binding method already used by these proteins, it is unsurprising that 
variation is observed in the protein binding. It is this variability in structure, 
interaction, and behaviours which gives rise to the great number of proteins, and 
therefore, the complexity and variability observed in the living cell. There were 
three goals to the series of experiments presented here, accessing low abundance  
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Figure 5.23 Examples of individual protein binding under two ionic strength 
conditions 
Examples of protein quantifications calculated using Maxquant for a) alcohol 
dehydrogenase 3, b) a peroxisomal protein, and c) vacuolar alpha mannosidase, 
under low and high ionic conditions, also d) ribosomal 60s subunit L5, e) 
ribosomal 60s protein L13B, and f) ribosomal protein L10.  
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Figure 5.24 The binding of ribosome proteins in low and high ionic strength 
50 proteins of the 60S ribosome subunit are identified across three replicates of 
starting material, 0.1 mg/mL and 10 mg/mL loads in both low and high ionic 
strength conditions, run on the QExactive and label free quantification 
performed using MaxQuant. 
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proteins, exploring the use of CPLL libraries in the quantification of proteins, and 
assessing the use of the technology for the analysis of protein complexes. 
The results presented here indicate that equaliser bead technology has provided a 
degree of normalisation of yeast cell proteins, increasing the number of proteins 
identified in each experiment. It would be possible to increase the range of proteins 
identified further by including additional experiments, such as altering the pH of the 
binding conditions, or allowing the binding to occur for longer, to promote the 
binding of different proteins using a variety of protein interactions. Using a range of 
experimental conditions, the combinatorial bead library technology could make the 
entire proteome of yeast cell lysate observable in just a few experiments.  
The results presented indicate the binding of proteins to the beads is not as simple 
as originally anticipated at the initial introduction of this technique. These results 
may show that the interaction between a protein and the beads are the result of 
proteins competing for binding sites, which they each have a higher or lower 
affinity for. Unfortunately, this then makes absolute quantification of less abundant 
proteins unlikely using this technology. If the protein-ligand interaction is the result 
of competition with other proteins for a few binding sites, it will not be possible to 
define the point at which a single bead reaches capacity, and to know whether a 
single protein has bound completely, or if some copies of the protein have been 
displaced from other peptide ligands they may interact with more weakly. This 
effect makes the protein binding unpredictable, so although the bead library is 
performing some degree of normalisation, it is not possible to use the beads in 
order to accurately quantify less abundant proteins. 
Interactions between proteins and the bead library can be any of those normally 
found between proteins. Unique proteins are found in each case, highlighting the 
variable nature of protein binding. The variable binding of proteins under different 
ionic conditions suggests that a number of the interactions occurring are 
electrostatic or hydrophobic interactions. 
In addition, it may be possible that the CPLL treatment is binding proteins that 
remain in complexes. It may, therefore, be possible to utilize the technology in the 
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investigation of protein complexes. In order to achieve this it would be necessary to 
prove the proteins are binding as a complex and not because the individual proteins 
have similar binding patterns. This could be achieved by denaturing the complex 
structure prior to CPLL treatment, however this may also affect protein structure, 
and the exposed surface area of the protein. Another method may be to produce 
individual recombinant proteins of all of the subunits from a complex, and spike 
these into a CPLL experiment. This would be a long and costly procedure, but if the 
recombinant proteins were heavy labelled, the binding could be compared to the 
original protein using LC-MS. 
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Chapter 6: General Discussion 
6.1 Summary of approaches 
The aim of this thesis was to explore quantitative proteomics methods for the 
analysis of the S. cerevisiae global proteome with respect to two specific areas, the 
analysis of protein complexes and accessing the less abundant proteins of the 
cellular environment.  Quantitative proteomics techniques were applied to analyse 
the stoichiometry and composition of protein complexes and assist in building a 
complete picture of the protein interactions occurring within the cellular 
environment. A further challenge in the analysis of the proteome was addressed in 
the attempted quantification of the entire dynamic range of the proteome 
simultaneously using a CPLL method. 
The mixed bed ion exchange chromatography method, when used in conjunction 
with label free methodologies, proved to be a successful for the identification of 
protein complexes. This was indicated by the high resolution co-elution of 
numerous proteins known to be part of complexes, as supported by literature. 
Although many protein assemblies that were identified separated at high 
resolution, such as the 20S proteasome or LSm complexes, some assemblies, such 
as the ribosomes, did not. Although there was an improvement in the resolution 
when mixed bed chromatography was used, in comparison to anion exchange 
chromatography, some proteins elute across a wider range of fractions, indicating 
they have a higher affinity for the chromatography medium or more surface area 
positions able to interact with the column. This could have also been an indication 
of the protein having binding partners, which were interacting with the column, and 
therefore the protein was retained for longer. Some individual proteins eluted 
across a range of fractions, for example the HSP70 SSA, which may indicate that it 
was forming a number of interactions. Other proteins have a wide elution profile as 
part of a complex, eluting across a wide range of fractions, such as 
phosphofructokinase or the ribosome subunits. The ribosome proteins did not elute 
as a complete assembly and there were a number of reasons explored for this 
behaviour, such as the dissociation of the assembly or the separation of partially 
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assembled sub-complexes. The dissociation of some weak interactions is a potential 
drawback to the use of ion exchange chromatography, for which a high 
concentration of NaCl is used for protein elution from the column. In the presence 
of these high ionic conditions, it is possible that some electrostatic interactions 
between members of protein complexes will be disrupted. Although other types of 
interaction will be maintained, which was evident by the successful separation of 
some assemblies, it is possible that more interactions could have been preserved 
with the use of a gentler method of chromatography, such as size exclusion.  
In other examples individual proteins are observed in multiple locations in the 
gradient, sometimes in complex with other proteins, such as in the case of zuotin, 
or the nucleosome complex. When elution of proteins in multiple discrete peaks 
was observed a number of explanations were put forward, including possible post 
translational modification causing the same protein to have different affinity for the 
column. Alternatively, it could be an indication of the protein exhibiting interactions 
with other proteins, as in the case of zuotin, which appears to elute in two positions 
through the binding of two different proteins. In the example of the nucleosome, 
the protein complex elutes in two positions, indicating two possible charge variants. 
Therefore, by exploring these elution profiles it is possible to use the combination 
of ion exchange chromatography and bottom up proteomics to discover potential 
interactions exhibited by some proteins. Further work will be necessary to confirm 
the theories presented here behind the multiple peaks. The existence of multiple 
conformations could be confirmed using a second type of chromatography, such as 
SEC or HIC, or by electrophoresis such as BN-PAGE.  
The large sets of data generated here provide an opportunity to explore the 
relationship between proteins using a bioinformatics strategy. A strategy could be 
developed to map the elution of each protein in the data tables, and compare them 
to each other. If strategies can be developed to examine these protein elution 
profiles new protein interactions can be discovered. These techniques could then 
also be used to map any alterations in protein complex composition under varying 
conditions, such as comparing native and nutrient starved conditions, or with the 
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presence of specific protein complex inhibitors. This would provide an efficient 
method of examining dynamic protein interactions.  
The label free quantification strategies used, though applicable for the mapping of 
protein assembly composition, did not prove appropriate for the investigation of 
protein complex stoichiometry. This was demonstrated by the subunits of the 
exosome and 20S proteasome complexes, which are equimolar in stoichiometry, 
but are not calculated as such in the label-free quantification. It is possible that the 
amount of protein is miscalculated in the label free software due to the use of 
poorly ionising peptides, or perhaps well ionising peptides (in comparison to the 
standard peptide ionisation) giving an erroneous indication of the amount of 
protein present. This is supported by the results from two mass spectrometers (one 
QTOF, one Q-orbitrap), processed by different software, which yield similar results. 
Label free quantification strategies rely on the peptides present to infer the 
concentration of the protein. While the number of peptides varies for each protein 
in each replicate, PLGS processed data quantified using the top three most intense 
peptides and the MaxQuant processing used all peptides, the results obtained are 
comparable. This indicates that error in quantification was the result of the higher 
intensity peptides identified, and may mean that those proteins which are 
supposedly less concentrated have fewer proteotypic peptides, or the peptide 
could be undergoing some type of PTM. The inherent variability in the 
physicochemical properties of peptides are a disadvantage associated with label-
free methods and label mediated strategies could offer an advantage in this 
respect, by using a standard peptide that is chemically identical to the analyte. The 
theory that label mediated quantification would provide a more accurate measure 
of complex subunit stoichiometry was therefore investigated using a label mediated 
strategy to assess the quantification of some protein complex subunits.  
The design of QconCAT proteins for the quantification of protein complex subunits 
proved to be challenging. In order to maximise the prospect of accurate 
quantification results, it was necessary to choose optimal Qpeptides, applying a 
series of filters that resulted in a number of peptides being unusable. Despite the 
procedures followed in filtering unsuitable peptides, a number of the Qpeptides 
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included proved sub-optimal for quantification in these experiments. Some of 
these, such as those that were potentially deamidated, could be used in future 
quantification experiments if both the modified and unmodified forms are included 
in the analysis.  
It was perhaps surprising that despite the advantages to using a label mediated 
method of quantification, there was little to no improvement observed in the 
analysis of protein complex stoichiometry. In some cases this was attributed to the 
use of poor peptides, and for some proteins the quantification relied on the result 
of just one peptide, when the aim was to use two. If two peptides were available 
for each protein the data may have been more reliable, and the results could 
therefore have been improved by using more Qpeptides, perhaps three per protein, 
to increase the likelihood of multiple peptides being observed. The accuracy of the 
experiment performed could have also been improved if a number of steps had 
been taken. The poor labelling of the QconCAT could have been eliminated given 
time to repeat the expression, and the quantification of the QconCAT itself could 
have been improved, for YEW1, if the sequence was redesigned to remove the 
miscleavege at the glufibrinopeptide sequence. However, the accurate 
quantification of the QconCAT would have improved the accuracy of each protein, 
though not relative to each other, so the stoichiometry would be unchanged. The 
accuracy of the QconCAT quantification could also have been improved if a co-
digest of the QconCAT and the fraction had been performed. This is the 
recommended method, and would have been particularly advantageous here, as 
the Qpeptides were used in the original sequence context. Due to the design of the 
experiment, which included label free analysis to detect the location of protein 
complexes in the IEX fractions, a co-digest was not performed. However, this could 
have been achieved if the fraction was aliquoted into two, with one half used in 
label free analysis and the other available for label mediated quantification. 
The conclusion of these experiments is therefore that the quantitative proteomics 
techniques used here are adequate for the analysis of protein complex 
composition, though not for the accurate analysis of subunit stoichiometry. There 
are a number of areas where there is scope to improve the QconCAT experiments 
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used here, which may allow accurate quantification, however the drawbacks of this 
technique could, in future, be avoided with the use of a PSAQ strategy. PSAQ has 
the advantage of allowing the study of all of the peptides from the parent protein in 
their native conditions. This may overcome the issues observed here of standard 
and analyte peptides performing differently under experimental conditions. 
Although the accuracy of the results is questioned, the QconCAT mediated 
quantification does provide confirmation of the identification of proteins provided 
by the label-free data, for example in the case of the EIF2 complex subunit SUI3 the 
data confirms the presence of a subunit in a second location.    
With regards to the second area of proteome analysis covered here, accessing low 
abundance proteins, there was an advantage to using CPLL technology for the 
reduction of the dynamic range. This is indicated by the additional proteins 
identified in S. cerevisiae cell lysate treated with beads. The loading experiments 
highlighted the dynamic range reduction, as some proteins increase in 
concentration, while others decreased. However, the actual binding to the beads 
appears to be more complicated, and it is possible that some competition for 
binding sites is occurring, as evident by proteins that increase in concentration in 
early loading, and decrease in later loadings, rather than the expected outcome of 
reaching a saturation point. The effect of the CPLL treatment was not as 
straightforward as expected, however, as rather than reach a saturation point, 
some of the proteins also increased in concentration far in excess of others. There 
are a number of reasons discussed for this, including additional affinity for the 
ligands, or interaction with other proteins already bound to the beads. The 
combination of proteins that are reduced in concentration after an initial increase 
in binding and the excessive increase in others means that it is not possible to 
calculate the saturation level of an individual protein.  Being unable to reliably 
detect the saturation point of the proteins on the beads means it is not possible to 
use the CPLL technology in quantitative analysis of proteins. 
Further analysis of the binding efficiency to the beads under different ionic 
conditions indicates that a number of proteins interact with the bead library using 
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electrostatic interactions. Despite this, some proteins are present in excessive 
amounts in the higher ionic conditions, indicating a propensity for hydrophobic 
interactions, either with the peptide ligands or other bead-bound proteins. This 
highlights the range of interactions possible between proteins and the CPLL, and 
unique proteins were identified in each condition. An additional level of analysis 
could have been performed in assessing the binding of S. cerevisiae proteins in the 
presence of varying pH buffers, which can extend the number of proteins identified 
by CPLL capture. This experiment would have provided an interesting addition to 
this thesis, in further investigating the contribution of electrostatic interactions in 
protein-ligand binding. 
Although the CPLL experiments fall short of the original goal to analyse the entire 
dynamic range of the proteome simultaneously, they do provide a means to access 
an additional set of proteins that are not originally found in the starting material. 
The investigation of protein binding under different ionic conditions also allows the 
identification of different subsets of proteins. Combined with an additional series of 
experiments spanning a pH range, the CPLL technology may potentially provide a 
method of accessing the entire dynamic range of the S. cerevisiae proteome.  
However, this would be in a series of experiments, spanning a range of protein 
loadings and buffer conditions, adding time and complexity to the analysis. 
6.2 Key conclusions 
 Mixed bed IEX followed by LC-MS provides an effective method for studying 
protein interactions 
 Employing a bioinformatics  strategy for examining the results will provide 
an efficient method of monitoring protein interactions and changes in 
protein complex composition 
 A QconCAT approach to study protein complex stoichiometry was not 
successful, and in this instance PSAQ may have been a more appropriate 
method 
 CPLL libraries provide an effective approach for accessing low abundance 
proteins in the S.cerevisiae proteome. 
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 Given perfect digest conditions, it may be possible, but challenging, to use 
CPLL libraries  quantifiably 
6.3 Future perspectives 
The overall aims of this thesis, the investigation of the application of quantitative 
proteomics strategies in the analysis of the proteome of S. cerevisiae, have been 
partially achieved. However with the method adjustments suggested they may be 
achievable. The combination of IEX, LC-MS and an SRM method provides an 
efficient workflow for the separation, identification and quantification of protein 
complexes. The texhnique has generated large data sets which, if examined using 
bioinformatics techniques, could give information on new protein relationships and 
provide a method of monitoring protein complexes under varying conditions. With 
some improvements to the QconCAT method used, absolute quantification of 
protein complex subunits could be possible. This would provide an efficient, high 
throughput method for studying protein interactions and assembling a complete 
picture of the proteome. With regards to accessing low abundance proteins using 
CPLL technology, it is evident that the protein-ligand binding is a complex 
procedure, involving a number of interaction types and efficiencies. This makes the 
estimation of protein saturation level, and therefore protein quantification, difficult 
to reliably estimate. However, the identification of the lower abundance subunits 
using CPLL technology could be combined with a targeted SRM approach for the 
later quantification of these subunits. However, improvements in mass 
spectrometry are reaching further into the proteome than ever, quantifying 
thousands of proteins in single experiments. It may therefore be possible to 
quantify an entire proteome without pre-fractionation in the near future.    
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